TOXICOLOGICAL PROFILE FOR 

2,4,6-TRINITROTOLUENE 

U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES
 

Public Health Service
 

Agency for Toxic Substances and Disease Registry 

June 1995 
2,4,6-TRINITROTOLUENE ii 

DISCLAIMER 

The use of company or product name(s) is for identification only and does not imply endorsement by 

the Agency for Toxic Substances and Disease Registry. 
2,4,6-TRINITROTOLUENE iii 

UPDATE STATEMENT 

Toxicological profiles are revised and republished as necessary, but no less than once every three 

years. For information regarding the update status of previously released profiles, contact ATSDR at: 

Agency for Toxic Substances and Disease Registry
 

Division of Toxicology/Toxicology Information Branch
 

1600 Clifton Road NE, E-29
 

Atlanta, Georgia 30333
 















2,4,6-TRINITROTOLUENE 1 

1. PUBLIC HEALTH STATEMENT
 

This Statement was prepared to give you information about 2,4,6-trinitrotoluene and to 

emphasize the human health effects that may result from exposure to it. The Environmental 

Protection Agency (EPA) has identified 1,397 sites on its National Priorities List (NPL). 

2,4,6-Trinitrotoluene has been found in at least 20 of these sites. However, we do not know 

how many of the 1,397 NPL sites have been evaluated for 2,4,6-trinitrotoluene. As EPA 

evaluates more sites, the number of sites at which 2,4,6-trinitrotoluene is found may change. 

This information is important for you to know because 2,4,6-trinitrotoluene may cause 

harmful health effects and because these sites are potential or actual sources of human 

exposure to 2,4,6-trinitrotoluene. 

When a chemical is released from a large area, such as an industrial plant, or from a 

container, such as a drum or bottle, it enters the environment as a chemical emission. This 

emission, which is also called a release, does not always lead to exposure. You can be 

exposed to a chemical only when you come into contact with the chemical. You may be 

exposed to it in the environment by breathing, eating, or drinking substances containing the 

chemical or from skin contact with it. 

If you are exposed to a hazardous chemical such as 2,4,6-trinitrotoluene, several factors will 

determine whether harmful health effects will occur and what the type and severity of those 

health effects will be. These factors include the dose (how much), the duration (how long), 

the route or pathway by which you are exposed (breathing, eating, drinking, or skin contact), 

the other chemicals to which you are exposed, and your individual characteristics such as age, 

sex, nutritional status, family traits, life-style, and state of health. 
 

2,4,6-TRINITROTOLUENE 2 

1. PUBLIC HEALTH STATEMENT 

1.1 WHAT IS 2,4,6-TRINITROTOLUENE? 

2,4,6-Trinitrotoluene is a yellow, odorless, solid manufactured compound that does not occur 

naturally in the environment. It is made by combining toluene with a mixture of nitric acid 

and sulfuric acid. 2,4,6-Trinitrotoluene is also known by other names such as symtrinitrotoluene, 

TNT, and 1 -methyl-2,4,6-trinitrobenzene. 2,4,6-Trinitrotoluene is produced in 

the United States only at military arsenals. It is not produced commercially. 2,4,6-Trinitrotoluene 

is an explosive used in military shells, bombs, and grenades, in industrial uses, and in 

underwater blasting. For more information on the chemical and physical properties of 

2,4,6-trinitrotoluene, see Chapter 3. For more information on its production and use, see 

Chapter 4. 

1.2 WHAT HAPPENS TO 2,4,6-TRINITROTOLUENE WHEN IT ENTERS THE

 ENVIRONMENT? 

2,4,6-Trinitrotoluene enters the environment in waste waters and solid wastes resulting from 

the manufacture of the compound, the processing and destruction of bombs and grenades, and 

the recycling of explosives. The compound moves in surface water and through soils to 

groundwater. In surface water, 2,4,6-trinitrotoluene is rapidly broken down into other 

chemical compounds by sunlight. Microorganisms in water and sediment break down the 

compound more slowly. Small amounts of 2,4,6-trinitrotoluene can accumulate in fish and 

plants. For more information on what happens to 2,4,6-trinitrotoluene when it enters the 

environment, see Chapter 5. 

1.3 HOW MIGHT I BE EXPOSED TO 2,4,6-TRINITROTOLUENE? 

You may be exposed to 2,4,6-trinitrotoluene as a result of its movement from chemical waste 

disposal sites to drinking water. Children may also be exposed through eating contaminated 

soil. Most exposure would result from drinking contaminated water, breathing contaminated 
 

2,4,6-TRINITROTOLUENE 3 

1. PUBLIC HEALTH STATEMENT 

air, or eating contaminated foods such as fruits and vegetables. 2,4,6-Trinitrotoluene has been 

measured at waste disposal sites in groundwater at 0.32 parts of 2,4,6-trinitrotoluene per 

million parts of water (ppm) and in soil at up to 13,000 ppm. We have no data on levels in 

air or foods. 2,4,6-Trinitrotoluene can be taken up by plants from contaminated soil and is 

probably present in the air as a result of disposal by burning at military sites. Therefore, 

intake of air and homegrown fruits and vegetables by people living near military sites may 

also be sources of exposure to 2,4,6-trinitrotoluene. 

Worker exposure to 2,4,6-trinitrotoluene is possible as a result of its use in the production of 

bombs and grenades. Most workplace exposure results from breathing in 2,4,6-trinitrotoluene 

dust or vapor and contact with dust on the skin. For additional information on how you can 

be exposed to 2,4,6-trinitrotoluene, see Chapter 5. 

1.4 HOW CAN 2,4,6-TRINITROTOLUENE ENTER AND LEAVE MY BODY? 

2,4,6-Trinitrotoluene rapidly and completely enters your body when you breathe in air or 

drink water that is contaminated with this chemical. We have no information on how much 

2,4,6-trinitrotoluene enters your body when it gets on your skin. We do know that it enters 

your body more slowly through the skin than when it is taken into your mouth. 

2,4,6-Trinitrotoluene in your blood travels throughout your body to all of your organs. When 

2,4,6-trinitrotoluene reaches your liver, it breaks down and changes into several different 

substances. Not all of these substances have been identified, and we do not know whether 

they are harmful or not. Most of these substances travel in your blood until they reach your 

kidneys and then leave your body in your urine. Studies in animals show that almost all of 

the 2,4,6-trinitrotoluene that enters the body breaks down and leaves the body in the urine 

within 24 hours. Chapter 2 contains more information on how 2,4,6-trinitrotoluene enters and 

leaves your body. 
 

2,4,6-TRINITROTOLUENE 4 

1. PUBLIC HEALTH STATEMENT 

1.5 HOW CAN 2,4,6-TRINITROTOLUENE AFFECT MY HEALTH? 

Workers involved in the production of high explosives experienced many harmful health 

effects as a result of exposure to 2,4,6-trinitrotoluene at their jobs. These effects included 

disorders of the blood, such as anemia, and abnormal liver function. However, the levels of 

2,4,6-trinitrotoluene in the workplace air at the time these effects were seen ranged from less 

than 0.01 to 1.49 milligrams of 2,4,6-trinitrotoluene per cubic meter of air (mg/m3). Some of 

the concentrations measured are higher than the level currently allowed in the workplace 

(0.5 mg/m3). Similar effects on the blood and the liver have been observed in animals that 

either breathed or were fed 2,4,6-trinitrotoluene. In addition, studies show that animals forcefed 

2,4,6-trinitrotoluene for an intermediate-duration (from 15-364 days) may have 

enlargement of the spleen and other harmful effects on the immune system. When people 

have prolonged skin contact with 2,4,6-trinitrotoluene, they may develop an allergic reaction 

of the skin to this chemical, such as itching and irritation. In addition, long-term exposure to 

2,4,6-trinitrotoluene has been associated with the development of cataracts in people. 

No information is available to indicate whether 2,4,6-trinitrotoluene causes birth defects. 

However, studies in animals that were treated with high doses of 2,4,6-trinitrotoluene have 

shown that it can cause serious effects on the male reproductive system. The available 

information for determining whether 2,4,6-trinitrotoluene causes cancer in humans is 

inadequate. However, rats that ate 2,4,6-trinitrotoluene for long periods developed tumors of 

the urinary bladder. Based on this study with rats, EPA has classified 2,4,6-trinitrotoluene in 

Group C, a possible human carcinogen. 
 

2,4,6-TRINITROTOLUENE 5 

1. PUBLIC HEALTH STATEMENT 

1.6 IS THERE A MEDICAL TEST TO DETERMINE WHETHER I HAVE BEEN

 EXPOSED TO 2,4,6-TRINITROTOLUENE? 

There are tests to determine if you have been exposed to 2,4,6-trinitrotoluene. These tests 

measure 2,4,6-trinitrotoluene or its breakdown products in your blood and urine and have 

been used to test exposed workers. Detection of the breakdown products in your urine is a 

clear indication that you have been exposed. The complex and expensive equipment needed 

to perform these tests is generally available only at specialized laboratories. Another simpler, 

but less specific, test of 2,4,6-trinitrotoluene exposure is a change in the color of your urine to 

amber or deep red. This change results from the presence of breakdown products and may 

indicate that you have been exposed to 2,4,6-trinitrotoluene. None of these tests can predict 

whether a person exposed to 2,4,6-trinitrotoluene will experience any health effects related to 

the exposure. For more information on tests for exposure, see Chapters 2 and 6. 

1.7 WHAT RECOMMENDATIONS HAS THE FEDERAL GOVERNMENT MADE TO

 PROTECT HUMAN HEALTH? 

The government has developed regulations and guidelines for 2,4,6-trinitrotoluene. These are 

designed to protect the public and workers exposed to 2,4,6-trinitrotoluene from potential 

harmful health effects of the chemical. Since 2,4,6-trinitrotoluene is explosive, flammable, 

and toxic, EPA has designated it as a hazardous waste. The Department of Transportation 

(DOT) regulates the transport of 2,4,6-trinitrotoluene because it is a hazardous material. DOT 

specifies that when 2,4,6-trinitrotoluene is shipped, it must be wet with at least 10% water (by 

weight) and it must be clearly labeled as a flammable solid (HSDB 1994). 

The Occupational Safety and Health Administration (OSHA) regulates levels of hazardous 

materials in the workplace. The maximum allowable amount of 2,4,6-trinitrotoluene in 

workroom air during an 8-hour workday, 40-hour workweek, is 0.5 mg/m3

. The National 

Institute for Occupational Safety and Health (NIOSH) recommends that the concentration in 
 

2,4,6-TRINITROTOLUENE 6 

1. PUBLIC HEALTH STATEMENT 

workroom air be limited to 0.5 mg/m3 for up to a 10-hour workday during a 40-hour 

workweek (NIOSH 1992). For more information on federal regulations about 2,4,6­

trinitrotoluene, see Chapter 7. 

1.8 WHERE CAN I GET MORE INFORMATION? 

If you have any more questions or concerns, please contact your community or state health or 

environmental quality department or: 

Agency for Toxic Substances and Disease Registry 

Division of Toxicology 

1600 Clifton Road NE, Mailstop E-29 

Atlanta, Georgia 30333 

This agency can also tell you where to find the nearest occupational and environmental health 

clinic. These clinics specialize in the recognition, evaluation, and treatment of illnesses 

resulting from exposure to hazardous substances. 
2,4,6-TRINITROTOLUENE 7 

2. HEALTH EFFECTS 

2.1 INTRODUCTION 

The primary purpose of this chapter is to provide public health officials, physicians, toxicologists, and 

other interested individuals and groups with an overall perspective of the toxicology of 

2,4,6-trinitrotoluene and a depiction of significant exposure levels associated with various adverse 

health effects. It contains descriptions and evaluations of studies and presents levels of significant 

exposure for 2,4,6-trinitrotoluene based on toxicological studies and epidemiological investigations. 

2.2 DISCUSSION OF HEALTH EFFECTS BY ROUTE OF EXPOSURE 

To help public health professionals and others address the needs of persons living or working near 

hazardous waste sites, the information in this section is organized first by route of exposure -­

inhalation, oral, and dermal; and then by health effect -- death, systemic, immunological, neurological, 

reproductive, developmental, genotoxic, and carcinogenic effects. These data are discussed in terms of 

three exposure periods -- acute (14 days or less), intermediate (15-364 days), and chronic (365 days 

or more). 

Levels of significant exposure for each route and duration are presented in tables and illustrated in 

figures. The points in the figures showing no-observed-adverse-effect levels (NOAELs) or 

lowestobserved-adverse-effect levels (LOAELs) reflect the actual doses (levels of exposure) used in the 

studies. LOAELs have been classified into “less serious” or “serious” effects. “Serious” effects are 

those that evoke failure in a biological system and can lead to morbidity or mortality (e.g., acute 

respiratory distress or death). “Less serious” effects are those that are not expected to cause significant 

dysfunction or death, or those whose significance to the organism is not entirely clear. ATSDR 

acknowledges that a considerable amount of judgment may be required in establishing whether an end 

point should be classified as a NOAEL, “less serious” LOAEL, or “serious” LOAEL, and that in some 

cases, there will be insufficient data to decide whether the effect is indicative of significant 
2,4,6-TRINITROTOLUENE 8 

2. HEALTH EFFECTS 

dysfunction. However, the Agency has established guidelines and policies that are used to classify 

these end points. ATSDR believes that there is sufficient merit in this approach to warrant an attempt 

at distinguishing between “less serious” and “serious” effects. The distinction between “less serious” 

effects and “serious” effects is considered to be important because it helps the users of the profiles to 

identify levels of exposure at which major health effects start to appear. LOAELs or NOAELs should 

also help in determining whether or not the effects vary with dose and/or duration, and place into 

perspective the possible significance of these effects to human health. 

The significance of the exposure levels shown in the Levels of Significant Exposure (LSE) tables and 

figures may differ depending on the user’s perspective. Public health officials and others concerned 

with appropriate actions to take at hazardous waste sites may want information on levels of exposure 

associated with more subtle effects in humans or animals or exposure levels below which no adverse 

effects have been observed. Estimates of levels posing minimal risk to humans (Minimal Risk Levels 

or MRLs) may be of interest to health professionals and citizens alike. 

Levels of exposure associated with carcinogenic effects (Cancer Effect Levels, CELs) of 2,4,6­

trinitrotoluene are indicated in Table 2- 1 and Figure 2- 1. 

Estimates of exposure levels posing minimal risk to humans (Minimal Risk Levels or MRLs) have 

been made for 2,4,6-trinitrotoluene. An MRL is defined as an estimate of daily human exposure to a 

substance that is likely to be without an appreciable risk of adverse effects (noncarcinogenic) over a 

specified duration of exposure. MRLs are derived when reliable and sufficient data exist to identify 

the target organ(s) of effect or the most sensitive health effect(s) for a specific duration within a given 

route of exposure. MRLs are based on noncancerous health effects only and do not consider 

carcinogenic effects. MRLs can be derived for acute, intermediate, and chronic duration exposures for 

inhalation and oral routes. Appropriate methodology does not exist to develop MRLs for dermal 

exposure. 
2,4,6-TRINITROTOLUENE 9 

2. HEALTH EFFECTS 

Although methods have been established to derive these levels (Barnes and Dourson 1988; EPA 1990), 

uncertainties are associated with these techniques. Furthermore, ATSDR acknowledges additional 

uncertainties inherent in the application of the procedures to derive less than lifetime MRLs. As an 

example, acute inhalation MRLs may not be protective for health effects that are delayed in 

development or are acquired following repeated acute insults, such as hypersensitivity reactions, 

asthma, or chronic bronchitis. As these kinds of health effects data become available and methods to 

assess levels of significant human exposure improve, these MRLs will be revised. 

A User’s Guide has been provided at the end of this profile (see Appendix A). This guide should aid 

in the interpretation of the tables and figures for Levels of Significant Exposure and the MRLs. 

2,4,6-Trinitrotoluene is the most widely used military high explosive. 2,4,6-Trinitrotoluene has been 

used extensively in the manufacture of explosives since the beginning of this century. Its use greatly 

increased during World War I when its toxicity was first observed (Hathaway 1985). Based on data 

from a number of epidemiological studies of exposed workers, numerous adverse health effects such as 

anemia (reduced number of red blood cells and reduced hemoglobin and hematocrit), Iiver function 

abnormalities, respiratory complications, and possibly aplastic anemia have been observed at 

2,4,6-trinitrotoluene exposure levels below the former standard of 1.5 mg/m3 (Hathaway 1977). 

Because of the seriousness of effects caused by exposure to relatively low levels of 

2,4,6-trinitrotoluene in the workplace, the threshold limit value (TLV) was lowered to 0.5 mg/m3 

(ACGIH 1993). 

As more information became available, and especially after World War II, the incidence of toxic 

effects associated with handling of 2,4,6-trinitrotoluene decreased sharply. This decrease is primarily 

the result of the introduction of protective measures for ammunition workers (e.g., protective clothing, 

change of contaminated clothes, use of indicator soap, and mandatory bathing) and the improvement of 

ammunition plant ventilation systems (Army 1978a; Goodwin 1972). 
2,4,6-TRINITROTOLUENE 10 

2. HEALTH EFFECTS 

2.2.1 Inhalation Exposure 

All the studies presented in the section on inhalation exposure are epidemiological reports or case 

reports of occupational exposure. In some of the studies, inhalation exposure may have occurred 

simultaneously with dermal exposure. Therefore, some of the effects described in this section may be 

due in part to dermal exposure to 2,4,6-trinitrotoluene. Furthermore, in several studies the precise 

levels of exposure are not known. Consequently, results from those studies are not presented in a 

table or figure. 

2.2.1.1 Death 

Historically, the greatest number of deaths among munitions workers were caused by adverse effects 

of 2,4,6-trinitrotoluene on the liver. Initial clinical symptoms included nausea, vomiting, pain in the 

abdomen, fatigue, dizziness, petechiae, and jaundice. Exposure to 2,4,6-trinitrotoluene eventually led 

to 475 deaths in the United States during World War I (McConnell and Flinn 1946). It is important to 

note, however, that the route of exposure was probably not exclusively inhalation, but also dermal. 

No studies were located regarding death in animals after inhalation exposure to 2,4,6-trinitrotoluene. 

2.2.1.2 Systemic Effects 

No studies were located regarding cardiovascular, gastrointestinal, musculoskeletal, or renal effects in 

humans or animals after inhalation exposure to 2,4,6-trinitrotoluene. 

Respiratory Effects. Extremely limited information is available regarding respiratory effects in 

humans after inhalation exposure to 2,4,6-trinitrotoluene. One study of occupational exposure (Morton 

et al. 1976) reported several cases of respiratory difficulties in ammunition plant workers who were 

exposed to 2,4,6-trinitrotoluene in the air at a level that was well above the current TLV of 0.5 mg/m3 

(ACGIH 1993). However, there are several serious limitations to this study. The report does not state 

the exact air concentration of 2,4,6-trinitrotoluene, the duration of exposure, or the number of exposed 
2,4,6-TRINITFIOTOLUENE 11 

2. HEALTH EFFECTS 

workers with respiratory difficulties. It also does not specify the nature of those difficulties. The air 

concentration of 2,4,6-trinitrotoluene in the same plant was brought down to 0.3 mg/m3 within a 

month, but there is no information on whether the respiratory difficulties disappeared or persisted in 

the affected workers (Morton et al. 1976). 

No studies were located regarding respiratory effects in animals after inhalation exposure to 

2,4,6-trinitrotoluene. 

Hematological Effects. In England during World War I, there were numerous cases of anemia and 

some reports of fatal aplastic anemia among workers using 2,4,6-trinitrotoluene in the production of 

explosives (Hathaway 1985). Similar experiences were seen in other countries involved in the war. 

However, with the improvement of protective measures used during the manufacturing process, the 

number of cases of 2,4,6-trinitrotoluene toxicity has decreased dramatically. The results of 2,4,6­

trinitrotoluene exposure on hemoglobin, hematocrit, and reticulocyte numbers are well documented. A 

dose-response relationship between 2,4,6-trinitrotoluene exposure and effects on the hematologic 

system was found in 626 workers exposed to 2,4,6-trinitrotoluene when they were compared with 

865 nonexposed controls. Tests were taken over a 6-week period. However, the actual duration of the 

workers’ exposures was not specified (Army 1976). The 2,4,6-trinitrotoluene estimated mean exposure 

levels ranged from <0.01 to 1.49 mg/m3

; this range includes exposures higher than the present TLV of 

0.5 mg/m3 (ACGIH 1993). Dose-related reductions in hemoglobin (9.9% lower than control) and 

hematocrit (11.6% lower that controls) and 50% higher reticulocyte counts were noted in exposed 

workers (Army 1976). 

No abnormal values for hemoglobin were found in 43 workers employed in the manufacture of 

2,4,6-trinitrotoluene who were monitored over a period of 5 months (Morton et al. 1976). During that 

time the air levels of 2,4,6-trinitrotoluene rose from 0.3 to 0.8 mg/m3

. This finding is indirectly 

supported by another occupational exposure study. Activities of two mitochondrial enzymes, 

δaminolevulinic acid synthase and heme synthase, were measured in reticulocytes in a chronic 

occupational exposure study of workers who developed cataracts (Savolainen et al. 1985). Mean 

2,4,6-trinitrotoluene concentrations were 0-35 mg/m3

. Although the levels of the two enzymes were 
2,4,6-TRINITROTOLUENE 12 

2. HEALTH EFFECTS 

lower in the exposed workers, none of them had clinical anemia. This finding indicates that 

2,4,6-trinitrotoluene may not affect hemoglobin synthesis in the bone marrow and that possible effects 

on reticulocytes may occur in the circulation after the oxygenation of cells in the lungs has taken 

place. 

Hyperplasia of the bone marrow is the first reaction of the hematopoietic system to 2,4,6-trinitrotoluene 

poisoning. The shaft of the femur and the ribs are usually filled with active red marrow. If 

the exposure to 2,4,6-trinitrotoluene continues, the bone marrow becomes hypocellular (Army 1978a). 

No studies were located regarding hematological effects in animals after inhalation exposure to 

2,4,6-trinitrotoluene. 

Hepatic Effects. Toxic hepatitis has been the principal manifestation of 2,4,6-trinitrotoluene toxicity 

in humans (Army 1978a). During World War I, 2,4,6-trinitrotoluene production increased and many 

cases of toxic hepatitis were fatal (Army 1978a). Industrial hygiene techniques improved by World 

War II; consequently, both the number of toxic hepatitis cases and the number of fatalities due to 

2,4,6-trinitrotoluene exposure decreased dramatically (Army 1978a). 

A statistically significant increase in hepatic enzymes (serum glutamic-oxaloacetic transaminase 

[SGOT] and lactic dehydrogenase [LDH]) was noted in ammunition plant workers when the 

2,4,6-trinitrotoluene level in the air increased from 0.3 to 0.8 mg/m3 (during a 4-month period) at the 

same time that 2,4,6-trinitrotoluene production increased from 80% to 100% (Morton et al. 1976). 

Both these 2,4,6-trinitrotoluene air levels were close to the TLV of 0.5 mg/m3

 (ACGIH 1993). The 

SGOT increase was 20% above the maximal normal value (Morton et al. 1976). In the same group of 

workers, the LDH values increased from about 51 units to over 106, but since isoenzyme studies were 

not performed, it is difficult to say if this increase was due to liver toxicity or to hemolysis 

(hemoglobin levels decreased only slightly-see Hematological Effects above and Morten et al. 1976). 
2,4,6-TRINITROTOLUENE 13 

2. HEALTH EFFECTS 

No significant differences in liver function were noted in a cross-sectional epidemiology study of 

626 munitions workers from four plants exposed to 2,4,6-ttinitrotoluene when compared to 

865 nonexposed controls (Army 1976). The majority of the workers were exposed to 0.5 mg/m3

 or 

less of 2,4,6-trinitrotoluene, and a few were exposed to 1.5 mg/m3. No changes were noted in the 

other liver parameters evaluated in the study: LDH, bilirubin (total and direct), alkaline phosphatase, 

SGOT, and serum glutamic-pyruvic transaminase (SGPT) (Army 1976). One possible explanation for 

these findings is that exposure to 2,4,6-trinitrotoluene causes more liver toxicity in potentially 

susceptible workers, and that in some cases of long-term exposure, liver cells may adapt to moderate 

exposure levels (Hathaway 1985). A case-control study of Chinese workers exposed to 2,4,6­

trinitrotoluene indicates that the likelihood of liver injury is increased among those workers who are 

heavy drinkers as compared to workers who are not heavy drinkers (Li et al. 1991). However, the 

parameters measured to arrive at the diagnosis of liver damage in these cases are not discussed. 

No studies were located regarding hepatic effects in animals after inhalation exposure to 2,4,6­

trinitrotoluene. 

Dermal Effects. In an occupational exposure study, several of the workers handling 2,4,6-trinitrotoluene 

in an ammunition plant complained of dermatitis (Morton et al. 1976). Inhalation seemed to 

be the major route of exposure, although dermal exposure was possible. Therefore, the dermatitis 

cannot be attributed to either a local or a systemic effect with certainty. In addition, the study did not 

report the precise number of affected workers or the duration and level of exposure. 

No studies were located regarding dermal effects in animals after inhalation exposure to 2,4,6­

trinitrotoluene. 

Ocular Effects. The appearance of cataracts is believed to be an effect of 2,4,6-trinitrotoluene 

exposure (Hathaway 1985; Savolainen et al. 1985) and is often associated with chronic exposures. 

Irreversible equatorial lens opacities/cataracts were reported in 6 out of 12 Finnish workers exposed to 

2,4,6-trinitrotoluene for an average of 6.8 years (2.1-11.5 years of exposure) (Harkonen et al. 1983). 

The principal routes of exposure were probably inhalation and dermal, although this is not clearly 
2,4,6-TRINITROTOLUENE 14 

2. HEALTH EFFECTS 

indicated in the report. Therefore, it is uncertain whether cataracts are a local or a systemic effect of 

2,4,6-trinitrotoluene exposure. The opacities were detectable only on the periphery of the lens and 

appeared either continuous or discontinuous. The opacities of the lens were bilateral and symmetrical 

and did not affect visual fields or visual acuity. The workroom 2,4,6-trinitrotoluene air concentration 

was about 0.3 mg/m3 with a range of 0.14-0.58 mg/m3 (Harkonen et al. 1983). The progression of the 

cataract stops if the exposure to 2,4,6-trinitrotoluene stops. The mechanism of 2,4,6-trinitrotoluene 

cataract formation is not understood, but the possibility was raised that free radicals may play a role 

(Harkonen et al. 1983). 

No studies were located regarding ocular effects in animals after inhalation exposure to 2,4,6­

trinitrotoluene. 

2.2.1.3 Immunological and Lymphoreticular Effects 

No studies were located regarding immunological or lymphoreticular effects in humans or animals 

after inhalation exposure to 2,4,6-trinitrotoluene. 

2.2.1.4 Neurological Effects 

Very limited information is available regarding neurological effects in humans following inhalation 

exposure to 2,4,6-trinitrotoluene. Several workers who handled 2,4,6-trinitrotoluene in an ammunition 

plant reported altered taste, but no quantitative data are provided in the study (Morton et al. 1976). 

The concentration of 2,4,6-trinitrotoluene in the air was 0.3 mg/m3

, which was below the TLV of 

0.5 mg/m3 (ACGIH 1993). However, no details were provided on the exposure time or symptoms, so 

it is difficult to estimate the extent of the effect. 

No studies were located regarding neurological effects in animals following inhalation exposure to 

2,4,6-trinitrotoluene. 
2,4,6-TRINITROTOLUENE 15 

2. HEALTH EFFECTS 

2.2.1.5 Reproductive Effects 

A case-control study in two 2,4,6-trinitrotoluene plants in China indicated that 50 of the 104 workers 

that were examined for possible effects on semen had significantly lower semen volumes and a smaller 

percentage of motile spermatozoa, as well as a significantly higher incidence of sperm malformation, 

than the 33 controls (Li et al. 1993). Controls were clerks matched to the workers by income and by 

the city where they lived. However, exposure to 2,4,6-trinitrotoluene was not estimated. The only 

data available were annual measurements of air concentrations, so dose and effects cannot be 

correlated. Furthermore, confounding variables (beyond smoking and drinking) were not discussed. 

Possible important variables would include simultaneous exposures to other chemicals and heat in the 

workplace. 

No studies were located regarding reproductive effects in animals after inhalation exposure to 

2,4,6-trinitrotoluene. 

2.2.1.6 Developmental Effects 

No studies were located regarding developmental effects in humans or animals after inhalation 

exposure to 2,4,6-trinitrotoluene. 

2.2.1.7 Genotoxic Effects 

The presence of mutagenic compounds in the urine of workers exposed to 2,4,6-trinitrotoluene was 

confirmed in two investigations (Ahlborg et al. 1985, 1988a). The initial study involved the screening 

of urine samples from 97 workers in a chemical plant producing pharmaceuticals and explosives 

(Ahlborg et al. 1985). Included in the study was a group of 14 individuals exposed to a maximum air 

concentration of 0.29 mg/m3

 2,4,6-trinitrotoluene. Urine samples were collected at the conclusion of a 

work shift, concentrated on XAD-2 resin, and assessed for mutagenic activity using Salmonella 

typhimurium TA98 and Escherichia coli WP2 uvrA in the presence or absence of exogenous metabolic 

activation. Baseline data for each participant were established from samples collected following a 
2,4,6-TRINITROTOLUENE 16 

2. HEALTH EFFECTS 

4-week vacation. The excretion of genotoxic agents was indicated by a significant increase (p<0.01) 

in mutant colonies of strain TA98 without metabolic activation in the urine of workers exposed to 

2,4,6-trinitrotoluene; baseline samples for this group were uniformly negative. The exclusion of 

smokers from the 2,4,6-trinitrotoluene exposure group did not alter these findings. Unmetabolized 

2,4,6-trinitrotoluene was detected in the urine of workers with the highest level of mutagenic activity. 

The findings of this study are consistent with the demonstrated mutagenic activity of 

2,4,6-trinitrotoluene in S. typhimurium TA98 without S9 activation (see Section 2.4). 

In the follow-up study, urine samples from 50 individuals exposed to varying concentrations of 

2,4,6-trinitrotoluene in the workplace were evaluated (Ahlborg et al. 1988a). Subjects were divided 

into three groups: no exposure (2,4,6-trinitrotoluene air concentrations were too low to be detected), 

mid-range exposure (0.1-0.3 mg/m3), and high-range exposure (0.2-0.5 mg/m3). For each individual, 

pre- and postexposure samples were collected, and health status data relative to smoking habits, 

alcohol consumption, diet, and medication were obtained. Samples were concentrated and assessed for 

mutagenic activity in S. typhimurium strain TA98 and a derivative of TA98 deficient in nitroreductase 

activity (TA98NR); the assays were conducted without exogenous metabolic activation. The 

concentrations of 2,4,6-trinitrotoluene and two major metabolites (4-aminodinitrotoluene [4-ADNT] 

and 2-aminodinitrotoluene [2-ADNT]) were also determined. In agreement with the earlier findings, 

evidence of mutagenic activity was present in the urine of groups exposed to 2,4,6-trinitrotoluene, but 

significant genotoxicity was confined to urine from individuals in the high exposure group. Strain 

TA98, rather than TA98NR, is the most sensitive indicator of induced gene mutations because of 

endogenous nitroreductase activity. The finding suggests that bacterial nitroreductase activity is the 

most probable primary cause of 2,4,6-trinitrotoluene-induced gene mutations. Although the relevancy 

of this finding to humans is not known, comparable nitroreductase activity may be present via 

intestinal microflora or mammalian cells. In contrast to the results of the earlier study (Ahlborg et al. 

1985) in which detectable levels of 2,4,6-trinitrotoluene were found in the urine samples that exhibited 

the highest level of mutagenicity, no correlation between 2,4,6-trinitrotoluene concentration and 

mutagenesis was seen. However, a weak correlation was seen between the concentration of the major 

metabolite (4-ADNT) and mutagenesis. The study authors concluded that the wide variation in 

individual urine sample mutagenicity data in conjunction with toxicokinetics and individual rates of 
2,4,6-TRINITROTOLUENE 17 

2. HEALTH EFFECTS 

2,4,6-trinitrotoluene uptake probably accounts for the lack of a correlation. Similarly, calculation of 

the uptake of 2,4,6-trinitrotoluene through inhalation based on air concentration provided much lower 

estimates than expected from the urine concentration of the metabolites. This finding indicates that 

dermal absorption may contribute significantly to total uptake. 

No studies were located regarding genotoxic effects in animals after inhalation exposure to 

2,4,6-trinitrotoluene. 

Other genotoxicity studies are discussed in Section 2.4. 

2.2.1.8 Cancer 

In a case of chronic occupational exposure to 2,4,6-trinitrotoluene, a 61-year-old male died of 

hepatocellular carcinoma (Garfinkel et al. 1988). Although he was exposed to 2,4,6-trinitrotoluene for 

39 years as an ammunition plant worker, it is not known if 2,4,6-trinitrotoluene had a promoting role 

or any role in the development of the primary liver carcinoma. No discussion of exposure routes was 

included. In general, inhalation is assumed to be the primary pathway for worker exposure, but 

dermal contact and incidental ingestion due to hand-mouth contact cannot be ruled out. 

No studies were located regarding cancer in animals after inhalation exposure to 2,4,6-trinitrotoluene. 

2.2.2 Oral Exposure 

2.2.2.1 Death 

No studies were located regarding death in humans after oral exposure to 2,4,6-trinitrotoluene. 

However, during World Wars I and II, many fatal cases of toxic jaundice and aplastic anemia 

occurred. The fatalities were attributed to 2,4,6-trinitrotoluene exposure during the manufacturing of 

munitions (Army 1978a; McConnell and Flinn 1946). 
2,4,6-TRINITROTOLUENE 18 

2. HEALTH EFFECTS 

The concentrations at which 2,4,6-trinitrotoluene is acutely lethal in animals vary depending on the 

species and sex. Reported oral LD50 values for 2,4,6-trinitrotoluene are 1,010 and 1,320 mg/kg/day for 

male rats, and 795 and 820 mg/kg/day for female rats (Army 1978b; Dilley et al. 1982b). Acute oral 

LD50 values in male and female mice are 1,012 and 660 mg/kg/day, respectively. Doses were 

administered by gavage with oil as a vehicle (Army 1978b; Dilley et al. 1982b). The animals 

developed tremors, followed by mild convulsions, l-2 hours after exposure. In some animals, death 

occurred within 4 hours following the exposure. The animals that survived the convulsions were still 

alive 14 days after exposure (Dilley et al. 1982b). 

2,4,6-Trinitrotoluene was found to be lethal to beagle dogs receiving 32 mg/kg/day orally (by capsule) 

for 26 weeks. One female dog died during week 16 after exhibiting considerable weight loss, 

diarrhea, and ataxia. A second female dog was sacrificed in a moribund state during week 14 of the 

study. The second female dog was observed to be dehydrated and emaciated, with low body 

temperature and signs of an advanced icteric state. No deaths occurred in male dogs (Levine et al. 

1990b). 

No deaths were observed in Fisher-344 rats fed 125 mg/kg/day of 2,4,6-trinitrotoluene for 13 weeks 

(Levine et al. 1990a). Similar observations were made in the chronic exposure studies. No changes in 

survival rates were seen in the same breed of rats that were fed 50 mg/kg/day of 2,4,6-trinitrotoluene 

for 24 months (Army 1984a). 

The LD50 values and all reliable LOAEL values for death in each species and duration category are 

recorded in Table 2- 1 and plotted in Figure 2-1. 

2.2.2.2 Systemic Effects 

No studies were located regarding respiratory, musculoskeletal, dermal, or ocular effects in humans or 

animals after oral exposure to 2,4,6-trinitrotoluene. 

The highest NOAEL values and all reliable LOAEL values for each study and for each end point are 

recorded in Table 2-l and plotted in Figure 2-l. 









2,4,6-TRINITROTOLUENE 28 

2. HEALTH EFFECTS 

Cardiovascular Effects. No studies were located regarding cardiovascular effects in humans after 

oral exposure to 2,4,6-trinitrotoluene. 

Very limi.ted information is available regarding cardiovascular effects in animals after oral exposure to 

2,4,6-trinitrotoluene. Intermediate exposure of beagle dogs to a 2,4,6-trinitrotoluene dose as high as 

32 mg/kg/day for 26 weeks did not cause any changes in electrocardiogram results or heart rates 

(Levine et al. 1990b). 

Gastrointestinal Effects. No studies were located regarding gastrointestinal effects in, humans after 

oral exposure to 2,4,6-trinitrotoluene. 

Adverse gastrointestinal effects were reported in dogs after intermediate oral exposure to 2,4,6­

trinitrotoluene. Dogs receiving 20 mg/kg/day of 2,4,6-trinitrotoluene for 13 weeks had mucoid stools and 

diarrhea (Dilley et al. 1982b). In another longer intermediate exposure study, histopathology revealed 

inflammation of a part of the small intestine in beagle dogs fed 0.5, 2, 8, or 32 mg/kg/day 2,4,6­

trinitrotoluene for 6 months. Although not dose related, the observed enteritis was more frequent in 

dogs treated with the highest dose of 2,4,6-trinitrotoluene. None of the control animals had enteritis 

(Levine et al. 1990b). 

Hematological Effects. No studies were located regarding hematological effects in humans after 

oral exposure to 2,4,6-trinitrotoluene. 

Anemia is one of the frequent signs of 2,4,6-trinitrotoluene toxicity. Adverse effects on standard 

hematologic parameters were observed in rats (Dilley et al. 1982b; Jiang et al. 1991; Levine et al. 

1984, 1990a), mice (Dilley et al. 1982b), and dogs (Dilley et al. 1982b; Levine et al. 1990b) after 

intermediate oral exposures to 2,4,6-trinitrotoluene. Compensatory responses occurring as a result of 

anemia (including reticulocytosis, macrocytosis, and increased levels of nucleated erythrocytes) were 

observed in Fischer-344 rats fed 125 mg/kg/day of 2,4,6-trinitrotoluene for 13 weeks (Levine et al. 

1990a). Dose-related anemia was also observed in Fischer-344 rats fed 10 or 50 mg/kg/day 
2,4,6-TRINITROTOLUENE 29 

2. HEALTH EFFECTS 

2,4,6-trinitrotoluene for 24 months (Army 1984a). In this chronic exposure study, both male and 

female rats had reduced hematocrit, hemoglobin, and red blood cells. These hematological effects 

were observed throughout the entire duration of the study in male rats, but only for the first year in 

female rats. Methemoglobin was observed in male rats at doses of 10 and 50 mg/kg/day. HowellJolley and Heinz Bodies occurred at 50 mg/kg/day in male rats. Therefore, male rats seemed 

somewhat more sensitive than female rats. Reticulocytosis, but not macrocytosis, was present as a 

compensatory response to the anemic state in all animals. Histopathology revealed splenic lesions 

consisting of sinusoidal congestion, extramedullary hematopoiesis, and increased amounts of 

hemosiderin-like pigment (Army 1984a). The findings are consistent with the hypothesis that 

2,4,6-trinitrotoluene induces anemia by causing hemolysis through oxidative damage which is mediated 

by 2,4,6-trinitrotoluene and/or its metabolites. This conclusion is further supported by the presence of 

methemoglobinemia, produced by the oxidation of the heme iron, observed when 2,4,6-trinitrotoluene 

was fed to rats at 300 mg/kg/day for 13 weeks (Levine et al. 1984), to rats at 10 or 50 mg/kg/day for 

24 months (Army 1984a), and to dogs at 32 mg/kg/day for 6 months (Levine et al. 1990b). Mild 

anemia was also noted in B6C3F1 mice fed 70 mg/kg/day 2,4,6-trinitrotoluene for 24 months (Army 

1984b). Anemia, as indicated by dose-dependent decreases in hematocrit and hemoglobin levels and 

decreased erythrocyte counts, was observed in dogs administered 2,4,6-trinitrotoluene (via capsules) for 

6 months (Levine et al. 1990b). The anemia was compensated by reticulocytosis, macrocytosis, and an 

increased number of nucleated erythrocytes. There was an elevated level of methemoglobin in all 

dogs treated with 32 mg/kg/day of 2,4,6-trinitrotoluene. No effects on methemoglobin levels, or blood 

cells and Heinz body counts were found in monkeys following gavage administration of 

2,4,6-trinitrotoluene at dose levels as high as 1.0 mg/kg/day (Martin and Hart 1974). 

Bone marrow fibrosis was present in a significant number of female rats fed 50 mg/kg/day of 2,4,6­

trinitrotoluene for 24 months (Army 1984a). 

Dogs treated daily with 8 mg/kg/day of 2,4,6-trinitrotoluene for 6 months had approximately a 68% 

and 22% increase in platelet levels over the control animals for males and females respectively (Levine 

et al. 1990b). A similar increase was noted in Fischer-344 rats treated with 50 mg/kg/day of 2,4,6­

trinitrotoluene for 24 months (Army 1984a). This increase occurred during the 2nd year of treatment 

and was not present at the end of the study period, week 104 (Army 1984a). Although the increase in 
2,4,6-TRINITROTOLUENE 30 

2. HEALTH EFFECTS 

the number of platelets appeared to be related to 2,4,6-trinitrotoluene treatment, its significance is not 

clear. 

Hepatic Effects. No studies were located regarding hepatic effects in humans after oral exposure to 

2,4,6-trinitrotoluene. However, toxic jaundice was often fatal in workers exposed to 2,4,6-trinitrotoluene 

in ammunition plants during World War I (Army 1978a). Between 1916 and 1941, 475 cases 

of toxic jaundice were recorded in a British ammunition plant; 125 of these were fatal (Army 1978a). 

During World War II, only eight fatal cases of toxic hepatitis were recorded in the United States 

because industrial hygiene techniques had improved since the first world war (Army 1978a). 

Limited information is available for adverse hepatic effects in animals after acute oral exposure to 

2,4,6-trinitrotoluene. The most common adaptive change observed in mice, rats, and dogs during 

intermediate exposure was an increase in liver weight and/or size. A significant increase in liver 

weight was noted in rats receiving 200 mg/kg/day of 2,4,6-trinitrotoluene for 6 weeks (Jiang et al. 

1991) or 125 mg/kg/day for 13 weeks (Levine et al. 1984). A similar observation was made in male 

mice treated with 193 mg/kg/day for 13 weeks (Dilley et al. 1982b). Dogs treated with 20 mg/kg/day 

of 2,4,6-trinitrotoluene for 13 weeks also had increased liver weight (Dilley et al. 1982b). Another 

adaptive response to 2,4,6-trinitrotoluene-induced hepatotoxicity was a reduction in serum 

glutamicpyruvic transaminase (SGPT) in rats treated with 160 mg/kg/day and dogs treated with 20 

mg/kg/day for 13 weeks (Dilley et al. 1982b). No change in serum glutamic-oxaloacetic transaminase 

(SGOT) was noted in those same animals (Dilley et al. 1982b). Dose-related changes such as 

hepatocytomegaly and cloudy swelling were present in dogs after exposure to doses of 0.5 mg/kg/day 

or greater of 2,4,6-trinitrotoluene for 6 months (Levine et al. 1990b). In addition, a reduction in SGPT 

activity was noted in dogs administered 8 or 32 mg/kg/day. Necrotic lesions in the liver were found 

in mice treated with 193 mg/kg/day for 13 weeks (Dilley et al. 1982b), while hepatic cirrhosis was 

seen in dogs treated with 8 mg/kg/day of 2,4,6-trinitrotoluene for 6 months (Levine et al. 1990b). 

Monkeys administered 1 mg/kg/day 2,4,6-trinitrotoluene (by gavage) for 90 days displayed ironpositive 

material in the liver (Martin and Hart 1974). However, results of the bromosulfophthalein 

(BSP) dye test revealed no effects on liver function. This study was limited because only three 

monkeys per sex per were used, precluding statistical analysis of the data. In addition, there was a 
2,4,6-TRINITROTOLUENE 31 

2. HEALTH EFFECTS 

high frequency of emesis in treated animals. These results indicate that there is a species difference 

regarding 2,4,6-trinitrotoluene hepatotoxicity. Dogs seem to respond to lower concentrations of 2,4,6­

trinitrotoluene than do mice or rats. 

The hepatotoxicity of 2,4,6-trinitrotoluene was reflected in elevated levels of cholesterol present in the 

serum after intermediate and chronic exposures. Increased serum cholesterol levels were present in 

rats treated with 25 (Levine et al, 1984), 125 (Levine et al. 1990a), and 160 mg/kg/day (Dilley et al. 

1982b) of 2,4,6-trinitrotoluene for 13 weeks. A similar finding was seen in dogs fed 20 mg/kg/day of 

2,4,6-trinitrotoluene for the same time period (Dilley et al. 1982b). Increased cholesterol levels were 

also found in male and female rats treated with 50 mg/kg/day for 24 months (Army 1984a). 

Evidence for adverse hepatic effects has also been revealed in studies of chronic exposure. Doserelated 

hepatomegaly resulting from hepatocellular hyperplasia was observed in Fischer-344 rats given 

10 or 50 mg/kg/day of 2,4,6-trinitrotoluene for 24 months (Army 1984a). 

Serum lipids were affected by chronic administration of 2,4,6-trinitrotoluene to rats (Army 1984a). 

The levels of serum triglycerides were affected differently in male and female rats exposed to 2, 10, or 

50 mg/kg/day of 2,4,6-trinitrotoluene (Army 1984a). Treatment-related hypotriglyceridemia was 

observed in females at 2 mg/kg/day; this change was statistically significant at 10 and 50 mg/kg/day 

during week 104 of treatment. In male rats treated with 50 mg/kg/day, a significant reduction in 

triglyceride levels was seen after 104 weeks of treatment (Army 1984a). The results indicate that 

female rats were more susceptible to 2,4,6-trinitrotoluene-induced reduction in serum triglyceride levels 

than male rats that showed reduced triglycerides only at the highest treatment doses. Hypoglyceridemia 

was also observed in mice treated with 70 mg/kg/day 2,4,6-trinitrotoluene for 24 months 

(Army 1984b), and a decrease in glucose levels was observed in dogs treated with 8 or 32 mg/kg/day 

2,4,6-trinitrotoluene (Levine et al. 1990b). 

Jaundice (icterus) was observed in beagle dogs treated with 32 mg/kg/day for 26 weeks (Levine et al. 

1990b). The presence of jaundice was evidenced by elevated bilirubin levels in both serum and urine 

and increased urobilinogen values (Levine et al. 1990b). Histopathological analysis of these animals 
2,4,6-TRINITROTOLUENE 32 

2. HEALTH EFFECTS 

revealed hemosiderosis in Kupffer’s cells in all dogs receiving 8 and 32 mg/kg/day and in one female 

receiving 2 mg/kg/day for 26 weeks (Levine et al. 1990b). 

One of the proposed mechanisms of 2,4,6-trinitrotoluene-induced toxicity is an increase in free radical 

levels which occurs after exposure. Superoxide radicals and hydrogen peroxide were measured in 

mitochondria and microsomes from livers of monkeys treated with 0, 60, or 120 mg/kg/day of 2,4,6­

trinitrotoluene for 12 weeks (Kong et al. 1989). The amount of superoxide radicals was indirectly 

measured by the formation of adrenochrome from adrenalin, and hydrogen peroxide production was 

evaluated by the conversion of methanol to formaldehyde. There was a dose-dependent increase in 

superoxide radicals and hydrogen peroxide production in liver mitochondria and microsomes (Kong et 

al. 1989). These findings were confirmed when mitochondria and microsomes obtained from various 

organs were treated in vitro with 0, 0.04, 0.2, or 1 mmol of 2,4,6-trinitrotoluene and then tested for 

adrenochrome and formaldehyde production. Different amounts of hydrogen peroxide were produced 

in the mitochondria of the various organs. The highest amount of hydrogen peroxide was present in 

the liver followed by brain, testicle, kidney cortex, and kidney medulla (Kong et al. 1989). 

Renal Effects. Discoloration of the urine is among the first indications of 2,4,6-trinitrotoluene 

intoxication in humans. The color of urine ranges from abnormal amber to a deep red, and in most 

cases the results are positive for Webster’s test (a qualitative urine test for 2,4,6-trinitrotoluene based 

on the formulation of purple color in acidified urine samples following extraction with ether and 

treatment with potassium hydroxide) (Army 1978a). 

Accumulation of yellowish-brown pigment in the renal cortex of rats treated with 125 mg/kg/day of 

2,4,6-trinitrotoluene for 13 weeks was seen during histopathological analysis. The authors suggest that 

this pigment may have represented known photolytic decomposition products of 2,4,6-trinitrotoluene 

(Levine et al. 1984, 1990b). The same observation was made in female rats treated with 10 or 

50 mg/kg/day for 24 months (Army 1984a). A dose-related increase in granular pigment within the 

cytoplasm of epithelial cells of proximal convoluted tubules was observed at the end of the treatment 

period in male rats receiving either 10 or 50 mg/kg/day for 24 months (Army 1984a). Increased 

filtration rate was also present in these chronically exposed animals (Army 1984a). 
2,4,6-TRINITROTOLUENE 33 

2. HEALTH EFFECTS 

2.2.2.3 Immunological and Lymphoreticular Effects 

Limited information was located regarding immunological effects in humans after oral exposure to 

2,4,6-trinitrotoluene. However, an early reaction to 2,4,6-trinitrotoluene intoxication was an increase 

in the number of mononuclear leukocytes found in the blood counts of 105 exposed individuals (Army 

1978a). This increase seems to precede any other symptom and remains positive for 2-3 months; 

therefore, it would be helpful in the differential diagnosis of 2,4,6trinitrotoluene poisoning, especially 

when Webster’s test is negative (Army 1978a). The route of exposure and precise dose were not 

defined in this report. 

An increase in lymphocyte numbers was also seen in nine fatal cases of 2,4,6-trinitrotoluene toxicity in 

humans. The normal range for lymphocytes is 20-40% of the total white blood cell count. In the 

affected patients, the average was 78% of the total white blood count (range, 61-92%) (Army 1978a). 

Patients who recovered after 2,4,6-trinitrotoluene intoxication had lymphocyte counts which were 

approximately 46% of the total white cell count (Army 1978a). 

No adverse lymphoreticular effects as assessed by changes in lymphocyte levels and histological 

changes in the spleen were seen in dogs treated with 2.0 mg/kg/day, rats treated with 34.7 mg/kg/day, 

or mice treated with 35.7 mg/kg/day of 2,4,6-trinitrotoluene for 13 weeks (Dilley et al. 1982b). 

Increased spleen weight was seen in mice, rats, and dogs after an exposure of 13 weeks to 

2,4,6-trinitrotoluene. The splenomegaly is possibly related to an increased clearance of hemolysed 

cells (Dilley et al. 1982b; Levine et al. 1984, 1990a). Male and female dogs exposed to 

20 mg/kg/day, mice exposed to 193 mg/kg/day (Dilley et al. 1982b), and rats exposed to 

125 mg/kg/day (Levine et al. 1984, 1990a) and 160 mg/kg/day (Dilley et al. 1982b) all had increased 

spleen weights after 13 weeks of exposure. Spleen enlargement related to 2,4,6-trinitrotoluene 

administration was also noted in dogs treated with 8 or 32 mg/kg/day for 26 weeks. The ratios of 

myeloid to erythroid cells were also significantly lower in these dogs, and they had varying degrees of 

splenic congestion (Levine et al. 1990b). Splenic hemosiderosis related to 2,4,6-trinitrotoluene 

treatment was also present in rats receiving 160 or 300 mg/kg/day (Dilley et al. 1982b; Levine et al. 

1984), mice receiving 193 mg/kg/day (Dilley et al. 1982b), and dogs receiving 20 mg/kg/day (Dilley 
2,4,6-TRINITROTOLUENE 34 

2. HEALTH EFFECTS 

et al. 1982b) of 2,4,6-trinitrotoluene for 13 weeks. Lymphopenia was present in mice treated with 

193 mg/kg/day for 13 weeks (Dilley et al. 1982b). Increased globulin levels and leukocytosis were 

noted in the dogs treated with 20 mg/kg/day after a 4 week recovery period. Leukocytosis was 

observed in rats fed 160 mg/kg/day of 2,4,6-trinitrotoluene for 13 weeks (Dilley et al. 1982b). 

Sinusoidal congestion, extramedullary hematopoiesis, and hemosiderin-like pigment in the spleen were 

observed in male and female rats fed 10 or 50 mg/kg/day of 2,4,6-trinitrotoluene for 24 months (Army 

1984a). Enlargement of the spleen and lymph nodes was noted in female mice treated with 

70 mg/kg/day of 2,4,6-trinitrotoluene for 24 months (Army 1984b). 

2.2.2.4 Neurological Effects 

No studies were located regarding neurological effects in humans after oral exposure to 2,4,6­

trinitrotoluene. 

In acute exposure studies, rats fed 182 mg/kg/day of 2,4,6-trinitrotoluene for 4 days showed no signs 

of neurotoxicity as measured by changes in zoxazolamine paralysis time and hexobarbital sleeping 

time (Short and Lee 1980). However, in a single-dose oral LD50 study in rodents, rats and mice 

showed signs of inactivity, were tremulous, developed convulsions, and died (Dilley et al. 1982b). 

Similar observations were made in intermediate-duration studies. No signs of neurotoxicity were seen 

after 13 weeks of 2,4,6-trinitrotoluene treatment in dogs receiving 0.2 mg/kg/day (Dilley et al. 1982b), 

monkeys receiving 1 mg/kg/day (Martin and Hart 1974), or rats receiving 1.42 mg/kg/day (Dilley et al. 

1982b). Dogs treated with 32 mg/kg/day for 6 months were ataxic (Levine et al. 1990b), while 

inactivity was observed in dogs after treatment with 20 mg/kg/day for 13 weeks (Dilley et al. 1982b). 

Dose-related changes in behavior such as lethargy and/or ataxia were seen in rats treated with 34.7 or 

125 mg/kg/day for 13 weeks (Dilley et al. 1982b; Levine et al. 1984). Brain lesions with focal 

vacuolation were seen in rats receiving 300 mg/kg/day of 2,4,6-trinitrotoluene for 13 weeks (Levine et 

al. 1984). 

No significant signs of neurotoxicity were seen in Fischer-344 rats treated with up to 50 mg/kg/day of 

2,4,6-trinitrotoluene for 24 months (Army 1984a). The combined results of acute and intermediate 
2,4,6-TRINITROTOLUENE 35 

2. HEALTH EFFECTS 

exposure studies indicate species differences in 2,4,6-trinitrotoluene-induced neurotoxicity, with dogs 

being more sensitive than rats or mice. 

2.2.2.5 Reproductive Effects 

No studies were located regarding reproductive effects in humans after oral exposure to 2,4,6­

trinitrotoluene. 

Significantly decreased testes weights and testes zinc and copper concentrations were observed in male 

rats exposed to 200 mg/kg/day 2,4,6-trinitrotoluene for 6 weeks (Jiang et al. 1991). In addition, the 

serum ceruloplasmin concentration was significantly lower in the male rats. Zinc metabolism seems to 

be affected more than copper metabolism by 2,4,6-trinitrotoluene treatment. Although there was a 

close correlation between testicular weight and testicular zinc concentration, the role of zinc in 

decreasing testicular weight is not clear (Jiang et al. 1991). However, zinc is known to be essential for 

maintenance of normal testicular function (Jiang et al. 1991). No adverse reproductive effects were 

noted in rats exposed to 1.42 mg/kg/day of 2,4,6-trinitrotoluene for 13 weeks (Dilley et al. 1982b). 

However, male rats treated with 125, 160, or 300 mg/kg/day for the same period of time had serious 

reproductive effects such as degenerated germinal epithelium, testicular atrophy, and atrophic 

seminiferous tubules (Dilley et al. 1982b; Levine et al. 1984, 1990a). Testicular atrophy was not 

reversible in rats allowed 4 weeks of recovery (Dilley et al. 1982b). 

2.2.2.6 Developmental Effects 

No studies were located regarding developmental effects in humans or animals after oral exposure to 

2,4,6-trinitrotoluene. 

2.2.2.7 Genotoxic Effects 

No studies were located regarding genotoxic effects in humans after oral exposure to 2,4,6-trinitrotoluene 
2,4,6-TRINITROTOLUENE 36 

2. HEALTH EFFECTS 

Results were negative from in viva studies employing the oral route of exposure to ascertain whether 

2,4,6-trinitrotoluene has the potential to induce clastogenic effects in somatic cells or increase the 

frequency of unscheduled deoxyribonucleic acid (DNA) synthesis (UDS) in liver cells. However, the 

findings from somatic cell cytogenetic assays with rats were compromised and, therefore, do not fully 

support a negative conclusion. 

In the bone marrow test, groups of five male Sprague-Dawley rats were administered dietary 

concentrations of 0.002% or 0.25% 2,4,6-trinitrotoluene for 28 days; two additional groups of five rats 

each were similarly treated and allowed a 28-day recovery period (Army 1978c). At the conclusion of 

the treatment or recovery period, animals were sacrificed; bone marrow cells were harvested and 

examined for abnormal chromosome morphology. No animals died prior to the scheduled sacrifice. 

The study authors attributed the reduced body weight observed in the high-dose group to the 

palatability of the test material rather than to a toxic effect. The slight depression in the mitotic 

indices for high-dose animals at the conclusion of treatment was not considered indicative of a 

cytotoxic effect on the target organ (bone marrow cells). Although no chromosome aberrations were 

scored in the exposure groups immediately after treatment or following the 28-day recovery period, the 

failure to demonstrate overt toxicity in the test animals or cytotoxic effects on the target organ renders 

the study insufficient to fully support the conclusion that 2,4,6-trinitrotoluene was negative in this in 

vivo cytogenetics assay. 

2,4,6-Trinitrotoluene was administered by oral gavage at doses of 100, 200, 500, or 1,000 mg/kg to 

male Alderley Park rats and at doses of 200, 500, and 1,000 mg/kg to male Fischer-344 rats (up to 

three rats/group/strain) to investigate UDS in liver cells (Ashby et al. 1985). There was no evidence 

of a cytotoxic or genotoxic effect on the hepatocytes of either strain 12 hours after 2,4,6-trinitrotoluene 

exposure. 

Other genotoxicity studies are discussed in Section 2.4. 
2,4,6-TRINITROTOLUENE 37 

2. HEALTH EFFECTS 

2.2.2.8 Cancer 

No studies were located regarding cancer in humans after oral exposure to 2,4,6-trinitrotoluene. 

However, a preliminary study of a German population living near the sites of two World War II 

munitions plants indicates an association between increased rates of some types of leukemia and living 

in a town near 2,4,6-trinitrotoluene waste from these plants (Kolb et al. 1993). The study shows 

increased relative risk of acute myelogenous leukemia (AML) for adult males and females living near 

the former explosives plants when compared with adults in a neighboring county. The relative risk is 

particularly high for individuals over 65 years of age. However, study case numbers are very small. 

The relative risk for chronic myelogenous leukemia (CML) is also increased for males but there was 

only one case among females so comparisons could not be made. The relative proximity of the cases 

of leukemia to the sites of 2,4,6-trinitrotoluene manufacture or disposal is not known, nor are any 

2,4,6-trinitrotoluene concentrations in the environment reported. No investigation of confounding 

variables (i.e., benzene exposure or occupational exposure to carcinogens) has been done. The study 

concludes that a causal relationship is suggested, but further investigation of the living and working 

conditions of the populations is required (Kolb et al. 1993). 

In a chronic study, groups of 150 (75 males and 75 female) Fischer-344 rats were exposed to 0, 0.4, 

2.0, 10.0, and 50.0 mg/kg/day of 2,4,6-trinitrotoluene in their food for 24 months (Army 1984a). A 

statistically significant number of female rats (12/55 or 21.8%) exposed to 50-mg/kg/day doses 

developed urinary bladder carcinomas. Urinary bladder papillomas were present in 1/55 and 5/55 

female rats fed 10 and 50 mg/kg/day, respectively. No metastases were observed in any of the 

animals. Histopathologic lesions included increased incidence of hyperplastic, preneoplastic, and 

neoplastic changes of the mucosal epithelium of the urinary bladder. The cancer incidence observed in 

this chronic exposure study is further supported by renal and urinary bladder hyperplasia observed in 

treated animals. None of the control animals developed lesions of the urinary bladder. In a similar 

study conducted in groups of 150 B6C3F1 mice (75 males and 75 females), a statistically significant 

incidence (p<0.01) of leukemia and/or malignant lymphoma of the spleen was present in female mice 

receiving 70 mg/kg/day of 2,4,6-trinitrotoluene for 24 months (Army 1984b). Leukemia and/or 

malignant lymphoma of the spleen was noted in 28% and 32% of the female mice administered 1.5 

and 10 mg/kg/day, respectively. The increase in the cancer incidence in the female mice receiving 1.5 
2,4,6-TRINITROTOLUENE 38 

2. HEALTH EFFECTS 

or 10 mg/kg/day of 2,4,6-trinitrotoluene was not statistically significant. Histopathology revealed that 

leukemia was of granulocytic or lymphocytic type, while lymphoma was histiocytic, lymphocytic, or 

of a mixed type. All the lesions were treatment related and systemic in nature. The neoplasias 

involved other organs and tissues such as adrenals, bone marrow, brain, gastrointestinal tract, eyes, 

kidneys, liver, lungs, and lymph nodes. The occurrence of combined leukemia/malignant lymphoma 

seemed to be dose related but was not statistically significant. Based on the information from these 

two chronic animal studies, EPA has classified 2,4,6-trinitrotoluene as a possible human carcinogen 

(Group C) (EPA 1989b). 

2.2.3 Dermal Exposure 

In many occupational studies, it is often difficult to make a definitive distinction between dermal and 

inhalation exposures, as was indicated in the section on inhalation exposure. Therefore, some of the 

findings described in the inhalation section will be repeated in this section. 

2.2.3.1 Death 

Adverse effects of 2,4,6-trinitrotoluene on the liver and hematopoietic system have caused the greatest 

number of deaths among munitions workers. There were 475 deaths out of about 17,000 cases of 

2,4,6-trinitrotoluene poisoning in the United States within 7.5 months during World War I (McConnell 

and Flinn 1946). In the same report, 22 cases of death due to occupational exposure to 2,4,6­

trinitrotoluene during World War II were described (McConnell and Flinn 1946). In this series of fatal 

cases, 8 died from toxic hepatitis, 13 died from aplastic anemia, and 1 died probably from the 

combination of both these conditions (McConnell and Flinn 1946). The authors indicated that exposure 

occurred by dermal contact and inhalation. 

No studies were located regarding death in animals after dermal exposure to 2,4,6-trinitrotoluene. 
2,4,6-TRINITROTOLUENE 39 

2. HEALTH EFFECTS 

2.2.3.2 Systemic Effects 

No studies were located regarding respiratory, cardiovascular, gastrointestinal, or musculoskeletal 

effects in humans or animals after dermal exposure to 2,4,6-trinitrotoluene. 

Hematological Effects. Acute hemolytic disease was described in three ammunition plant workers 

who filled shells with 2,4,6-trinitrotoluene (Djerassi and Vitany 1975). All three were deficient in 

glucose-6-phosphate dehydrogenase (G6PD), an enzyme that catalyzes the oxidation of glucose 

6-phosphate to 6-phosphoglucono-lactone. All three cases developed acute severe hemolysis 2-3 days 

after being exposed to 2,4,6-trinitrotoluene and had very similar symptoms: paleness, weakness, and 

vertigo. They also had decreased hemoglobin levels, decreased hematocrit, and increased reticulocyte 

numbers (Djerassi and Vitany 1975). All three recovered and had no further complications when 

examined 5 and 10 years later. Limitations of this report are that the routes of exposure are not 

specified, although it seems that there was dermal and inhalation exposure, and that the level of 

exposure is not known. However, the authors note that the air levels of 2,4,6-trinitrotoluene were 

higher than the allowed daily exposure limit, which was 1.5 mg/m3

 at that time. 

No studies were located regarding hematological effects in animals after dermal exposure to 

2,4,6-trinitrotoluene. 

Hepatic Effects. A modified MacLagen test (thymol turbidity test) was used to give evidence of 

cirrhosis or hepatitis resulting from 2,4,6-trinitrotoluene exposure in ammunition workers (Goodwin 

1972). In a retrospective study spanning 20 years, the data showed that 40 out of 4,641 workers had 

>5 MacLagen units (2.9 MacLagen units is considered to be normal); the length of exposure and dose 

of 2,4,6-trinitrotoluene were not specified. However, the hepatotoxicity was reversible. All the 

workers with a MacLagen test result of >5 units were transferred to other jobs, and their readings 

returned to normal within 3 weeks (Goodwin 1972). 

No studies were located regarding hepatic effects in animals after dermal exposure to 2,4,6­

trinitrotoluene. 
2,4,6-TRINITROTOLUENE 40 

2. HEALTH EFFECTS 

Renal Effects. No adverse renal effects were reported in humans after acute exposure to 

2,4,6-trinitrotoluene as measured by Webster’s reaction and the aminodinitrotoluene (ADNT) test 

(Hassman and Hassmanova 1976). In this study, the exposure route was not clearly specified, but it 

seems that dermal contact and inhalation were the major routes of exposure. 

No studies were located regarding renal effects in animals after dermal exposure to 2,4,6-trinitrotoluene. 

Dermal Effects. Allergic contact dermatitis with erythema (Goh 1988) and erythematous papillar 

rush with edema (Goh and Rajan 1983) were reported in two ammunition workers after intermediate 

exposures to 2,4,6-trinitrotoluene. In both cases, patch tests were used to determine the allergen. The 

results showed that 5% is the most suitable concentration for patch testing in order to avoid false 

positive or negative results (Goh and Rajan 1983). In both affected workers, dermal reactions 

developed on parts of the body that were exposed and in direct contact with 2,4,6-trinitrotoluene, such 

as hands and forearms. These reactions subsided and disappeared when the workers were transferred 

to different jobs and were no longer in contact with 2,4,6-trinitrotoluene. 

No studies were located regarding dermal effects in animals after dermal exposure to 2,4,6-trinitrotoluene. 

Ocular Effects. The development of cataracts in humans is believed to be specific to 2,4,6-trinitrotoluene 

exposure (Hathaway 1985) and is often associated with chronic exposures. Equatorial lens 

opacities/cataracts were reported in 6 out of 12 Finnish workers (mean age, 39.5±8.9 years) exposed to 

2,4,6-trinitrotoluene for an average of 6.8±4.7 years (Harkonen et al. 1983). The principal routes of 

exposure were dermal and inhalation, although this fact is not clearly indicated in the report. 

Therefore, it is not known whether cataracts were a systemic or a local effect. The opacities were 

detectable only on the periphery of the lens and appeared continuous or discontinuous. The opacities 

of the lens were bilateral and symmetrical and did not affect visual fields or visual acuity. The 

workroom 2,4,6-trinitrotoluene air concentration was about 0.3 mg/m3 with a range of 0.14-0.58 mg/m3 

(Harkonen et al. 1983). There was no control population in the study. The formation of cataracts did 
2,4,6-TRINITROTOLUENE 41 

2. HEALTH EFFECTS 

not progress further after exposure to 2,4,6-trinitrotoluene was terminated; however, the cataracts were 

not reversible. The mechanism of 2,4,6-trinitrotoluene cataract formation is not understood, but the 

authors raised the possibility that oxidative damage may play a role since cellular defense mechanisms 

protective against oxidative damage (i.e., glucose-6-phosphate dehydrogenase and glutathione 

concentration) may be deficient after exposure to 2,4,6-trinitrotoluene (Harkonen et al. 1983). 

No studies were located regarding ocular effects in animals after dermal exposure to 2,4,6-trinitrotoluene. 

2.2.3.3 Immunological and Lymphoreticular Effects 

Two ammunition plant workers developed an allergic contact dermatitis with erythema (Goh 1988) and 

erythematous papillar rush with edema (Goh and Rajan 1983) after intermediate exposures to 

2,4,6-trinitrotoluene. Patch tests were used to identify the allergen using 5% as the most suitable 

concentration (Goh and Rajan 1983). Dermal reactions were observed to occur on the exposed parts 

of the body such as the hands and forearms. Once removed from environments containing 

2,4,6-trinitrotoluene, the workers sensitivity subsided and the dermatitis disappeared. 

No studies were located regarding immunological or lymphoreticular effects in animals after dermal 

exposure to 2,4,6-trinitrotoluene. 

2.2.3.4 Neurological Effects 

No studies were located regarding neurological effects in humans or animals after dermal exposure to 

2,4,6-trinitrotoluene. 

2.2.3.5 Reproductive Effects 

No studies were located regarding reproductive effects in humans or animals after dermal exposure to 

2,4,6-trinitrotoluene. 
2,4,6-TRINITROTOLUENE 42 

2. HEALTH EFFECTS 

2.2.3.6 Developmental Effects 

No studies were located regarding developmental effects in humans or animals after dermal exposure 

to 2,4,6-trinitrotoluene. 

2.2.3.7 Genotoxic Effects 

Two studies involving genotoxic effects in individuals occupationally exposed to 2,4,6-trinitrotoluene 

suggested that in addition to inhalation exposure, dermal exposure may have occurred (Ahlborg et al. 

1985, 1988a). These studies are discussed in detail in Section 2.2.1.7. No other studies were located 

regarding genotoxic effects in humans or animals after dermal exposure to 2,4,6-trinitrotoluene. 

Other genotoxicity studies are discussed in Section 2.4. 

2.2.3.8 Cancer 

In a case of chronic occupational exposure to 2,4,6-trinitrotoluene, a 61-year-old male died of 

hepatocellular carcinoma (Garfinkel et al. 1988). The routes of exposure were not specified in the 

study, and it is possible that the worker was exposed via the inhalation and/or dermal route. 

No studies were located regarding cancer in animals after dermal exposure to 2,4,6-trinitrotoluene. 

2.3 TOXICOKINETICS 

Occupational studies indicate humans readily absorb 2,4,6-trinitrotoluene dusts via inhalation or dermal 

contact, but quantitative studies have not been done. Toxicokinetic data from animal studies are 

limited in that the fate of the radiolabelled dose of 2,4,6-trinitrotoluene was followed, and it is not 

possible to differentiate between parent compound and metabolites. However, studies in dogs, rabbits, 

mice, and rats indicate that more than 60% of the administered dose of 2,4,6-trinitrotoluene is 

absorbed when ingested; dermal exposure these animals results in significantly lower (16-68%) 

absorbance than oral exposure. 
2,4,6-TRINITROTOLUENE 43 

2. HEALTH EFFECTS 

No studies of the distribution of 2,4,6-trinitrotoluene in humans were located. However, in animal 

studies the highest concentrations of 2,4,6-trinitrotoluene are found in the liver, skeletal muscle, blood, 

and fat. 

Studies indicate 2,4,6-trinitrotoluene is metabolized to several identifiable intermediates in the urine of 

exposed workers, including the major reduction product aminodinitrotoluene (ADNT). In several 

studies of oral exposure of rats and other laboratory animals, 2,4,6-trinitrotoluene was rapidly 

metabolized to molecules too low in concentration to be identified by chromatographic analysis of 

urine. Trace amounts of 2,4,6-trinitrotoluene could be detected in the urine of exposed animals in 

isolated cases. After a single dermal exposure of 2,4,6-trinitrotoluene administered to dogs, rabbits, 

mice, and rats, more unchanged 2,4,6-trinitrotoluene was found in the urine than was found after oral 

exposure. This result indicates the route of exposure may influence the rate and extent of 2,4,6­

trinitrotoluene metabolism. 

No studies of the excretion of 2,4,6-trinitrotoluene in humans were located. However, studies indicate 

that 2,4,6-trinitrotoluene and its metabolites are primarily eliminated in the urine in laboratory animals. 

In most studies excretion is rapid. 

The mechanisms by which 2,4,6-trinitrotoluene and its derivatives exert their toxic effects are largely 

unknown. A theory of the mechanism of toxicity by 2,4,6-trinitrotoluene is that the chemical and 

some of the metabolic intermediates of 2,4,6-trinitrotoluene generate reactive oxygen species that cause 

lipid peroxidation in the liver and injury of the lens resulting in cataracts. 

2.3.1 Absorption 

2.3.1.1 Inhalation Exposure 

Studies that directly measure the absorption of 2,4,6-trinitrotoluene in humans following inhalation 

exposure of known amounts of this chemical were not located. The amount of 2,4,6-trinitrotoluene in 

the urine as measured by Webster’s reaction and the amount of 2-ADNT in the urine were compared 

in 88 factory workers working with 2,4,6-trinitrotoluene (Hassman and Hassmanova 1976). The 
2,4,6-TRINITROTOLUENE 44 

2. HEALTH EFFECTS 

concentration of 2,4,6-trinitrotoluene in the air varied from 0.045 to 0.93 mg/m3 in different parts of 

the plant. The results showed that there was a good correlation between the amounts of 2,4,6­

trinitrotoluene and its main metabolite ADNT in the urine of exposed workers. The levels of ADNT 

increased rapidly during the workday and then declined within 24 hours to close to the levels at the 

beginning of the workday. These results suggest that 2,4,6-trinitrotoluene is rapidly absorbed and 

eliminated in the course of an acute inhalation exposure. The study is limited in that there was no 

information on the route of exposure, the length of exposure in the course of a working day, or the 

exposure dose. 

In an attempt to simulate inhalation exposure, 50 mg/kg of radiolabelled 2,4,6-trinitrotoluene 

suspended in methyl cellulose was instilled into the trachea of anesthetized, tracheotomized SpragueDawley rats (Army 1981d). At the same time, another group of rats was treated orally with the same 

dose of radiolabelled 2,4,6-trinitrotoluene. Both groups were sacrificed 4 hours later, and tissue and 

urine samples were collected for radioactivity analysis. The rate of absorption was faster after 

intratracheal instillation than after oral administration of 2,4,6-trinitrotoluene. Urinary excretion 

averaged 19.3% of the dose after intratracheal administration and 14.6% of the dose after oral 

administration. These results indicate that there are differences in the absorption rate of 2,4,6­

trinitrotoluene depending on the administration route. 

2.3.1.2 Oral Exposure 

Discoloration of the urine is among the first indications that metabolism has occurred after 

2,4,6-trinitrotoluene absorption in humans. The color of urine ranges from abnormal amber to deep 

red (Army 1978a). 

Similar observations were made in rats and mice. Sixty minutes after a single exposure to 10,000 

mg/kg/day of 2,4,6-trinitrotoluene, the urine of mice and rats becomes red in color (Dilley et al. 

1982b). This is an indirect indication of 2,4,6-trinitrotoluene absorption. A more direct estimate of 

absorption of 2,4,6-trinitrotoluene was done in rats, mice, rabbits, and dogs after a single oral dose of 

50 mg/kg of radiolabelled 2,4,6-trinitrotoluene (Army 1981d). Twenty-four hours later, the recovery 

of radiolabel was measured in rats, mice, dogs, and rabbits. The largest percentage of radioactivity 
2,4,6-TRINITROTOLUENE 45 

2. HEALTH EFFECTS 

was recovered from urine: 59.5%, 59%, and 61% for rats, mice, and dogs, respectively. Rabbits had 

a slightly higher recovery (74.3%) of radiolabelled 2,4,6-trinitrotoluene in their urine, with a 

proportional decrease in the radioactivity recovered from the gastrointestinal tract and feces (Army 

1981d). Total recovery of the radioactivity (including feces, gastrointestinal tract, and urine) was 

92.2%, 94.4%, 94.2%, and 103.6% in rats, mice, dogs, and rabbits, respectively. The red pigment in 

the urine was not detected in rabbits or dogs. The results of this study indicate that 2,4,6-trinitrotoluene 

is relatively quickly absorbed after oral administration and that a majority of the ingested 

compound is excreted within 24 hours. 

Findings in rats, mice, and dogs support the observations made in humans. Discoloration of urine was 

noted in both rats and mice exposed to 34.7 and 35.7 mg/kg/day, respectively, for 13 weeks (Dilley et 

al. 1982b). Dogs treated with 20 mg/kg/day for 13 weeks had urine that was orange in color (Dilley 

et al. 1982b), while dogs receiving 8 or 32 mg/kg/day for 26 weeks had light to dark brown urine 

throughout the treatment period (Levine et al. 1990b). No adverse hepatic effects and no change in 

urine color were observed in monkeys treated with 1 mg/kg/day for 90 days (Martin and Hart 1974). 

The Martin and Hart (1974) study was limited in that only three monkeys per sex per group were 

utilized, thereby precluding statistical analyses of the data. Also, a high frequency of emesis was 

observed in the treated monkeys. It is believed that the species differences in urine color are due to 

the presence of unidentified metabolites of 2,4,6-trinitrotoluene. Species differences in 2,4,6­

trinitrotoluene toxicity may be attributed to the different metabolic pathways of 2,4,6-trinitrotoluene and 

its metabolites. Once identified, these urine metabolites may be used as markers of 2,4,6-trinitrotoluene 

exposure. 

2.3.1.3 Dermal Exposure 

Although data are limited regarding absorption of 2,4,6-trinitrotoluene following dermal exposure in 

humans, it appears that it occurs rapidly (Woollen et al. 1986). 2,4,6-Trinitrotoluene absorption was 

assessed by measuring the urinary concentration of one of its metabolites, ADNT, in 25 exposed 

workers. There were wide variations between individual workers in the rate of clearance of ADNT 

from the body. Furthermore, when urine samples were collected from a subgroup of workers from the 

original group of 25, eight out of nine subjects had detectable ADNT levels in their urine even though 
2,4,6-TRINITROTOLUENE 46 

2. HEALTH EFFECTS 

these workers had been away from the workplace for 17 days. This is an indication that a portion of 

absorbed 2,4,6-trinitrotoluene or its metabolites is slowly excreted (Woollen et al. 1986). Additionally, 

when five workers from the total group of 25 exposed workers were monitored more closely during 

two workshifts, it was shown that 2,4,6-trinitrotoluene was absorbed rapidly during the exposure 

period. The limitations of this study are that the dermal exposure dose was not measured and workers’ 

were also exposed to 2,4,6-trinitrotoluene via the inhalation route. 

The differences in absorption and excretion of radiolabelled 2,4,6-trinitrotoluene after dermal and oral 

exposures were investigated in mice, rabbits, rats, and beagle dogs (Army 1981d). Rats and mice were 

exposed dermally and orally (by gavage) to 50 mg/kg, and dogs and rabbits to 5 or 50 mg/kg. 

Twenty-four hours after exposure, animals were sacrificed and urine, gastrointestinal tract, feces, and 

various tissues were analyzed for radioactivity. Total recovered radioactivity was significantly lower 

in all species after dermal exposure as compared to after oral exposure (Army 1981d). The highest 

degree of dermal absorption was observed in rabbits and mice, in which 68.3% and 41.7% of the 

administered radiolabel was recovered, respectively. The total recovery of radiolabel in dogs and rats 

was much lower, 17% and 24%, respectively. These results suggest that absorption of radiolabelled 

2,4,6-trinitrotoluene is species-dependent and is significantly lower after dermal rather than oral 

exposure. 

2.3.2 Distribution 

2.3.2.1 Inhalation Exposure 

No studies were located regarding distribution following inhalation exposure to 2,4,6-trinitrotoluene in 

humans. 

In rats that received 50 mg/kg of radiolabelled 2,4,6-trinitrotoluene by intratracheal administration, the 

highest tissue concentrations of radiolabel after 4 hours were found in both male and female animals in 

the fat (82 and 155 μg eq/g, respectively) and gastrointestinal tract (82 and 40 μg eq/g, respectively) 

(Army 1981d). Since the gastrointestinal tract contained considerable amounts of radioactivity, some 

of the rats in this experiment were bile-duct cannulated in order to collect bile and estimate the amount 
2,4,6-TRINITROTOLUENE 47 

2. HEALTH EFFECTS 

of radiolabel. The results were given as a percent of the administered dose. The radioactivities 

recovered in bile-duct cannulated male and female rats were 20% and 15%, respectively, from the bile, 

and 18% and 13%, respectively, from the urine (Army 1981d). When these results were compared to 

excretion results following oral administration, the percent of radioactivity recovered in the urine and 

bile was significantly higher after intratracheal exposure in both male and female rats. The opposite 

was true for the amount of radioactivity recovered in the gastrointestinal tract; it was significantly 

higher in the orally treated rats regardless of cannulation (Army 1981d). These results indicate that 

the route of administration contributes to the differences in 2,4,6-trinitrotoluene distribution. 

2.3.2.2 Oral Exposure 

No studies were located regarding distribution following oral exposure to 2,4,6-trinitrotoluene in 

humans. 

Twenty-four hours after administration of a single oral dose of radiolabelled 2,4,6-trinitrotoluene to 

rats and mice (100 mg/kg), and rabbits and dogs (5 mg/kg), the blood and different tissues were 

analyzed for radioactivity. The blood and liver, kidney, spleen, lungs, brain, and skeletal muscle of 

dogs contained a higher percentage of radioactivity than the blood and tissues of rats, mice, and rabbits 

(Army 1981d). Recovery of radioactivity was greatest in the liver, skeletal muscle, and blood in all 

four species. However, the amount of radioactivity recovered from tissues was small, ranging from 

<0.1% to 5.4% of the dose, because the majority of the label is excreted in urine (an average of 60% 

of the dose) and feces (an average of 11% of the dose) (Army 1981d). This indicates both rapid 

absorption and rapid distribution in different species after oral exposure to 2,4,6-trinitrotoluene. The 

limitations of this study are that a small number of animals was analyzed for distribution of radiolabel 

and that the amount of unchanged 2,4,6-trinitrotoluene was not discussed. 

2.3.2.3 Dermal Exposure 

No studies were located regarding distribution following dermal exposure to 2,4,6-trinitrotoluene in 

humans or animals. However, the recovery of radiolabel after a single dermal application of 50 mg/kg 

of 2,4,6-trinitrotoluene was significantly lower in rats, mice, dogs, and rabbits than in those exposed 
2,4,6-TRINITROTOLUENE 48 

2. HEALTH EFFECTS 

orally (Army 1981d). Skin and fat around the site of dermal application were not included in the final 

radiolabel recovery estimates. This may account for the lower radiolabel recovery obtained after the 

dermal exposure (Army 1981d). The recovery of radiolabel from urine, feces, gastrointestinal tract, 

blood, and tissue differed among the four species examined: rabbits (56.9%) > mice (41.7%) > rats 

(22.8) > dogs (15.9%). 

2.3.3 Metabolism 

2.3.3.1 Inhalation Exposure 

No studies were located regarding metabolism following inhalation exposure to 2,4,6-trinitrotoluene in 

humans or animals. However, in a retrospective study (covering a 5-year period) of 2,4,6-trinitrotoluene 

workers, no correlation was found between the presence in urine of one of the main 

2,4,6-trinitrotoluene metabolites, ADNT, and the results of Webster’s reaction, which measures urine 

2,4,6-trinitrotoluene levels (Hassman and Hassmanova 1976). This result provides indirect evidence 

that 2,4,6-trinitrotoluene is metabolized completely and that no detectable amounts of unchanged 

compound are present in the urine. This study is limited in that it does not clearly define the route of 

exposure and does not specify the dose or the length of exposure. 

2.3.3.2 Oral Exposure 

No studies were located specifically addressing metabolism following oral exposure to 2,4,6­

trinitrotoluene in humans. 

The 2,4,6-trinitrotoluene molecule may undergo various metabolic transformations, such as oxidation 

of the methyl group, oxidation of the benzene ring, reduction of the three nitro groups, and 

conjugation (EPA 1989b). A metabolic pathway illustrating some possible transformation products of 

2,4,6Mnitrotoluene is shown in Figure 2-2 (Army 1981d). The failure to detect unmetabolized 

2,4,6-trinitrotoluene in the urine of humans (Hassman and Hassmanova 1976) provides indirect 

evidence that 2,4,6-trinitrotoluene is extensively metabolized. Trace amounts of unmetabolized 

2,4,6-trinitrotoluene were found in the urine of rats, mice, rabbits, and dogs (Army 1981d). Several 

2,4,6-TRINITROTOLUENE 50 

2. HEALTH EFFECTS 

metabolites have been identified in human urine: 4-ADNT, 2-ADNT, 2,4-diatnino-6-nitrotoluene, 

4-hydroxylamino-2,6-dinitrotoluene, and amino-nitrocresol (Army 1986c; Channon et al. 1944; 

Lemberg and Callaghan 1945). 

2,4,6-Trinitrotoluene was extensively metabolized in rats, mice, dogs, and rabbits after a single oral 

dose of 50 mg/kg of radiolabelled 2,4,6-trinitrotoluene (Army 1981d). Only minute amounts of the 

unmetabolized 2,4,6-trinitrotoluene were found in urine. The majority of urinary metabolic products 

have high polarity and very low extractability in organic solvents. It was therefore difficult to identify 

them. The metabolic profiles of urine from the four species differed only quantitatively (Army 

1981d). 4,6-Diamine, 2,6-diamine, and monoamines of 2,4,6-trinitrotoluene were the predominant 

metabolites detected in the urine of rats. Smaller quantities of 2- and 4-hydroxylamines and 

azoxytoluene were present. In contrast to rat urine, greater amounts of the monoamines and 

hydroxylamines and smaller quantities of polar metabolites and diamines were found in the urine of 

mice. The urine of dogs contained appreciable amounts of diamines and monoarnines and small 

amounts of the 4-hydroxylamine and 2-hydroxylamine. Substantial amounts of monoarnines, 

hydroxylamines, and diamines were noted in rabbit urine (Army 1981d). Treatment of urine of all 

species with β-glucuronidase increased the amount of extractable radioactivity, indicating that 

conjugation of 2,4,6-trinitrotoluene metabolites with UDP-glucuronic acid is an important route of 

metabolism. Urine from treated mice contained the least amount of glucuronide conjugates (Army 

1981d). 

2.3.3.3 Dermal Exposure 

No studies were located regarding metabolism following dermal exposure to 2,4,6-trinitrotoluene in 

humans. 

The differences in metabolic profiles from the urine of mice, rats, dogs, and rabbits after a single 

dermal dose of 50 mg/kg of radiolabelled 2,4,6-trinitrotoluene were only quantitative (Army 1981d). 

There was an increased amount of unchanged 2,4,6-trinitrotoluene in urine after a single dermal 

exposure which was not found after a single oral exposure (Army 1981d). This suggests that the 

exposure route plays a role in the extent of 2,4,6-trinitrotoluene biotransformation. 
2,4,6-TRINITROTOLUENE 51 

2. HEALTH EFFECTS 

2.3.4 Excretion 

2.3.4.1 Inhalation Exposure 

4-ADNT, which is considered to be a major metabolite of 2,4,6-trinitrotoluene, was shown to be 

present in the urine of munitions workers exposed to 0.045-0.93 mg/m3 of 2,4,6-trinitrotoluene by 

both the Webster reaction and by a polarographic technique (Hassman and Hassmanova 1976). 

Similar findings were made using a sensitive gas chromatographic method (Almog et al. 1983). No 

unchanged 2,4,6trinitrotoluene was detected in this study. However, no detail was provided regarding 

the exposure dose or route. 

Recovery of radiolabel from urine of Sprague-Dawley rats 4 hours after intratracheal instillation of 

50 mg/kg of radiolabelled 2,4,6-trinitrotoluene was similar to the recovery after oral exposure. The 

amount of radiolabel in the urine, expressed as a percentage of the dose, was 19% and 13% in male 

and female animals, respectively (Army 1981d). 

2.3.4.2 Oral Exposure 

No studies were located regarding excretion following oral exposure to 2,4,6-trinitrotoluene in humans. 

The results from animal studies indicate that urine is the major excretion route after a single oral dose 

of radioactive 2,4,6-trinitrotoluene. The excretion of radioactive label was studied in Sprague-Dawley 

rats after a single oral dose of 100 mg/kg (Army 1981d). In the course of 24 hours after exposure, 

53-65% of the radioactivity was recovered from the urine; 2-8% from the feces; and 30-34% from 

the gastrointestinal tract and its contents. Similar results on the recovery of radiolabel in urine were 

obtained after oral exposure of albino CD1 mice (100 mg/kg), rabbits (5 mg/kg), and dogs (50 mg/kg) 

to radioactive 2,4,6-trinitrotoluene (Army 1981d). These results were confirmed when a 24-hour 

recovery of radiolabelled 2,4,6-trinitrotoluene was evaluated in rats, mice, dogs, and rabbits after a 

single oral exposure of 50 mg/kg (Army 1981d). The percentages of radiolabel in urine were 59.5%, 

59%, and 61% for rats, mice, and dogs, respectively. The highest amount of radiolabel was recovered 

from the urine of rabbits, 74.3%. The amounts of label from feces were 11%, 24%, 5%, and 22% for 
2,4,6-TRINITROTOLUENE 52 

2. HEALTH EFFECTS 

rats, mice, rabbits, and dogs, respectively. Although the number of animals in these studies was 

relatively small, the results indicate that there are species differences regarding excretion after acute 

oral exposure to 2,4,6-trinitrotoluene. The urine of rats and mice in these studies was bright red in 

color, indicating formation of some species-specific, unknown metabolite(s); no such color was 

observed in dogs and rabbits (Army 1981d). 

2.3.4.3 Dermal Exposure 

No studies were located regarding excretion following dermal exposure to 2,4,6-trinitrotoluene in 

humans. 

Total recovery of radioactive label (from blood, liver, kidneys, lungs, spleen, brain, muscle, 

gastrointestinal tract, feces, and urine) after a single dermal exposure of 50 mg/kg of radiolabel 

2,4,6-trinitrotoluene was evaluated in rats, mice, dogs, and rabbits and compared to total recovery after 

oral exposure (Army 198 Id). In all species, the total recovery of the radiolabel was significantly 

lower after dermal exposure as compared to oral exposure. Total radioactivity recovered after dermal 

exposure was 16%, 23%, 42%, and 57% in dogs, rats, mice, and rabbits, respectively. For 

comparison, the recovery after oral exposure was 92%, 94%, 94%, and 104% in rats, dogs, mice, and 

rabbits (Army 1981d). These results indicate that the total recovery of the label after a single dermal 

exposure to 2,4,6-trinitrotoluene varies depending on the species. Recovery is also affected by the 

exposure route; recovery after oral exposure is significantly higher than after dermal exposure (Army 

1981d). 

2.3.5 Mechanisms of Action 

Although the mechanisms by which 2,4,6-trinitrotoluene and its derivatives exert their toxic effects on 

organ systems (including the blood, liver, and eye lens) are largely unknown, a general theory has 

been developed to explain the toxicity of 2,4,6-trinitrotoluene. 

As discussed in Section 2.3.1, in limited studies of humans and animals it appears 2,4,6-trinitrotoluene 

is readily absorbed by inhalation, ingestion, or dermal routes of exposure. Also, it has been 
2,4,6-TRINITROTOLUENE 53 

2. HEALTH EFFECTS 

demonstrated that 2,4,6-trinitrotoluene is lipid soluble; tracer studies have shown accumulation in 

subcutaneous fat, and it would be expected to be present in lipids in the liver and marrow. A theory 

of the mechanism of toxicity by 2,4,6-trinitrotoluene is that the parent compound and some metabolic 

intermediates are active oxygen generators (Kong et a1.1989) and are involved in lipid peroxidation in 

the liver and in oxygenation of the lens to form cataracts (Liu et al. 1992; Savolainen et al. 1985). In 

addition, it is postulated that in the rat 2,4,6-trinitrotoluene undergoes rapid reduction to 

hydroxylamine and that this intermediate can be bioactivated to bind sulfhydryl proteins (Liu et al. 

1992). This bioactivation is postulated to occur in the liver or in the blood via different pathways. In 

the liver, bioactivation of hydroxylamine is postulated to involve oxidation by NADPH-dependent 

hepatic microsomal enzymes. In the blood, bioactivation of hydroxylamine is postulated to involve a 

reaction with oxyhemoglobin (Liu et al. 1992). 

2.4 RELEVANCE TO PUBLIC HEALTH 

The general public is not likely to be exposed to 2,4,6-trinitrotoluene. However, there is a possibility 

that populations will be exposed in the vicinity of munitions fabrication plants, demilitarization 

facilities, and particularly at incinerator facilities and former and current open-bum and opendetonation 

facilities. Occupational or accidental exposure to 2,4,6-trinitrotoluene may occur by the 

oral, inhalation, or dermal routes. 

Oral exposure to 2,4,6-trinitrotoluene in aquatic environments in the vicinity of ammunition plants is 

not likely because 2,4,6-trinitrotoluene stays unchanged for only a short period because of photolysis 

(half-life of less than 24 hours) and biological degradation (half-life of less than 65 days). However, if 

there is 2,4,6-trinitrotoluene-contaminated soil in the vicinity of a munitions plant, oral exposure 

through terrestrial food products (especially homegrown produce or locally grazed animals) cannot be 

completely ignored as a possible exposure pathway. Dermal exposure through contaminated soil is 

more likely since the degradation of 2,4,6-trinitrotoluene in soil is less effective than in water (Army 

1986c). Volatilization of 2,4,6-trinitrotoluene from surface water is negligible, making inhalation 

exposure unlikely. 
2,4,6-TRINITROTOLUENE 54 

2. HEALTH EFFECTS 

Information on the effects that occur in humans after exposure to 2,4,6-trinitrotoluene comes from case 

reports of accidental intoxication and from studies of occupationally exposed workers in the 

manufacture of high explosives. Because of improvements in the work environment, numerous 

adverse health effects caused by exposure to 2,4,6-trinitrotoluene, such as anemia, liver function 

abnormalities, respiratory complications, and possibly aplastic anemia, have been greatly reduced. 

Historically, adverse effects on the liver have caused the greatest number of deaths among munitions 

workers; 475 deaths were reported in the United States during World War I (McConnell and Flinn 

1946). Cases of aplastic anemia, which is usually fatal, were also reported during that time. As stated 

in the previous paragraph, these adverse effects have been almost eliminated with the introduction of 

more effective protection measures for workers handling 2,4,6-trinitrotoluene. 

The major effects observed in animals after intermediate or chronic exposures to 2,4,6-trinitrotoluene 

are reduced number of red blood cells, reduced hemoglobin and hematocrit, anemia, testicular damage, 

hepatomegaly, and splenomegaly. 

Inhalation 

No MRLs were derived for acute, intermediate, or chronic exposure by the inhalation route. 

Oral 

An MRL of 0.0005 mg/kg/day has been derived for intermediate oral exposure to 2,4,6­

trinitrotoluene. This MRL is based on the occurrence of dose-related liver effects (cloudy 

swelling and hepatocytomegaly) noted in dogs administered 0.5 mg/kg/day by capsule for 6 

months (Levine et al. 1990b). More severe liver injury (hemosiderosis in Kupffer’s cells and 

hepatic cirrhosis) was observed at high doses, supporting the sensitivity of the selected end 

point. In addition, liver toxicity (jaundice, elevated serum and urine bilirubin levels, 

hepatocellular hyperplasia, cloudy swelling, focal necrosis, changes in the levels of serum 

triglycerides, and increased serum cholesterol levels) have been reported in animals orally 
2,4,&TRINITROTOLUENE 55 

2. HEALTH EFFECTS
 

exposed to 2,4,6-trinitrotoluene for intermediate or chronic durations (Army 1984a; Dilley et 

al. 1982b; Levine et al. 1984). 

Insufficient information was available to calculate an acute-duration oral MRL for neurological effects. 

Additional studies in acute oral exposures to 2,4,6-trinitrotoluene are needed to determine the threshold 

level for neurological effects. Chronic-duration exposure to the intermediate-duration oral MRL of 

0.0005 mg/kg/day, which is the same value as the EPA’s chronic oral Reference Dose (RfD), would 

not be anticipated to cause adverse health effects. 

Death. In the United States, 475 deaths were reported among munitions workers during World War I 

(McConnell and Flinn 1946). One death from hepatocellular carcinoma was reported in a case of 

chronic occupational exposure to 2,4,6-trinitrotoluene (Garfmkel et al. 1988). It is not clear, however, 

if 2,4,6-trinitrotoluene played a role in the carcinogenic process. Death has been observed in rats, 

mice, and dogs (Dilley et al. 1982b; Levine et al. 1990b) after oral exposure to sufficient amounts of 

2,4,6-trinitrotoluene. Reported oral LD50 values are 1,010 and 1,320 mg/kg/day for male rats, and 820 

and 795 mg/kg/day for female rats (Army 1978b; Dilley et al. 1982b). Acute oral LD50 values in male 

and female mice are 1,012 and 660 mgkglday, respectively (Army 1978b; Dilley et al. 1982b). 

2,4,6-Trinitrotoluene was lethal in beagle dogs receiving 32 mg/kg/day orally for 26 weeks (Levine et 

al. 1990b). 

It is extremely unlikely that sufficient levels of 2,4,6-trinitrotoluene could be ingested acutely by 

persons living in the vicinity of an ammunition plant to cause death. Furthermore, the low levels of 

2,4,6-trinitrotoluene that are likely to be present in the soil near the plants are substantially below the 

levels that are necessary to cause death. 

Systemic Effects 

Respiratory Effects. Extremely limited information was located regarding respiratory effects in 

humans after exposure to 2,4,6-trinitrotoluene. One study of occupational exposure (Morton et al. 

1976) reported several cases of respiratory difficulties in workers exposed to 2,4,6-trinitrotoluene levels 
2,4,6-TRINITROTOLUENE 56 

2. HEALTH EFFECTS 

in the air that were above the TLV of 0.5 mg/m3 (ACGIH 1993). However, there are several 

limitations to this study. The report does not state the exact air concentration of 2,4,6-trinitrotoluene, 

the exposure duration, or the number of exposed workers reporting difficulties. No details are given 

about the nature of the reported difficulties. No studies in animals were located that described 

potential respiratory effects of 2,4,6-trinitrotoluene. Therefore, insufficient evidence exists to assess 

the relevance of these findings to public health. 

Cardiovasclilar Effects. No studies were located regarding cardiovascular effects in humans. 

Intermediate oral exposure to doses as high as 32 mg/kg/day of 2,4,6-trinitrotoluene for 26 weeks did 

not cause any changes in electrocardiogram or heart rates in beagle dogs (Levine et al. 1990b). The 

available information is not sufficient to evaluate the effects of 2,4,6-trinitrotoluene on populations 

living close to ammunition plants. 

Gastrointestinal Effects. There are no studies on gastrointestinal effects in humans after exposure to 

2,4,6-trinitrotoluene. However, two studies in dogs reported adverse gastrointestinal effects following 

intermediate oral exposure to 2,4,6-trinitrotoluene. Dogs receiving 20 mg/kg/day for 13 weeks had 

mucoid stools and diarrhea (Dilley et al. 1982b), while inflammation of a part of the small intestine 

was observed in beagle dogs fed 0.5, 2, 8, and 32 mg/kg/day of 2,4,6-trinitrotoluene for 25 weeks 

(Levine et al. 1990b). The inflammation was dose-dependent and was more pronounced in dogs 

receiving the highest dose. Based on the available information, it is possible, although unlikely, that 

oral exposure to 2,4,6-trinitrotofuene may cause some adverse gastrointestinal effects, but it is not 

known if such effects would occur after dermal exposure in the vicinity of an ammunition plant or a 

demilitarization facility. Although dermal exposure has been indicated as the most likely route of 

exposure in occupational situations, limited exposure to 2,4,6-trinitrotoluene may result from ingestion 

of produce contaminated by deposition from fugitive particles or resuspension of contaminated soil, or 

from ingestion of animal products from animals that graze in the vicinity of an ammunition or 

demilitarization facility (Army 1986d). 

Hematological Effects. Fatal cases of aplastic anemia among workers engaged in the production of 

explosives have not been reported in the recent literature, although they occurred in England 
2,4,6-TRINITROTOLUENE 57 

2. HEALTH EFFECTS 

(Hathaway 1985) and other countries involved in World War I. The incidence of adverse health 

effects of 2,4,6-trinitrotoluene including aplastic anemia have decreased dramatically because of 

improvements in protective measures in munitions factories. 

Dose-related reductions in hemoglobin and hematocrit and a 50% increase in reticulocyte counts were 

noted in 626 workers exposed to 2,4,6-trinitrotoluene air levels ranging from <0.1 to 1.49 mg/m3 

(Army 1976). The duration of exposure was not specified. In another study, no abnormal values for 

hemoglobin were found in 43 workers employed in the manufacture of 2,4,6-trinitrotoluene who were 

monitored for 5 months (Morton et al. 1976). 

Acute hemolytic disease was described in three ammunition plant workers (Djerassi and Vitany 1975) 

who were also glucose-6-phosphate dehydrogenase (GGPD) deficient. This study is limited in that the 

exposure route is not specified, so it is not clear how relevant the finding is for general public health. 

Anemia (consisting of reduced number of red blood cells and reduced hemoglobin and hematocrit) is 

one of the major signs of 2,4,6-trinitrotoluene toxicity. These adverse effects were observed in rats 

(Dilley et al. 1982b; Jiang et al. 1991; Levine et al. 1984, 1990a), mice (Dilley et al. 1982b), and dogs 

(Dilley et al. 1982b; Levine et al. 1990b) after intermediate oral exposure to 2,4,6-trinitrotoluene. 

Similar observations were made in Fischer-344 rats fed 10 or 50 mg/kg/day for 24 months (Army 

1984a). In this chronic exposure study, male rats were somewhat more sensitive than female rats to 

the toxic effects of 2,4,6-trinitrotoluene. Reticulocytosis was present as a compensatory response to 

the anemic state in all animals. Methemoglobinemia was noted in rats fed 300 mg/kg/day for 

13 weeks (Levine et al. 1984), in rats fed 10 or 50 mg/kg/day for 24 months (Army 1984a), and in 

dogs fed 32 mg/kg/day for 6 months (Levine et al. 1990b). 

Bone marrow fibrosis and leukocytosis were present in rats orally exposed to 2,4,6-trinitrotoluene for 

24 months or 13 weeks; these animals were also anemic (Army 1984a; Dilley et al. 1982b). 

Dogs and rats had increased platelet levels after exposure for 6 and 24 months, respectively (Army 

1984a; Levine 1990b). The significance of this finding was not discussed. 
2,4,6-TRINITROTOLUENE 58 

2. HEALTH EFFECTS 

Based on this information, it seems unlikely that sufficient amounts of 2,4,6-trinitrotoluene would be 

present near ammunition plants to cause adverse hematological effects in the population living in the 

vicinity. Individuals who are G6PD deficient may need to be evaluated as a potentially susceptible 

population. 

Hepatic Effects. Toxic hepatitis has been the principal manifestation of 2,4,6-trinitrotoluene toxicity 

in humans, and many cases recorded during World War I were fatal (Army 1987a). 

Reports on adverse hepatic effects of 2,4,6-trinitrotoluene in humans have been located. Increases in 

hepatic enzymes (SGOT and LDH) were noted in ammunition plant workers exposed when air levels 

of 2,4,6-trinitrotoluene rose from 0.3 to 0.8 mg/m3 (Morton et al. 1976). The duration of the study 

was 5 months. In another study, no significant differences in liver function (LDH, bilirubin, alkaline 

phosphatase, SGOT and SGPT) were noted in a cross-sectional study on 626 munitions workers 

exposed to 0.5 mg/m3

 of 2,4,6-trinitrotoluene (Army 1976). 

In a retrospective study spanning 20 years, liver cell irritation (measured with the MacLagen thymol 

turbidity test) was present in 40 munitions workers (Goodwin 1972). The report did not specify the 

exposure dose or route. Exposure of animals to moderate-to-high levels (0.5-200 mg/kg/day) of 

2,4,6-trinitrotoluene over intermediate-to-chronic periods has been reported to cause adverse effects 

such as jaundice, elevated serum and urine bilirubin levels, hyperplasia, cloudy swelling, focal necrosis 

and cirrhosis of the liver, changes in the levels of serum triglycerides, and increased serum cholesterol 

levels (Army 1984a; Dilley et al. 1982b; Levine et al. 1984, 1990b). It is not known if chronic 

exposure to the levels of 2,4,6-trinitrotoluene described above would cause similar adverse hepatic 

effects in exposed humans. 

These degenerative effects are distinct from the adaptive changes observed in livers of a number of 

nonhuman species in response to exposure to 2,4,6-trinitrotoluene. The most common adaptive 

change observed in several animal species during intermediate exposure to 2,4,6-trinitrotoluene was an 

increase in liver weight and/or size (Dilley et al. 1982b; Jiang et al. 1991; Levine et al. 1984). It is 

not known if these effects would occur in humans. 
2,4,6-TRINITROTOLUENE 59 

2. HEALTH EFFECTS 

Renal Effects. No studies were located regarding renal effects in humans after exposure to 

2,4,6-trinitrotoluene. However, studies have shown that discoloration of the urine is among the first 

indications of 2,4,6-trinitrotoluene exposure in humans and is due to the presence of 2,4,6­

trinitrotoluene metabolites. The color of urine ranges from abnormal amber to deep red (Army 

1978a). 

Discoloration of the urine from the presence of 2,4,6-trinitrotoluene metabolites also occurs in rats, 

mice, and dogs. Sixty minutes after acute exposure to 10,000 mg/kg/day of 2,4,6-trinitrotoluene, the 

urine in mice and rats became red in color because of the presence of 2,4,6-trinitrotoluene metabolites 

(Dilley et al. 1982b). The same effect was observed in rats and dogs treated with higher doses and for 

a longer period (Dilley et al. 1982b). Increased filtration rate was present in rats chronically exposed 

to 10 and 50 mg/kg/day of 2,4,6-trinitrotoluene (Army 1984a). 

In rats treated with higher doses of 2,4,6-trinitrotoluene for 13 weeks (Levine et al. 1984; 1990b) or 

24 months (Army 1984a), histopathological analysis revealed the accumulation of yellowish-brown 

pigment in the renal cortex and in the epithelial cells of proximal convoluted tubules. It is therefore 

possible that persons exposed to extremely high levels of 2,4,6-trinitrotoluene may be at increased risk 

of renal toxicity. 

Dermal Effects. Exposure to 2,4,6-trinitrotoluene can cause dermatitis in workers handling the 

compound (Morton et al. 1976). Two incidences of allergic contact dermatitis were reported in two 

ammunition plant workers after intermediate-duration exposure to 2,4,6-trinitrotoluene (Goh 1988; Goh 

and Rajan 1983). These findings indicate that prolonged exposure to relatively low levels of 

2,4,6-trinitrotoluene may cause an allergic reaction manifested by dermatitis appearing in the areas of 

contact with the chemical. 

Ocular Effects. The appearance of irreversible cataracts is believed to be specific to 2,4,6-trinitrotoluene 

exposure. It is often associated with chronic exposures to relatively low levels of 2,4,6-trinitrotoluene 

(Hathaway 1985). Equatorial lens opacities/cataracts were reported in 6 out of 12 workers 

exposed to 2,4,6-trinitrotoluene for an average of 6.8 years (Harkonen et al. 1983). The average 
2,4,6-TRINITROTOLUENE 60 

2. HEALTH EFFECTS 

concentration of 2,4,6-trinitrotoluene in the air was 0.3 mg/m3, which is well below the threshold limit 

of 0.5 mg/m3 (ACGIH 1993). It is therefore possible that chronic exposure to low levels of 

2,4,6-trinitrotoluene in the vicinity of ammunition plants may have adverse ocular effects. 

Immunological and Lymphoreticular Effects. An increase in the number of mononuclear 

leukocytes was found in reviewing blood cell counts of 105 individuals exposed to 2,4,6-trinitrotoluene 

(Army 1978a). This increase precedes any other symptom, remains positive for 2-3 months, and 

could be helpful in differential diagnosis. Also increased were lymphocyte numbers in nine cases of 

fatal 2,4,6-trinitrotoluene poisoning (Army 1974). Since the doses necessary to produce these effects 

were not established, the possibility that susceptible persons living in the vicinity of ammunition plants 

may be exposed to sufficient amounts of 2,4,6-trinitrotoluene to trigger such immunological effects 

cannot be excluded. 

Exposure to 2,4,6-trinitrotoluene can cause dermatitis in workers handling the compound (Morton et al. 

1976). Two incidences of allergic contact dermatitis were reported in two ammunition plant workers 

after intermediate exposure to 2,4,6-trinitrotoluene (Goh 1988; Goh and Rajan 1983). These findings 

indicate that prolonged exposure to relatively low levels of 2,4,6-trinitrotoluene may cause an allergic 

reaction manifested by dermatitis appearing in the areas of contact with the chemical. 

Increased spleen weight was the most common effect seen in several nonhuman species after 

intermediate exposure to medium-to-high doses of 2,4,6-trinitrotoluene (Dilley et al. 1982b; Levine et 

al. 1984, 1990a). Other changes, such as splenic congestion and hemosiderosis, reduced lymphocyte 

counts, increased lymphocyte counts, and increased globulin levels, were also noted. Thus, persons 

exposed to sufficiently high levels of 2,4,6-trinitrotoluene near ammunition plants may be at risk of 

developing immune system or lymphoreticular effects including splenomegaly with splenic congestion 

and hemosiderosis, lymphocytosis due to reduced lymphocyte counts, and higher globulin levels. 
2,4,6-TRINITROTOLUENE 61 

2. HEALTH EFFECTS 

Neurological Effects. Only minor neurological effects, such as altered taste, were noted in humans 

after an inhalation exposure of 0.3 mg/m3 of 2,4,6-trinitrotoluene (Morton et al. 1976). On the basis of 

this limited information, it is difficult to speculate on possible adverse neurological effects that may 

occur in 2,4,6-trinitrotoluene-exposed people living in the vicinity of ammunition plants. 

Rats showed no signs of neurotoxicity after acute exposure to 182 mgtkglday (Short and Lee 1980). 

However, when fed an extremely high dose of 10,000 mg/kg/day, both rats and mice showed signs of 

inactivity; some developed convulsions and died (Dilley et al. 1982b). Similar observations were 

made in the intermediate-duration studies in dogs, rats, and monkeys fed low doses of 2,4,6­

trinitrotoluene (Dilley et al. 1982b; Martin and Hart 1974). When higher doses were used (32 mg/kg/day 

for 26 weeks), dogs became ataxic (Levine et al. 1990b). In rats exposed to 300 mg/kg/day of 

2,4,6-trinitrotoluene for 13 weeks, brain lesions (consisting of focal vacuolation and malacia of the 

white tracts of the cerebellar folia) were seen in histopathological analysis (Levine et al. 1984). In 

contrast, no significant signs of neurotoxicity were seen in rats treated with up to 50 mg/kg/day for 

24 months (Army 1984a). Since these results indicate species differences after acute, intermediate, and 

chronic exposures, it is difficult to estimate potential neurotoxic effects for humans living close to 

ammunition plants. 

Reproductive Effects. A preliminary case control study of workers in two 2,4,6-trinitrotoluene 

plants in China indicates exposure to 2,4,6-trinitrotoluene may have adverse effects on several 

indicators of male reproductive status (Li et al. 1993). Workers exposed to 2,4,6-trinitrotoluene had 

significantly lower semen volumes and a smaller percentage of motile spermatozoa as well as a 

significantly higher incidence of sperm malformation than the control group. However, exposure 

concentrations and route of exposure are not known. Possible important variables which are not 

discussed include exposure to other chemicals and heat in the workplace. 

Serious reproductive effects, such as testicular atrophy and atrophic seminiferous tubules, were 

observed in rats treated with high doses of 2,4,6-trinitrotoluene for 13 weeks (Dilley et al. 1982b; 

Levine et al. 1984, 1990a). These changes were not reversible after a 4-week recovery period. Based 
2,4,6-TRINITROTOLUENE 62 

2. HEALTH EFFECTS 

on this limited information, adverse reproductive effects after exposure of males to sufficiently high 

concentrations of 2,4,6-trinitrotoluene cannot be excluded. 

Developmental Effects. No studies were located regarding developmental effects in humans or 

animals following exposure to 2,4,6-trinitrotoluene by any exposure route. It is therefore not possible 

to predict the potential developmental toxicity of 2,4,6-trinitrotoluene at hazardous waste sites or near 

ammunition plants. 

Genotoxic Effects. No studies were found that directly assess the potential of 2,4,6-trinitrotoluene 

to induce genotoxic effects in humans. However, there is convincing evidence that the urine of 

individuals occupationally exposed to 2,4,6-trinitrotoluene contains mutagenic components (Ahlborg et 

al. 1985, 1988a). The primary metabolite of 2,4,6-trinitrotoluene appears to be 4-aminodinitrotoluene 

(6ADNT); major intermediate forms, including 4-ADNT, are weakly mutagenic in bacteria (Spanggord 

et a1.1982b). By contrast, 2,4,6-trinitrotoluene is a confirmed mutagen in bacterial and 

mammalian cells in vitro and;2,4,6-trinitrotoluene-induced mutagenesis is either markedly diminished 

or abolished by the inclusion of exogenous metabolic activation into these test systems (see discussion 

of in vitro results below). 

The detection of unmetabolized 2,4,6-trinitrotoluene in the urine of exposed workers exhibiting a high 

level of mutagenic activity (Ahlborg et al. 1985) tends to support the assumption that the parent 

compound rather than its derivatives was responsible for the observed response. However, a more 

detailed follow-up study found no correlation between mutagenicity and 2,4,6-trinitrotoluene 

concentration in urine (Ahlborg et al. 1988a). It is nevertheless possible that these conflicting results 

could be resolved if more appropriate concentration procedures improved the detection of 

2,4,6-trinitrotoluene. This would elucidate the possible connection between mutagenesis and the 

concentrations of 2,4,6-trinitrotoluene and/or its metabolites in the urine of exposed workers. 

Only one in vitro study employing a human cell line (WI-38 human fibroblasts) was found in the 

existing literature (Army 1978~). In this study, target cells were exposed to 2,4,6-trinitrotoluene doses 

ranging from 2 to 2,000 μg/mL without S9 activation and from 6 to 6,000 μg/mL in the presence of an 
2,4,6-TRINITROTOLUENE 63 

2. HEALTH EFFECTS 

uninduced mouse liver homogenate. Precipitation of the test material occurred at ≥200 μg/mL 

(without S9) and at 375 μg/mL (in the presence of S9). At nonactivated levels of 500 and 

1,000 μg/mL, a significant (p<0.05) increase in UDS was obscured by discoloration of the samples; 

however, significant (p<0.05) effects were also obtained at 250 μg/mL. No discoloration of the test 

samples occurred in the S9-activated phase of testing, and no evidence of a genotoxic response was 

uncovered. Although a definitive conclusion could not be reached because of compound interference 

with the nonactivated assay results, the data do not suggest that 2,4,6-trinitrotoluene was genotoxic in 

this human cell line. Similarly, the lack of an effect in the presence of auxiliary metabolic activation 

is consistent with other in vitro assay results. 

The single in vivo animal study assessing potential adverse effect on the chromosome structure of 

somatic cells following oral administration of 2,4,6-trinitrotoluene was negative but compromised 

because neither a toxic effect in the rats nor a cytotoxic effect on the target organ (i.e., bone marrow 

cells) was demonstrated (Army 1978c). However, the results of a well-conducted mouse micronucleus 

assay, which evaluated 2,4,6-trinitrotoluene at a level (80 mg/kg) that approximated 80% of the 

maximum tolerated dose, provided no indication of a clastogenesis (Ashby et al. 1985). For this 

study, groups of five male CBA x Balb C mice received single intraperitoneal injections of 40 or 

80 mg/kg 2,4,6-trinitrotoluene; animals were sacrificed 24, 48, and 72 hours post-treatment, and bone 

marrow cells were examined for the presence of micronucleated polychromatic erythrocytes (MPEs). 

Results indicated that there were no significant increases in the frequency of MPEs in bone marrow 

cells sampled over the entire hematopoietic cycle. Similarly, the in vivo / in vitro rat liver UDS assay 

performed by the same investigators was negative. 

As the above discussion indicates, deleterious genetic events resulting from exposure to 

2,4,6-trinitrotoluene have not been extensively investigated in either humans or animals. Since the 

only available studies in humans were from occupational settings, inhalation must be considered an 

important pathway of 2,4,6-trinitrotoluene exposure. However, quantifiable dermal absorption 

indicates that 2,4,6-trinitrotoluene is absorbed through the skin. It also suggests that dermal absorption 

plays an important role in 2,4,6-trinitrotoluene uptake, which may be more important than uptake 

through inhalation (Ahlborg et al. 1988a). The identification of the agent(s) responsible for the 
2,4,6-TRINITROTOLUENE 64 

2. HEALTH EFFECTS 

mutagenic activity observed in the urine of workers exposed to 2,4,6-trinitrotoluene is of considerable 

importance, because human metabolism of 2,4,6-trinitrotoluene has not been fully characterized. It is 

possible that the parent compound, a known mutagen, and its metabolites, which are also mutagens in 

S. typhimurium TA98, are contributors to 2,4,6-trinitrotoluene-induced mutagenesis (Spanggord et al. 

1982b). 

Although only three in vivo studies were found, the overall results provided no evidence that 

2,4,6-trinitrotoluene is genotoxic in whole animals. This assumption is supported by the results of the 

in vitro UDS assay with human cells indicating that 2,4,6-trinitrotoluene-induced UDS was abolished 

by the inclusion of exogenous metabolic activation (Army 1978c). Similar results, as discussed below, 

were obtained in other test systems using both cultured bacterial and mammalian cells. 

The implications of both the whole animal and in vitro human cell assay findings are highly relevant 

to human health. If 2,4,6-trinitrotoluene can be reduced to nonmutagenic metabolic products, the 

potential health hazard to humans would be greatly reduced. Refer to Tables 2-2 and 2-3 for a further 

summary of these studies. 

In contrast to the absence of genotoxicity in animal studies, numerous investigators (Ahlborg et al. 

1985, 1988a; Army 1978a, 1978c, 1979b, 1980d; Kaplan and Kaplan 1982c; Pearson et al. 1979; 

Spanggord et al. 1982b; Whong and Edwards 1984; Won et al. 1976) have demonstrated that 

2,4,6-trinitrotoluene is a microbial mutagen. There is good agreement that 2,4,6-trinitrotoluene 

primarily causes frameshift mutations in S. typhimurium TA1537, TA1538, and TA98 and that the 

mutagenic response is not dependent on auxiliary metabolic activation nor substantially influenced by 

microbial nitroreductase activity. Data also exist showing that 2,4,6-trinitrotoluene is mutagenic in 

S. typhimurium strains TA1535 and TA100, which detect agents that cause base-pair substitution 

mutations (Army 1978c, 1979b, 1980d; Whong and Edwards 1984). The weight of evidence, 

however, is consistent with a frameshift mutagen; appreciably higher levels of 2,4,6-trinitrotoluene 

(≥30 μg/plate) were required to achieve positive responses in TA1535 and TA100 as compared to the 

reactivity (≥2 μg/plate) of 2,4,6-trinitrotoluene with strains TA1538 and/or TA98. Metabolites of 

2,4,6-trinitrotoluene have not been shown as consistently to be mutagens in S. typhimurium. While the 


2,4,6-TRINITROTOLUENE 67 

2. HEALTH EFFECTS 

parent compound induced a dose-related increase in mutant colonies of S. typhimurium TA98 over a 

concentration range of 2-10 μg/plate, the seven investigated metabolites were negative (Won et al. 

1976). In a study using the same assay system, one of the tested metabolites (2-amino-4,6­

dinitrotoluene) was positive, while the second one (4-amino-2,6-dinitrotoluene) was only slightly 

positive; both needed nitroreductase to induce mutagenicity (Spanggord et al. 1982b). Similarly, in a 

third study the four possible mono- and diamino metabolites of 2,4,6-trinitrotoluene were all less 

mutagenic than the parent compound in TA98 or TA100 (Tan et al. 1992). Mutagenicity in 

Salmonella tester strains seems dependent on endogenous nitroreductase activity. Strains deficient in 

nitroreductase show decreased sensitivity to 2,4,6-trinitrotoluene while strains constructed with 

increased nitroreductase activity show increased sensitivity (Einisto et al. 1991). 

2,4,6-Trinitrotoluene is also capable of causing gene mutations in mammalian cells (Styles and Cross 

1983). In a well-conducted study, 2,4,6-trinitrotoluene (8-l,000 μg/mL) caused dose-dependent 

cytotoxicity and significant increases in mutation at the TK+/- locus in mouse lymphoma cells. In 

agreement with other in vitro assay findings, S9 activation was not required to demonstrate the 

response. 2,4,6-Trinitrotoluene was negative under conditions of exogenous metabolic activation. No 

studies investigating potential clastogenic effects in vitro were found. 

Although the database for in vitro genetic toxicology testing with 2,4,6-trinitrotoluene is limited, a 

high degree of concordance exists among different assay systems. Based on the existing information, 

there is sufficient valid in vitro data to conclude that 2,4,6-trinitrotoluene is a direct-acting mutagen in 

bacterial and mammalian cells. There is also suggestive evidence that 2,4,6-trinitrotoluene is a 

directacting genotoxic agent in cultured human cells. Refer to Table 2-2 for a further summary of these 

results. 

Cancer. One preliminary epidemiological study of German populations living in the proximity of 

former munitions plants suggests 2,4,6-trinitrotoluene may increase leukemia rates in exposed adult 

human populations (Kolb et al. 1993). However, the case numbers in this study are very small. Also 

the proximity of the cases of leukemia to sites where 2,4,6-trinitrotoluene was manufactured during 

World War II or to disposal sites is not reported nor are any environmental 2,4,6-trinitrotoluene 
2,4,6-TRINITROTOLUENE 68 

2. HEALTH EFFECTS 

concentrations. Therefore, there is only slight circumstantial evidence linking the observed leukemia 

cases to possible 2,4,6-trinitrotoluene exposure. Furthermore, no investigation of confounding 

variables (e.g., benzene exposure or occupational exposure to carcinogens) has been done. 

Several female Fisher-344 rats developed urinary bladder carcinoma after exposure to 10 or 

50 mg/kg/day of 2,4,6-trinitrotoluene for 24 months (Army 1984a). A similar study conducted in 

B6C3F1 mice showed that a statistically significant (p<0.01) incidence of leukemia and/or malignant 

lymphoma of the spleen was present in female mice receiving 70 mg/kg/day for 24 months (Army 

1984b). On the basis of this result, EPA has classified 2,4,6-trinitrotoluene as a possible human 

carcinogen (Group C) (EPA 1989b). 

2.5 BIOMARKERS OF EXPOSURE AND EFFECT 

Biomarkers are broadly defined as indicators signaling events in biologic systems or samples. They 

have been classified as markers of exposure, markers of effect, and markers of susceptibility 

(NAS/NRC 1989). 

A biomarker of exposure is a xenobiotic substance or its metabolite(s) or the product of an interaction 

between a xenobiotic agent and some target molecule(s) or cell(s) that is measured within a 

compartment of an organism (NAS/NRC 1989). The preferred biomarkers of exposure are generally 

the substance itself or substance-specific metabolites in readily obtainable body fluid(s) or excreta. 

However, several factors can confound the use and interpretation of biomarkers of exposure. The 

body burden of a substance may be the result of exposures from more than one source. The substance 

being measured may be a metabolite of another xenobiotic substance (e.g., high urinary levels of 

phenol can result from exposure to several different aromatic compounds). Depending on the 

properties of the substance (e.g., biologic half-life) and environmental conditions (e.g., duration and 

route of exposure), the substance and all of its metabolites may have left the body by the time biologic 

samples can be taken. It may be difficult to identify individuals exposed to hazardous substances that 

are commonly found in body tissues and fluids (e.g., essential mineral nutrients such as copper, zinc, 

and selenium). Biomarkers of exposure to 2,4,6-trinitrotoluene are discussed in Section 2.5.1. 
2,4,6-TRINITROTOLUENE 69 

2. HEALTH EFFECTS 

Biomarkers of effect are defined as any measurable biochemical, physiologic, or other alteration within 

an organism that, depending on magnitude, can be recognized as an established or potential health 

impairment or disease (NAS/NRC 1989). This definition encompasses biochemical or cellular signals 

of tissue dysfunction (e.g., increased liver enzyme activity or pathologic changes in female genital 

epithelial cells), as well as physiologic signs of dysfunction such as increased blood pressure or 

decreased lung capacity. Note that these markers are often not substance specific. They also may not 

be directly adverse, but can indicate potential health impairment (e.g., DNA adducts). Biomarkers of 

effects caused by 2,4,6-trinitrotoluene are discussed in Section 2.5.2. 

A biomarker of susceptibility is an indicator of an inherent or acquired limitation of an organism’s 

ability to respond to the challenge of exposure to a specific xenobiotic substance. It can be an 

intrinsic genetic or other characteristic or a preexisting disease that results in an increase in absorbed 

dose, biologically effective dose, or target tissue response. If biomarkers of susceptibility exist, they 

are discussed in Section 2.7, “Populations That Are Unusually Susceptible.” 

2.5.1 Biomarkers Used to Identify or Quantify Exposure to 2,4,6-Trinitrotoluene 

The availability of biomarkers is useful in estimating the degree of exposure in cases where the 

exposure is suspected or known. Identification of 2,4,6-trinitrotoluene in blood and urine is the most 

direct confirmation that exposure to 2,4,6-trinitrotoluene has occurred. Sensitive methods have been 

developed for determination of 2,4,6-trinitrotoluene and its metabolites in human blood and urine (for 

more information see Chapter 6). 

Detection of 2,4,6-trinitrotoluene in the blood or urine is an indication of a recent dermal, oral, or 

inhalation exposure. However, since 2,4,6-trinitrotoluene is rapidly metabolized, it may be difficult to 

determine trace amounts of the unchanged compound in blood or urine. In such cases, identification 

of major 2,4,6-trinitrotoluene metabolites such as 4-ADNT and 2-ADNT in the urine can be used as an 

indication of exposure. In one case of acute, primarily dermal exposure to 2,4,6-trinitrotoluene, these 

two metabolites were present in the urine of exposed workers 17 days after exposure (Woolen et al. 

1986). This finding indicates that they can be used as indicators of not only recent, but also past, 

acute exposures to 2,4,6-trinitrotoluene. Another early sign of 2,4,6-trinitrotoluene exposure is the 
2,4,6-TRINITROTOLUENE 70 

2. HEALTH EFFECTS 

change of urine color that can range in humans from abnormal amber to deep red (Army 1978a). The 

identification of the metabolite responsible for this color change would represent a good biomarker for 

early detection of 2,4,6-trinitrotoluene exposure. 

In the study on distribution of 2,4,6-trinitrotoluene after oral, inhalation and dermal exposure of rats, 

mice, rabbits and dogs it was found that 2,4,6-trinitrotoluene distributes to fat (Army 1981d). 

Therefore the lipid concentration of 2,4,6-trinitrotoluene could be used as a potential biomarker of 

exposure, provided adequate methodology is available. 

No information was found on tissue levels of 2,4,6-trinitrotoluene after relatively long-term exposure 

to constant levels of 2,4,6-trinitrotoluene. However, since absorption, biodegradation, and excretion 

occur rapidly, it can be assumed that the presence of 2,4,6-trinitrotoluene metabolites may be used to 

identify exposure. Because of rapid conversion of 2,4,6-trinitrotoluene into its metabolites, it is also 

reasonable to assume that long-term exposure will not lead to a steady state of 2,4,6-trinitrotoluene 

levels. 

2.5.2 Biomarkers Used to Characterize Effects Caused by 2,4,6-Trinitrotoluene 

Prior to the use of blood and urine levels to monitor exposure to 2,4,6-trinitrotoluene (during the two 

World Wars, and especially during World War I), jaundice was one of the main indicators of 

2,4,6-trinitrotoluene intoxication. However, jaundice is a sign of serious hepatic toxicity, that develops 

over a period of time, and it is not useful as an early indicator compared to other signs such as urine 

discoloration. Since jaundice is a latent phenomenon, many cases had fatal outcomes before the 

jaundice was observed. In addition, jaundice is not specific for 2,4,6-trinitrotoluene exposure and may 

be caused by other factors. 

Decreased hemoglobin and hematocrit levels and increased reticulocyte numbers are among the first 

changes to occur after exposure to sufficiently high levels of 2,4,6-trinitrotoluene (Army 1976). The 

levels of these three blood parameters reflected in a complete blood count can be used as nonspecific 

biomarkers; their determination is rapid, relatively inexpensive, and useful for monitoring cohorts of 

persons possibly exposed to 2,4,6-trinitrotoluene. 
2,4,6-TRINITROTOLUENE 71 

2. HEALTH EFFECTS 

An early reaction to 2,4,6-trinitrotoluene intoxication is an increase in mononuclear leukocytes, which 

seems to precede any other symptom and remains positive for 2-3 months (Army 1978a). Also found 

in nine fatal cases of 2,4,6-trinitrotoluene poisoning was a significant increase in lymphocyte counts 

(Army 1974a). The extent and significance of these findings need further elucidation since both are 

commonly present in a number of other pathological states. 

Changes in the hepatic enzymes SGOT and LDH were noted after the levels of 2,4,6-trinitrotoluene 

increased from 0.3 to 0.8 mg/m3 (Morton et al. 1976). In another study, however, no changes in liver 

function were seen in 626 munitions workers exposed to an average of 0.5 mg/m3 (Army 1976). An 

explanation for these different findings may be that new or increased exposure to 2,4,6-trinitrotoluene 

causes more liver toxicity in potentially susceptible workers, while in cases of longer exposure liver 

cells may adapt to moderate exposure levels (Hathaway 1985). Although many other substances and 

diseases can cause changes in the levels of hepatic enzymes, a record of pre-exposure levels could 

resolve these problems and allow for the use of hepatic enzymes as effective exposure markers. It is 

possible that in the future a battery of tests to indicate liver disease could be used to identify the 

causal agent. For example, cholylglycine is a bile acid that accumulates in serum in cases of hepatic 

dysfunction, and interleukin-1 is indicative of inflammation. Both of these markers were found 

elevated in all patients with viral hepatitis, but only 37.5% or 25% were positive, respectively, in 

2,4,6-trinitrotoluene-induced liver damage (Li et al. 1992). 

Another potential adverse effect of 2,4,6-trinitrotoluene exposure is the formation of cataracts. It is 

believed to be specific to 2,4,6-trinitrotoluene and is often associated with chronic, low-level exposure 

(Hathaway 1985). Bilateral, symmetrical equatorial lens opacities were reported in workers exposed to 

2,4,6-trinitrotoluene for an average of 6.8 years (Harkonen et al. 1983). 

Two cases of contact dermatitis were reported in workers after an intermediate exposure to 

2,4,6-trinitrotoluene (Goh 1988; Goh and Rajan 1983). On the basis of this information, skin patch 

testing could be done to detect individuals potentially hypersensitive to 2,4,6-trinitrotoluene. 
2,4,6-TRINITROTOLUENE 72 

2. HEALTH EFFECTS 

2.6 INTERACTIONS WITH OTHER CHEMICALS 

Limited information was located regarding the influence of other chemicals on the toxicity of 

2,4,6trinitrotoluene. However, one extensive animal study evaluated the acute and intermediate 

effects of a mixture of 2,4,6-trinitrotoluene and 1,3,5-trinitrohexahydro-1,3,5-triazine (RDX) on rats, 

mice, dogs, and rabbits (Army 1978c). The mixture of the two compounds is designated as LAP 

(load, assemble, and pack) mixture. The ratio of 2,4,6-trinitrotoluene and RDX in the LAP mixture in 

this study was 1.6:1. Acute oral toxicity of the LAP mixture was investigated in rats, mice, and 

rabbits. The results indicate that there was a distinct species difference regarding acute oral toxicity 

after exposure to the LAP mixture. The acute oral LD50 values indicate that rats were more susceptible 

to toxic effects of the LAP mixture than to 2,4,6-trinitrotoluene alone. The opposite was true for mice 

which were more resistant to the LAP mixture than to 2,4,6-trinitrotoluene (Army 1978c). LAP 

applied to the eyes of rabbits produced conjunctivitis, iritis, and/or cornea1 opacity. Intermediate oral 

toxicity was determined in a 90-day exposure study in rats, mice, and dogs. The results indicate that 

the main target organs for LAP toxicity are the same as those for 2,4,6-trinitrotoluene, namely blood 

and liver. Mild-to-moderate hemolytic anemia, enlarged spleens and livers, hemosiderosis of the 

spleen, and colored urine were common effects of intermediate exposure to LAP seen in all three 

species. LAP-induced testicular atrophy (dogs and rats), uterine hypoplasia (rats), and numerous 

neurological signs (dogs) were also observed. These observations indicate that 2,4,6-trinitrotoluene 

was the principal, but not the only factor, contributing to the intermediate oral toxicity of LAP; some 

of the observed toxicity is due to RDX (Army 1978c). 

Because 2,4,6-trinitrotoluene is rapidly degraded in the environment, it is possible that it would 

interact with its degradation products to amplify adverse health effects. However, it is not known how 

the interaction of 2,4,6-trinitrotoluene with these co-contaminants affects or alters predicted health 

effects. 

2.7 POPULATIONS THAT ARE UNUSUALLY SUSCEPTIBLE 

A susceptible population will exhibit a different or enhanced response to 2,4,6-trinitrotoluene than will 

most persons exposed to the same level of 2,4,6-trinitrotoluene in the environment. Reasons include 
2,4,6-TRINITROTOLUENE 73 

2. HEALTH EFFECTS 

genetic make-up, developmental stage, health and nutritional status, and chemical exposure history. 

These parameters result in decreased function of the detoxification and excretory processes (mainly 

hepatic and renal) or the pre-existing compromised function of target organs. For these reasons we 

expect that the elderly with declining organ function and the youngest of the population with immature 

and developing organs will generally be more vulnerable to toxic substances than healthy adults. 

Populations who are at greater risk due to their unusually high exposure are discussed in Section 5.6, 

“Populations With Potentially High Exposure.” 

No information was located on populations that are known to be unusually susceptible to toxic effects 

of 2,4,6-trinitrotoluene. However, in the review of the literature one report described the occurrence of 

acute hemolytic disease (Djerassi and Vitany 1975) in three individuals deficient in GGPD enzyme. 

All three developed hemolytic crisis with similar symptoms 2-4 days after being exposed to 

2,4,6-trinitrotoluene. All three also recovered and were complication free at 5- and 10-year followup. 

Populations that may show increased sensitivity to 2,4,6-trinitrotoluene would include very young 

children, who have immature hepatic detoxification systems; individuals with impaired liver function, 

including alcoholics (Li et al. 1991), or impaired kidney function; and those who are prone to anemia 

or who are anemic. Also at increased risk may be individuals with such genetic traits as G6PD 

deficiency, sickle cell trait, genetically induced unstable hemoglobin forms, or congenital 

hypercholesterolemia. Another subpopulation that may be at increased risk is comprised of individuals 

with a potential immune reaction to 2,4,6-trinitrotoluene. 

2.8 METHODS FOR REDUCING TOXIC EFFECTS 

This section will describe the clinical practice and research concerning methods for reducing toxic 

effects of exposure to 2,4,6-trinitrotoluene. However, because some of the treatments discussed may 

be experimental and unproven, this section should not be used as a guide for treatment of exposures to 

2,4,6-trinitrotoluene. When specific exposures have occurred, poison control centers and medical 

toxicologists should be consulted for medical advice. 
2,4,6-TRINITROTOLUENE 74 

2. HEALTH EFFECTS 

2.8.1 Reducing Peak Absorption Following Exposure 

No chemical-specific recommendations have been reported for reducing absorption following 2,4,6­

trinitrotoluene exposure via any route (Haddad and Winchester 1990; HSDB 1994). General methods 

for reducing exposure can be found for explosives (Bronstein and Currance 1988). Other sources 

recommend the same treatment for overexposure to 2,4,6-trinitrotoluene as for aniline (Gosselin et al. 

1984) or aromatic nitro compounds (Stutz and Ulin 1992). General procedures suggested for reducing 

absorption following accidental industrial exposure include moving the exposed person into fresh air, 

removing contaminated clothing and shoes, and flushing exposed skin or eyes with running water 

(HSDB 1994). 

In recent years, there have been very few reported cases of overexposure via inhalation or dermal 

contact because simple industrial hygiene methods are used to effectively prevent contact with high 

concentrations of 2,4,6-trinitrotoluene in the workplace. However, during both World Wars some 

cases of industrial exposure have resulted in fatalities (Haddad and Winchester 1990). 

Oral exposure to toxic quantities of 2,4,6-trinitrotoluene have not been reported for humans, although 

it is possible that some of the cases of overexposure of workers were caused in part by inadvertent 

ingestion via hand-to-mouth contact as well as by inhalation and dermal contact with 2,4,6­

trinitrotoluene. In general, only supportive treatment has been recommended (HSDB 1994). In some 

cases, gastric lavage, activated charcoal, and emetics have been suggested as useful in reducing 

absorption of the general class of nitro compounds to which 2,4,6-trinitrotoluene belongs (Gosselin et 

al. 1984; Stutz and Ulin 1992). Other sources state emesis should not be used for explosives 

(Bronstein and Currance 1988). 

2.8.2 Reducing Body Burden 

No quantitative studies of human retention or elimination of 2,4,6-trinitrotoluene were located. Acute 

laboratory studies of animals show rapid elimination in the urine of 2,4,6-trinitrotoluene and its 

metabolites when it is administered orally or dermally. Historically, only a small proportion of the 

munitions workers during World War I and II who were exposed to high concentrations of 
2,4,6-TRINITROTOLUENE 75 

2. HEALTH EFFECTS 

2,4,6-trinitrotoluene experienced hepatic disease. The only treatment was to remove the affected
 

workers from areas where they could be exposed to 2,4,6-trinitrotoluene. Because the onset of
 

symptoms was frequently delayed for 1 to 4 months following exposure, in some cases no symptoms
 

appeared until days or weeks after exposure to 2,4,6-trinitrotoluene had ended (Haddad and Winchester
 

1990).
 

A more recent study of workers exposed to 2,4,6-trinitrotoluene found that a subgroup of workers
 

showed signs of liver cell irritation. These workers were removed from areas with 2,4,6-trinitrotoluene
 

exposure and fed diets high in protein and calories. After 3 weeks, signs of liver cell irritation
 

disappeared, and they were returned to work requiring contact with 2,4,6-trinitrotoluene (Goodwin
 

1972).
 

In some cases of exposure to 2,4,6-trinitrotoluene, methemoglobinemia has been reported. This effect
 

is independent of hepatic damage. Some sources suggest treatment of methemoglobinemia with
 

methylene blue (Ellenhorn and Barceloux 1988; Gosselin et al. 1984; Stutz and Ulin 1992).
 

However, it has been noted that methylene blue should be used with caution (Stutz and Ulin 1992)
 

especially if there is a possibility of glucose-6-phosphate dehydrogenase (G6PD) deficiency (Ellenhorn
 

and Barceloux 1988).
 

2.8.3 Interfering with the Mechanism of Action for Toxic Effects 

The mechanism of toxic action by 2,4,6-trinitrotoluene and the compounds formed by the metabolism 

of 2,4,6-trinitrotoluene are not known. A theory is that, at a biochemical level, 2,4,6-trinitrotoluene or 

its metabolites generate active oxygen species (Kong et al. 1989; Liu et al. 1992; Savolainen et al. 

1985). No information was located on established therapies designed to interfere with this possible 

mechanism of action of 2,4,6-trinitrotoluene. Because 2,4,6-trinitrotoluene is known to cause liver 

damage and may decrease glutathione concentrations (Liu et al. 1992), it is possible an intervention 

that acts by increasing the cellular concentrations of antioxidants (especially glutathione, glutathione 

peroxidase, and those that are lipid soluble such as vitamin E) could reduce liver damage caused by 

2,4,6-trinitrotoluene. 
2,4,6-TRINITROTOLUENE 76 

2. HEALTH EFFECTS 

The impetus to search for an agent that reduces the toxicity of 2,4,6-trinitrotoluene or its metabolites is 

generally lacking since the use of good hygiene in the workplace has eliminated the health effects 

formerly detected in the United States and Western Europe. It should be noted that with industrial or 

military accidents involving large quantities of 2,4,6-trinitrotoluene, the most immediate critical hazard 

is one of explosion or fire (HSDB 1994; Stutz and Ulin 1992). 

2.9 ADEQUACY OF THE DATABASE 

Section 104(i)(5) of CERCLA, as amended, directs the Administrator of ATSDR (in consultation with 

the Administrator of EPA and agencies and programs of the Public Health Service) to assess whether 

adequate information on the health effects of 2,4,6-trinitrotoluene is available. Where adequate 

information is not available, ATSDR, in conjunction with the National Toxicology Program (NTP), is 

required to assure the initiation of a program of research designed to determine the health effects (and 

techniques for developing methods to determine such health effects) of 2,4,6-trinitrotoluene. 

The following categories of possible data needs have been identified by a joint team of scientists from 

ATSDR, NTP, and EPA. They are defined as substance-specific informational needs that, if met, 

would reduce or eliminate the uncertainties of human health assessment. This definition should not be 

interpreted to mean that all data needs discussed in this section must be filled. In the future, the 

identified data needs will be evaluated and prioritized, and a substance-specific research agenda may 

be proposed. 

2.9.1 Existing Information on Health Effects of 2,4,6-Trinitrotoluene 

The existing data on health effects of inhalation, oral, and dermal exposure of humans to 2,4,6­

trinitrotoluene are summarized in Figure 2-3. The purpose of this figure is to illustrate the existing 

information concerning the health effects of 2,4,6-trinitrotoluene. Each dot in the figure indicates that 

one or more studies provide information associated with that particular effect. The dot does not imply 

anything about the quality of the study or studies. Missing information in this figure should not be 

interpreted as “data needs” information (i.e., data gaps that must necessarily be filled). 

2,4,6-TRINITROTOLUENE 78 

2. HEALTH EFFECTS 

Recent literature pertaining to the health effects of 2,4,6-trinitrotoluene in humans described case 

reports and retrospective, intermediate- and chronic-duration studies of workers employed in the 

manufacture of ammunition. No acute human exposure data were located. For those employed in the 

manufacturing process using 2,4,6-trinitrotoluene, the major routes of exposure are dermal and 

inhalation. Thus, information on intermediate- and chronic-duration exposures comes exclusively from 

derrnal and inhalation exposure data. Information from occupational and retrospective studies is 

frequently limited by a lack of data regarding quantification of doses and precise duration of exposure. 

No information was located regarding developmental, reproductive, genotoxic, or cancer effects in 

humans by any route. Information on any effects in humans after oral exposure to 2,4,6-trinitrotoluene 

was also not found. 

Virtually all of the data on animals regarding health effects from 2,4,6-trinitrotoluene exposure were 

obtained from studies in which 2,4,6-trinitrotoluene was administered orally. Over the past 25 years, 

the majority of the extensive studies done in several mammalian species (i.e., rat, mouse, and dog) 

were performed for the Army. One of those studies addresses the effects of 2,4,6-trinitrotoluene after 

derrnal exposure and intratracheal (performed under anesthesia) instillation. 

Releases from hazardous waste sites or from military installations involved in the manufacture of 

2,4,6-trinitrotoluene and the processing of munitions that contain the compound are the main sources 

of potential exposure of the general population to 2,4,6-trinitrotoluene. Because persons living in the 

vicinity of these two types of sites may be exposed by oral, dermal, or inhalation routes, additional 

information on the effects via these routes would be valuable. 

2.9.2 Identification of Data Needs 

Acute-Duration Exposure. Available data are not sufficient to derive acute oral or inhalation 

MRLs. There are no data regarding acute-duration exposure of humans to 2,4,6-trinitrotoluene by 

inhalation or oral routes. Additional studies in acute oral exposures to 2,4,6-trinitrotoluene are needed 

to determine the threshold level for neurological effects because the only available data demonstrate 

serious neurological effects in a single oral LD50 study in rodents (Dilley et al. 1982b). Populations 
2,4,6-TRINITROTOLUENE 79 

2. HEALTH EFFECTS 

living in the vicinity of ammunition plants or hazardous waste disposal sites may be exposed to 

2,4,6-trinitrotoluene. Exposure would most probably occur via the dermal route, but there is a 

possibility that inhalation and oral exposures may occur. A dermal patch test for 2,4,6-trinitrotoluene 

was positive in one case of contact dermatitis in a worker previously exposed to 2,4,6-trinitrotoluene 

(Goh 1988). In a week-long study of workers handling 2,4,6-trinitrotoluene, two metabolites 

(aminodinitrotoluenes) were present in the urine: 4-ADNT and 2-ADNT. No other effects of 

exposure were reported (Woolen et al. 1986). Renal effects were observed in mice and rats 

(discoloration of the urine) after oral exposure to a relatively high dose of 2,4,6-trinitrotoluene (Dilley 

et al. 1982b). Other signs of exposure were inactivity, tremors, and death in both species. Since 

populations living in the vicinity of ammunition plants may be exposed to 2,4,6-trinitrotoluene by all 

three routes, animal studies of exposure via all three routes would be useful in elucidating possible 

effects in humans after acute exposure. 

Intermediate-Duration Exposure. One occupational intermediate-duration study of inhalation 

exposure to low levels of 2,4,6-trinitrotoluene in workers found a significant increase in the hepatic 

enzymes SGOT and LDH when the air concentration was increased from 0.3 to 0.8 mg/m3

 (Morton et 

al. 1976). Unspecified respiratory difficulties were reported in some workers. Hemoglobin levels 

remained within a normal range. Because of the very low exposure level, it is difficult to determine 

the major target organ since adaptation can mask changes in circulating hemoglobin levels. Another 

occupational report identified the immunological system as the target organ in a case of contact 

dermatitis (Goh and Rajan 1983). However, studies in laboratory animals following intermediateduration 

oral exposure did confirm the blood as a major target organ (Dilley et al. 1982b; Jiang et al. 

1991; Levine et al. 1984, 1990a, 1990b). Other target organs identified in intermediate-duration oral 

studies include liver, kidney, gastrointestinal tract, spleen, central nervous system, and reproductive 

system (Dilley et al. 1982b; Levine et al. 1984, 1990a, 1990b). An intermediate-duration oral MRL 

for 2,4,6-trinitrotoluene has been calculated based on a study that noted dose-related liver effects in 

dogs receiving 0.5 mg/kg/day for 6 months (Levine et al. 1990b). 
2,4,6-TRINITROTOLUENE 80 

2. HEALTH EFFECTS 

Chronic-Duration Exposure and Cancer. Few studies have been conducted on workers that have 

been chronically exposed to 2,4,6-trinitrotoluene. Increased levels of zinc and copper were found in 

hair samples of workers exposed for 3-7 years, mainly by the inhalation route (Jiang et al. 1991). 

Three other studies, two of inhalation (Harkonen et al. 1983; Savolainen et al. 1985) and one of 

dermal exposure (Harkonen et al. 1983), showed the occurrence of varying degrees of cataracts in 

exposed workers. Another effect after chronic inhalation exposure was the decreased activity of two 

mitochondrial enzymes necessary for heme synthesis: heme synthase and S-aminolevulinic acid 

synthase (Savolainen et al. 1985). More studies are needed to elucidate the meaning of that finding 

and its role in the possible development of anemia. One case of cirrhosis was reported after chronic 

occupational exposure (35 years) to 2,4,6-trinitrotoluene (Garfinkel et al. 1988). 2,4,6-Trinitrotoluene 

is known to cause hepatic damage, but it is not known whether it caused the cirrhosis, 

The major adverse effects observed in Fisher rats fed 50 mg/kg/day for 24 months were anemia, 

hepatotoxicity and splenic lesions (Army 1984a). On the basis of this study’s finding, chronicduration 

exposure to the intermediate-duration oral MRL of 0.0005 mg/kg/day (same value as the RfD) 

would not be anticipated to cause adverse health effects. 

One case of hepatocellular carcinoma was reported after chronic occupational exposure (35 years) to 

2,4,6-trinitrotoluene (Garfinkel et al. 1988). Carcinoma of the urinary bladder was observed in Fisher 

rats (in females only) fed 50 mg/kg/day for 24 months (Army 1984a). On the basis of these findings 

of bladder carcinoma, 2,4,6-trinitrotoluene was classified by EPA as a possible human carcinogen-­

Group C (EPA 1989b). Additional animal studies on chronic dermal and inhalation exposures would 

clarify if bladder carcinoma occurs after exposure by those routes, and if it is sex related. 

Genotoxicity. Evidence that mutagenic substances are present in human urine comes from studies of 

occupationally exposed individuals (Ahlborg et al. 1985, 1988a). These exposures occurred via both 

inhalation and dermal routes, although the latter one appears to be more important in 

2,4,6-trinitrotoluene uptake. The lack of a correlation between mutagenesis and 2,4,6-trinitrotoluene 

concentration in the urine of exposed workers is of considerable relevance and should be thoroughly 

investigated. The major metabolites of 2,4,6-trinitrotoluene are known to exert a mutagenic effect in 
2,4,6-TRINITROTOLUENE 81 

2. HEALTH EFFECTS 

bacteria. It therefore appears likely that biotransformation products are responsible for the genotoxic 

activity in the urine of exposed workers since 2,4,6-trinitrotoluene concentrations are low. Similarly, 

the dose-response relationship between 2,4,6-trinitrotoluene exposure and the mutagenicity of exposed 

worker urine should be fully characterized in order to establish the urine assay as a reliable biomarker 

for exposure screens. 

The limited whole animal studies provide assurance that 2,4,6-trinitrotoluene is not genotoxic in 

somatic cells. However, no information related to potential adverse effects on germinal cells was 

found; therefore, studies (e.g., dominant lethal mutation assay) should be considered to ensure that all 

relevant genetic end points have been investigated. There is reliable evidence that 2,4,6-trinitrotoluene 

induces mutations in bacterial (Army 1978a,c, 1979b, 1980c; Spanggord et al. 1982b) and mammalian 

cells (Styles and Cross 1983) and inconclusive evidence that 2,4,6-trinitrotoluene causes UDS in 

cultured human fibroblasts (Army 1978c). The relevance of these in vitro findings to human health 

should not be underestimated. The weight of evidence clearly suggests that the genotoxic activity of 

2,4,6-trinitrotoluen(b is markedly inhibited or abolished in the presence of exogenous metabolic 

activation systems. Thus, the potential hazard to human genetic material resulting from exposure to 

2,4,6-trinitrotoluene is very limited. It is, therefore, doubtful whether the performance of additional in 

vitro assays would substantially alter the established genetic toxicology profile of 2,4,6-trinitrotoluene. 

Confirmation of the mammalian cell assay findings is, nevertheless, desirable to establish full 

confidence in the validity of the existing data. 

Reproductive Toxicity. Significantly lower semen volumes, a smaller percentage of motile 

spermatozoa, and a higher incidence of sperm malformation were reported in a case-control study in 

two 2,4,6-trinitrotoluene plants in China (Li et al. 1993). However, exposure to 2,4,6-trinitrotoluene 

was not estimated. No studies were found describing reproductive effects of 2,4,6-trinitrotoluene in 

human females. Studies in laboratory animals show dose-dependent reproductive toxicity after 

intermediate oral exposure to 2,4,6-trinitrotoluene. Testicular atrophy, degenerated germinal 

epithelium, and atrophic seminiferous tubules were effects observed in male rats after exposure to high 

doses of 2,4,6-trinitrotoluene (Levine et al. 1984). Additional studies of these effects after dermal and 

inhalation exposure would be helpful in determining if the effects are specific for the oral exposure 
2,4,6-TRINITROTOLUENE 82 

2. HEALTH EFFECTS 

route. The results from one rat study indicate that there is a close correlation between reduction of 

testes weight and decreased zinc concentration (Jiang et al. 1991). The role of zinc and its possible 

effect on the male sex function needs further investigation. No studies were located that examined 

reproductive toxicity in females. 

Developmental Toxicity. No human or animal studies were located on developmental effects for 

any exposure route. Studies in animals assessing postnatal survival after maternal exposure by all 

three routes would be useful. 

Immunotoxicity. Very little information was located on immunological effects in humans after 

dermal and inhalation exposure to 2,4,6-trinitrotoluene. An increase in mononuclear leukocytes and 

lymphocytes was noted in a retrospective study of blood counts of exposed munitions workers (Army 

1978a). The significance of this finding needs further investigation since no such data were presented 

in animal studies. Two isolated cases of allergic contact dermatitis were described in workers handling 

2,4,6-trinitrotoluene (Goh 1988; Goh and Rajan 1983). The importance of 2,4,6-trinitrotoluene as an 

allergen needs to be examined further in order to understand the mechanisms involved in the possible 

development of hypersensitivity to 2,4,6-trinitrotoluene. 

Dose-dependent immunological reactions were seen in mice, rats, and dogs after intermediate oral 

exposure to 2,4,6-trinitrotoluene. Spleen enlargement and/or increased weight was the most often 

observed effect (Dilley et al. 1982b; Levine et al. 1984, 1990a). Histopathology revealed 

hemosiderosis and varying degrees of splenic congestion. Further studies of immunological effects in 

animals after chronic exposure would be important for estimating human susceptibility for populations 

potentially exposed in the vicinity of ammunition plants. 

Neurotoxicity. Limited information regarding neurological effects in humans indicates only minor 

effects such as altered taste (Morton et al. 1976). Dose-related changes in behavior were observed in 

several animal species after acute and intermediate oral exposure to 2,4,6-trinitrotoluene. Most 

common were depression (Dilley et al. 1982b), lethargy, and ataxia (Levine et al. 1990b). Brain 

lesions were present in rats receiving the highest dose of 2,4,6-trinitrotoluene (Dilley et al. 1982b; 
2,4,6-TRINITROTOLUENE 83 

2. HEALTH EFFECTS 

Levine et al. 1984). The results also show species differences in 2,4,6-trinitrotoluene-induced 

neurotoxicity, with dogs being more sensitive than rats or mice. Dose-response studies in animals and 

studies focusing on the mechanism of 2,4,6-trinitrotoluene-induced neurotoxicity would be useful in 

better understanding the possible neurotoxicity of 2,4,6-trinitrotoluene in humans. 

Epidemiological and Human Dosimetry Studies. Human studies on 2,4,6-trinitrotoluene consist 

of either retrospective studies of occupational exposure or case reports of workers employed in the 

manufacture of munitions. Exposures in both cases are primarily dermal and by inhalation. Locating 

populations for future epidemiological studies will be possible as long as 2,4,6-triaitrotoluene is 

produced and used in the manufacture of munitions. The two subgroups with the greatest possible 

exposure to 2,4,6-trinitrotoluene are those employed in the manufacturing process and those living in 

the vicinity of military installations/ammunition plants. If such groups are located, information 

regarding the immunologic, reproductive, developmental, genotoxic, and cancer effects and correlation 

of these effects with blood or urine levels of 2,4,6-trinitrotoluene that are associated with exposure 

would be extremely useful. 

Biomarkers of Exposure and Effect. Exposure to 2,4,6-trinitrotoluene is currently measured by 

determining the level of 2,4,6-trinitrotoluene in the blood or urine. However, since 2,4,6-trinitrotoluene 

is rapidly metabolized it may be difficult to determine trace amounts of unchanged compound 

in either blood or urine. In such cases, the presence of major 2,4,6-trinitrotoluene metabolites such as 

4-ADNT and 2-ADNT metabolites, which are present in the urine for over 2 weeks after acute 

exposure, can be used to indicate recent and past exposures (Woolen et al. 1986). Although the 

sensitivity of these biomarkers seems to be sufficient at the present time, it would be useful to 

determine the metabolite responsible for urine color change that occurs after exposure to 2,4,6­

trinitrotoluene. Identification of this metabolite in urine would provide an early biomarker of 2,4,6­

trinitrotoluene exposure. Since 2,4,6-trinitrotoluene has been found to bind to blood and liver proteins, the 

identity of these adducts and their tissue lifetimes would greatly enhance the use of these biomarkers 

as a measure of exposure. 
2,4,6-TRINITROTOLUENE 84 

2. HEALTH EFFECTS 

Decreases in hemoglobin and hematocrit levels and increases in reticulocyte numbers can be monitored 

and accurately determined after exposure to 2,4,6-trinitrotoluene. In some cases of prolonged 

exposure, these changes lead to the development of an anemic state. However, the changes in these 

blood parameters are not specific for exposure to 2,4,6-trinitrotoluene. What would be useful is a 

better understanding of the fundamental mechanism by which 2,4,6-trinitrotoluene causes changes in 

hemoglobin and hematocrit levels. Such an understanding might ultimately lead to the development of 

antidotes to decrease or completely alleviate some of the toxic effects caused by 2,4,6-trinitrotoluene. 

There are no tests that are specific for 2,4,6-trinitrotoluene-induced hepatic toxicity, but standard liver 

function tests should be able to identify hepatic toxicity caused by 2,4,6-trinitrotoluene. Although not 

specific for 2,4,6-trinitrotoluene exposure, more information is needed on changes in indicators of 

2,4,6-trinitrotoluene-induced hepatotoxicity, for example, SGOT and LDH levels. 

Jaundice may develop as a result of 2,4,6-trinitrotoluene exposure. Since jaundice is a late 

phenomenon, it is important to be sure that it is due to serious hepatic injury and not merely to the 

yellowing of the body’s surface exposed to the compound. 

Cataract formation is believed to be a specific 2,4,6-trinitrotoluene effect, developing primarily after 

chronic exposures (Harkonen et al. 1983; Savolainen et al. 1985). Since initial changes are small and 

often difficult to detect, development of more sensitive detection techniques would allow for earlier 

detection and prevention of potential adverse ocular effects due to 2,4,6-trinitrotoluene exposure. This 

is important because in the course of chronic occupational exposure, cataract formation may be the 

only sign of 2,4,6-trinitrotoluene toxicity. Additional studies are also needed to establish if cataract 

formation is a dose-response phenomenon. 

Absorption, Distribution, Metabolism, and Excretion. The majority of information regarding 

the rapid absorption of 2,4,6-trinitrotoluene in humans and animals comes indirectly from detectable 

levels of 2,4,6-trinitrotoluene metabolites in the urine after inhalation, oral, or dermal exposures. 

Occupational studies indicate that humans readily absorb 2,4,6-trinitrotoluene dusts via inhalation or 

dermal contact, but quantitative data are lacking. Animal studies indicate that 2,4,6-trinitrotoluene is 
2,4,6-TRINITROTOLUENE 85 

2. HEALTH EFFECTS 

absorbed relatively quickly and that the absorbed amount is dose related for the oral route (Army 

1981d). Information concerning absorption rates for all three routes is needed. Because there are few 

absorption studies for all three routes, additional quantitative data in animals would be useful as a 

basis for estimates of absorption in humans. 

No studies were located regarding distribution following inhalation, oral, or dermal exposure to 

2,4,6-trinitrotoluene in humans; limited information is available regarding distribution in animals after 

acute exposure to radiolabelled 2,4,6-trinitrotoluene via all three routes. These studies in animals 

indicate that 2,4,6-trinitrotoluene is rapidly distributed to blood, liver, fat, and skeletal muscle, but in 

very small amounts because the majority of the label was recovered from the gastrointestinal tract and 

urine (Army 1981d). Additional animal distribution studies on dermal exposure would be valuable to 

establish the biological half-lives in relevant tissues and because there is a potential for human 

exposure to occur via this route. 

No studies were located regarding the metabolism of 2,4,6-trinitrotoluene in humans after oral 

exposure. Data for the oral route are important because there is a potential for human exposure to 

occur via this route near waste sites containing 2,4,6-trinitrotoluene. Limited information comes from 

the analysis of urine of munitions workers after dermal (Woolen et al. 1986) or inhalation exposures 

(Hassman and Hassmanova 1976). The results from human and animal studies indicate that 

2,4,6-trinitrotoluene is readily metabolized and that very small amounts of unchanged compound are 

present in the urine. More studies are needed to define sex-related and species-related metabolic 

differences. Since differences in metabolism may occur with differences in the route of exposure, 

additional information is needed from inhalation and dermal metabolic studies in order to fully 

characterize the metabolic pathway of 2,4,6-trinitrotoluene. 

No studies were located regarding excretion after oral or dermal exposure to 2,4,6-trinitrotoluene in 

humans. The results from animal studies indicate that urine is the major site of radiolabel recovery 

after a single oral dose of 2,4,6-trinitrotoluene and that differences in excretion rate are exposure 

routedependent (Army 1981d). The recovery of radiolabel indicates that excretion was most efficient after 

inhalation exposure, followed by oral, and was least efficient after dermal exposure. Additional, more 
2,4,6-TRINITROTOLUENE 86 

2. HEALTH EFFECTS 

detailed studies on excretion after dermal exposure would be useful since that is an expected major 

exposure route for humans in the vicinity of waste sites and workers handling 2,4,6-trinitrotoluene. 

Comparative Toxicokinetics. Studies using different animal species (rats, mice, dogs, rabbits) 

indicate the kinetics of 2,4,6-trinitrotoluene differ across species. The observed differences are 

primarily quantitative (Army 1981b). On the basis of kinetic data alone, it is not possible to identify 

target organs common to humans and animals, but distribution data together with toxicity data after 

oral exposure suggest similar target organs: blood, liver, spleen, the kidneys and gastrointestinal tract. 

Interspecies differences, especially in metabolism and excretion have been noted in rats, mice, dogs, 

and rabbits (Army 1981b). Further animals studies covering all three exposure routes would be 

helpful in determining similarities and differences in absorption, metabolism and excretion between 

humans and animals. 

Methods for Reducing Toxic Effects. Animal studies addressing the possibility of diminishing or 

alleviating toxic effects of 2,4,6-trinitrotoluene are needed since no information was located on 

possible 2,4,6-trinitrotoluene antidotes. 

2.9.3 On-going Studies 

On-going studies regarding the health effects of 2,4,6-trinitrotoluene were reported in the Federal 

Research in Progress File (FEDRIP 1991) database. One study addressing health effects of 

2,4,6-trinitrotoluene in humans, “Deposition of volatile aerosols in the respiratory tract,” is being 

investigated at the University of Rochester, Rochester, New York, by Sidney Soderholm, principal 

investigator. The sponsoring organization is the National Institute of Environmental Health Sciences, 

No additional studies have been reported in the FEDRIP 1994, but it is likely that research in China 

on industrial exposure will continue (Li et al. 1991, 1992, 1993). The studies in Germany of 

populations surrounding former munitions manufacturing and disposal areas are being refined (Kolb et 

al. 1993). 
2,4,6-TRINITROTOLUENE 87 

3. CHEMICAL AND PHYSICAL INFORMATION 

3.1 CHEMICAL IDENTITY 

Information regarding the chemical identity of 2,4,6-trinitrotoluene is located in Table 3- 1. 

3.2 PHYSICAL AND CHEMICAL PROPERTIES 

Information regarding the physical and chemical properties of 2,4,6-trinitrotoluene is located in 

Table 3-2. 



2,4,6-TRINITROTOLUENE 91 

4. PRODUCTION, IMPORT, USE, AND DISPOSAL 

4.1 PRODUCTION 

2,4,6-Trinitrotoluene is prepared by the nitration of toluene with a mixture of nitric acid and sulfuric 

acid (Fisher and Taylor 1983; Sax and Lewis 1987). Toluene is nitrated in a three-step operation by 

using increasing temperatures and mixed-acid concentrations to successively introduce nitro groups to 

form mononitrotoluene (MNT), dinitrotoluene (DNT), and trinitrotoluene (Mark et al. 1980). The 

nitration can be accomplished in three separate steps or by continuous flow (Budavari et al. 1989). 

Numerous other compounds are also formed during the nitration of toluene including unsymmetrical 

isomers of 2,4,6-trinitrotoluene, and oxidation products such as tetranitromethane, nitrobenzoic acid, 

nitrocresol, and partially nitrated toluenes (Hamilton and Hardy 1974; Mark et al. 1980). The 

unsymmetrical 2,4,6-trinitrotoluene isomers are removed by washing with aqueous sodium sulfite 

solution (Fisher and Taylor 1983; Mark et al. 1980; Sax and Lewis 1987). 

2,4,6-Trinitrotoluene is not produced commercially in the United States; production is limited to 

military arsenals (HSDB 1994). Data on production volumes for 2,4,6-trinitrotoluene are not available. 

2,4,6-Trinitrotoluene is purchased from the U.S. Army Armament Material Command (Gibbs and 

Popolato 1980). Army ammunition plants that have been involved in the production and storage of 

2,4,6-trinitrotoluene include Shreveport (Louisiana), Anniston (Alabama), Crane (Indiana), Fort 

Wingate (New Mexico), Hawthorne (Nevada), Letterkenny (Pennsylvania), Lexington (Kentucky), 

McAlester (Oklahoma), Navajo (Arizona), Pine Bluff (Arkansas), Pueblo (Colorado), Red River and 

Lone Star (Texas), Savanna and Joliet (Illinois), Seneca (New York), Sierra (California), Tooele 

(Utah), and Umatilla (Oregon) Weldon Spring (Missouri), West Virginia Ordnance Works (West 

Virginia), Radford (Virginia), and Volunteer (Tennessee) (Army 1986a, 1986d; Haroun et al. 1990; 

Kraus et al. 1985; Phung and Bulff 1981). 

Since 2,4,6-trinitrotoluene releases are not required to be reported under SARA Section 313, there are 

no data on 2,4,6-trinitrotoluene in the 1988 Toxics Release Inventory (TRI88 1990). 
2,4,6-TRINITROTOLUENE 92 

4. PRODUCTION, IMPORT, USE, AND DISPOSAL 

4.2 IMPORT/EXPORT 

In 1985, an estimated 9.2 million pounds of 2,4,6-trinitrotoluene were imported into the United States 

(USDOC 1986). However, current import and export data for 2,4,6-trinitrotoluene are not available. 

4.3 USE 

2,4,6-Trinitrotoluene has been classified as a high explosive (Eveleth and Kollonitsch 1990). The 

compound is used as a military explosive in bombs and grenades (HSDB 1994; OHM/TADS 1985). It 

has been widely used for filling shells and airborne demolition bombs since it is sufficiently 

insensitive to the shock of ejection from a gun barrel but can be exploded on impact by a detonator 

mechanism (Eveleth and Kollonitsch 1990). 2,4,6-Trinitrotoluene has been used either as the pure 

explosive or in binary mixtures (Gibbs and Popolato 1980). The most common binary mixtures of 

2,4,6-trinitrotoluene are cyclotols (mixtures with RDX), octols (mixtures with HMX), amatols 

(mixtures with ammonium nitrate), and tritonals (mixtures with aluminum) (Eveleth and Kollonitsch 

1990; Gibbs and Popolato 1980). In addition to military use, small amounts of 2,4,6-trinitrotoluene 

may be used for industrial explosive applications, such as deep well and underwater blasting (HSDB 

1994). 

Other industrial uses of 2,4,6-trinitrotoluene include use as a chemical intermediate in the manufacture 

of dyestuffs and photographic chemicals (Sax and Lewis 1987). 

4.4 DISPOSAL 

Wastes generated in the manufacture of 2,4,6-trinitrotoluene are characterized as hazardous wastes by 

EPA, and EPA regulations for disposal must be followed (EPA 1990). For more information on the 

regulations that apply to 2,4,6-trinitrotoluene, see Chapter 7. 

Disposal of 2,4,6-trinitrotoluene has been accomplished effectively by burning in an incinerator 

equipped with an afterburner and a scrubber (OHM/TADS 1985). 2,4,6-Trinitrotoluene has been 

pretreated before incineration by pouring or sifting onto sodium bicarbonate or a sand-soda ash 
2,4,6-TRINITROTOLUENE 93 

4. PRODUCTION, IMPORT, USE, AND DISPOSAL 

mixture. The resulting combination is mixed and packaged in heavy paper cartons with plenty of 

paper packaging to serve as fuel (OHM/TADS 1985). 2,4,6-Trinitrotoluene has also been prepared for 

incineration by mixing with a flammable solvent, such as alcohol or benzene, and spraying the 

resulting mixture into the fire chamber of an incinerator (OHM/TADS 1985). 

Demilitarization is the use of various technologies to process munitions so they are no longer suitable 

for military applications. Demilitarization of munitions involves a number of techniques. Both 

destructive and nondestructive methods are used. Destructive methods include incineration, open 

detonation, and open burning. Nondestructive methods are aimed at recovering various components 

for reuse or sale. Destructive methods are the most predominant type used at the various depots and 

ammunition plants across the country (Army 1986). Munitions are demilitarized because of 

obsolescence of weapons, deterioration of chemical components, and poor serviceability. 

2,4,6-Trinitrotoluene is the primary explosive filler in the demilitarization inventory. 

Bench-scale cornposting of up to 10% 2,4,6-trinitrotoluene showed that almost complete removal of 

2,4,6-trinitrotoluene occurred in 55 days, and many of the toxic transformation products formed in 

activated sludge and soil were not found in the composted 2,4,6-trinitrotoluene (Fisher and Taylor 

1983). Field studies have demonstrated composting is effective in removing 2,4,6-trinitrotoluene from 

contaminated lagoon sediments under both thermophilic and mesophilic conditions (Williams et al. 

1992). The mutagenicity of the metabolites of 2,4,6-trinitrotoluene formed by cornposting was found 

to be less than the parent compound (Tan et al. 1992). Waste water contaminated with 

2,4,6-trinitrotoluene and various concentrations of nitrobodies, such as RDX, was successfully oxidized 

electrochemically from a range of 60-105 ppm 2,4,6-trinitrotoluene to below acceptable disposal 

concentrations (0.5 ppm); the oxidation process did not produce any toxic by-products (HSDB 1994). 

Other methods of treating waste waters contaminated with 2,4,6-trinitrotoluene and related products 

that have been investigated include ultrafiltration, activated carbon, and resin adsorption (EPA 1982). 

2,4,6-TRINITROTOLUENE 95 

5. POTENTIAL FOR HUMAN EXPOSURE 

5.1 OVERVIEW 

2,4,6-Trinitrotoluene is released to the environment from manufacturing and munitions processing 

facilities. Upon release to surface waters, 2,4,6-trinitrotoluene undergoes rapid photolysis to a number 

of products. Biodegradation by microorganisms including bacteria and fungi also occurs in surface 

waters but at rates much slower than photolysis. 2,4,6-Trinitrotoluene is expected to be transported 

mainly in the aqueous phase; the compound is not expected to volatilize from surface water to the 

atmosphere or significantly partition to soils or sediments. Bioconcentration of 2,4,6-trinitrotoluene by 

plants and aquatic organisms is limited, and biomagnification of the compound in terrestrial and 

aquatic food chains is not expected. Little information is available on the concentrations of 

2,4,6-trinitrotoluene or its degradation products in ambient media. The most important routes of 

human exposure to the compound, that the general public may be exposed to, appear to be ingestion of 

contaminated drinking water and dermal contact with contaminated surface water. However, members 

of the general public may also be exposed to 2,4,6-trinitrotoluene released to the atmosphere as a 

result of ordnance demilitarization and disposal through incineration and detonation, as well as by 

ingestion of foods contaminated through uptake of the compound from contaminated soils or 

deposition of 2,4,6-trinitrotoluene particulates from the atmosphere. Workers may be exposed via 

inhalation and dermal contact. Workers involved in the manufacture of 2,4,6-trinitrotoluene or the 

processing of munitions containing the compound may be exposed to high concentrations of 

2,4,6-trinitrotoluene through inhalation and dermal contact. 

2,4,6-Trinitrotoluene has been identified in at least 20 of the 1,397 hazardous waste sites on the EPA 

National Priorities List (NPL) (HAZDAT 1994). However, the number of sites evaluated for 

2,4,6-trinitrotoluene is not known. The frequency of these sites within the United States can be seen 

in Figure 5-l. 

2,4,6-TRINITROTOLUENE 97 

5. POTENTIAL FOR HUMAN EXPOSURE 

5.2 RELEASES TO THE ENVIRONMENT 

5.2.1 Air 

2,4,6-Trinitrotoluene is released to the ambient atmosphere as a result of open detonation and open 

burning techniques used in the demilitarization of munitions (Army 1986e) (also see Section 4.4). 

Gases and particulates are released to the atmosphere as a result of these activities and from the 

disposal of munitions containing 2,4,6-trinitrotoluene in rotary kiln incinerators. 2,4,6-Trinitrotoluene 

dusts and vapor are released into indoor air atmospheres in military production and processing 

facilities during manufacturing of 2,4,6-trinitrotoluene and munitions (Hathaway 1985). Fugitive dusts 

containing the compound are probably generated at sites with contaminated surface soils (e.g., military 

installation burning grounds) (Kraus et al. 1985). 

5.2.2 Water 

2,4,6-Trinitrotoluene has historically been discharged in large quantities in the aqueous effluents of 

explosives production/manufacturing facilities and ammunition load, assemble, and pack (LAP) plants, 

from decommissioning activities, and through field use/disposal. Estimates of the loadings of 

2,4,6-trinitrotoluene in these effluents vary. Some investigators have reported concentrations of about 

120 mg/L in manufacturing facility waste waters and 25 mg/L in loading plant facility effluents 

(Freeman and Colitti 1982). Others report concentrations of 40-120 mg/L in manufacturing plant 

effluents, with generally higher concentrations in LAP plant waste waters (Andren et al. 1977b). 

Concentrations of 0.1-3.4 mg/L have been detected in about 20% of the samples of sellite 

manufacturing process condensate wastewater collected from a 2,4,6-trinitrotoluene manufacturing 

facility (Army 1980b; Spanggord et al. 1982a). 

Estimates of historical 2,4,6-trinitrotoluene releases to surface waters from Army ammunition plants 

have been developed on the basis of surveys of munitions facilities. Sources include production plants 

(emissions range from 61 to 210 pounds/day) and LAP plants (l-150 pounds/day). Estimates of 

average downstream concentrations of 2,4,6-trinitrotoluene in the surface waters receiving these 
2,4,6-TRINITROTOLUENE 98 

5. POTENTIAL FOR HUMAN EXPOSURE 

effluents are 0.006-0.025 mg/L for production plants and <0.001-0.038 mg/L for LAP plants 

(Rosenblatt et al. 1973; Small and Rosenblatt 1974). 2,4,6-Trinitrotoluene has been detected in the 

effluent of the Radford, Virginia, production plant at 101-143 ppm (Nay 1972a). 

5.2.3 Soil 

2,4,6-Trinitrotoluene is released to soils from spills, disposal of solid waste, open incineration and 

detonation of ordnances, leaching from inadequately sealed impoundments (e.g., pits, ponds, and 

lagoons), and demilitarization of munitions (EPA 1989c; Kraus et al. 1985; Army 1986e). 

Demilitarization of munitions can result in contamination of surface soils by activities such as open 

burning and open detonation or landfilling of solid wastes generated during rotary kiln incineration and 

nondestructive reprocessing of munitions containing 2,4,6-trinitrotoluene (Army 1986e). 

5.3 ENVIRONMENTAL FATE 

5.3.1 Transport and Partitioning 

On the basis of the relatively low vapor pressure (1.99x10-4 mmHg at 20°C) and relatively high water 

solubility (130 mg/L at 20°C) (see Table 3-2) of 2,4,6-trinitrotoluene, the compound is not expected to 

partition from surface waters to the atmosphere. Limited volatilization from aqueous solutions was 

found in air stripping tests on raw and neutralized waste water samples, where only 8-10% of the 

2,4,6-trinitrotoluene concentration was lost during an 18-day test period (Nay 1972a). Volatilization 

half-lives of 10,000 days have been estimated for ponds, streams, and lakes (Spanggord et al. 1985). 

A volatilization half-life of 119 days has been estimated from a model river at 20°C 1 meter deep 

flowing at the rate of 1 meter/second, with a wind speed of 3 meters/second (HSDB 1994). 

On the basis of the measured and estimated values for the soil organic carbon adsorption coefficient 

(Koc) of 300-1,100, 2,4,6-trinitrotoluene is not expected to significantly partition from surface waters 

to sediment or strongly sorb to soil particulates (Spanggord et al. 1985). This expected behavior has 

been confirmed in short-term laboratory adsorption/desorption tests and long-term lysimeter studies. 

Short-term (24-hour) laboratory batch adsorption/desorption tests were conducted using 
2,4,6-TRINITROTOLUENE 99 

5. POTENTIAL FOR HUMAN EXPOSURE 

uncontaminated surface soils collected from 13 Army ammunition plants. Limited 2,4,6-trinitrotoluene 

adsorption was found in these tests. The average adsorption coefficient (Kd) for all soils tested was 4, 

which indicates limited sorption potential. Adsorption was found to be consistently lower under 

oxidized conditions than under reduced conditions. Almost all of the 2,4,6-trinitrotoluene adsorbed 

was desorbed upon multiple extraction of the test soils. The pH of the soils exerted no effect on 

2,4,6-trinitrotoluene adsorption/desorption or transformation. Transformation products (4-ADNT and 

2-ADNT) were detected under both oxidized and reduced conditions (Pennington and Patrick 1990). 

In long-term lysimeter studies, ring-labeled 14C-2,4,6-trinitrotoluene was added to the top 3 inches of 

soils in eolmnns (2 feet long and 2 inches in diameter). Four soil types were used, ranging in texture 

from fine to coarse. The lysimeters were regularly irrigated during the 6-month test period, and 

column leachate samples were taken every 2 weeks. At the end of the test period, the soil columns 

were sectioned for analysis. 2,4,6-Trinitrotoluene and its transformation products were retained in the 

test soil columns. Neither 2,4,6-trinitrotoluene nor its typical biodegradation products were detected in 

the leachate samples. Analysis of the leachate samples with high 14C activity indicated the presence of 

only highly polar, nonvolatile products. These products could not be separated or identified. 

However, two transformation products were identified in the soil columns: 2-ADNT and 4-ADNT. 

The concentration of these products in the soil columns ranged from 0.01% to 6% of the radiolabelled 

2,4,6-trinitrotoluene added to the columns (Kayser and Burlinson 1988). 

In other mobility tests with sediments, ring-labeled 14C-2,4,6-trinitrotoluene was added to unsterilized 

sediments collected from two farm ponds in Syracuse, New York and from the Holston River in 

Kingsport Tennessee, upstream from an Army Ammunition Plant site. 2,4,6-Trinitrotoluene was not 

extensively sorbed in short-term (24 hour) tests, partition coefficients varied with pH and temperature. 

Desorption of 2,4,6-trinitrotoluene or its breakdown products proceeded slowly; steady state conditions 

were reached after 92 hours in only 1 sediment (Army 1980b). 

The log octanol/water partition coefficient (Kow) values of 2.2-2.7 (see Table 3-2) suggest that the 

compound will not bioconcentrate to high levels (i.e., concentrations ≥ 1,000 times media 

concentrations) in the tissues of exposed plants and animals or biomagnify in terrestrial or aquatic food 

chains (Spanggord et al. 1985). Limited bioconcentration was demonstrated in aquatic bioassays with 
2,4,6-TRINITROTOLUENE 100 

5. POTENTIAL FOR HUMAN EXPOSURE 

water fleas (Daphnia magna), worms (Lumbriculus variegatus), algae (Selenastrum capricornutum), 

and bluegill sunfish (Lepomis macrochirus). Bioconcentration factors (BCFs) in 96-hour static tests 

were found to be 209 for the water flea, 202 for the worms, 453 for algae, 9.5 for fish muscle, and 

338 for fish viscera (Liu et al. 1983b). 

Bioconcentration of 2,4,6-trinitrotoluene by yellow nutsedge was studied in hydroponic cultures 

containing 5, 10, and 20 mg/L 2,4,6-trinitrotoluene. After a 42-day exposure period, the rhizomes, 

roots, tubers, and leaves of the plants were analyzed for 2,4,6-trinitrotoluene and metabolites. 

2,4,6-Trinitrotoluene and its metabolites, 4-ADNT and 2-ADNT, were taken up and translocated 

throughout the plants, although the highest concentrations were found in the roots. Concentrations of 

2,4,6-trinitrotoluene and metabolites in plant tissues generally increased with increasing 

2,4,6-trinitrotoluene concentrations in the growth medium. At the 20-mg/L treatment level, the 

concentrations in plant roots were 714 mg/kg, 614 mg/kg, and 2,180 mg/kg for 2,4,6-trinitrotoluene, 

2-ADNT, and 4-ADNT, respectively (Palazzo and Leggett 1986). 

5.3.2 Transformation and Degradation 

5.3.2.1 Air 

No information was found on the transformation of 2,4,6-trinitrotoluene in the atmosphere. However, 

2,4,6-trinitrotoluene released to the atmosphere should undergo direct photolysis, as it does in surface 

water. Estimates of the photolytic half-life of the compound in air range from 3.7 to 11.3 hours; these 

estimates are based on the rate of photolysis of the compound in distilled water. Estimates of the 

photooxidation half-life of the compound in the atmosphere range from 18.4 to 184 days. These 

estimates are based on the estimated rate constant for reaction with hydroxyl radicals in the 

atmosphere (Howard et al. 1991). 
2,4,6-TRINITROTOLUENE 101 

5. POTENTIAL FOR HUMAN EXPOSURE 

5.3.2.2 Water 

2,4,6-Trinitrotoluene does not undergo hydrolysis, as demonstrated by the stability of the compound in 

sea water after 108 days at room temperature (Hoffsommer and Rosen 1973). 

Photolysis of 2,4,6-trinitrotoluene in aqueous solutions is a well-known phenomenon, which is 

responsible for the development of “pink water,” and is probably the most important fate process for 

2,4,6-trinitrotoluene in aqueous systems. For example, the estimated half-life of 2,4,6-trinitrotoluene in 

surface waters is 0.16-1.28 hours, based on the rate of photolysis and photooxidation in sunlit natural 

waters (Howard et al. 1991). The rate of photolysis of 2,4,6-trinitrotoluene in natural surface waters 

has been found to be much greater than that of the compound in pure water. Phototransformation of 

2,4,6-trinitrotoluene in surface waters occurs via direct and indirect photolysis. Direct photolysis of 

the compound is rapid; the estimated half-life varies from 14 to 84 hours, depending on season and 

latitude. These rates are increased in natural waters through the influence of humic acids on indirect 

photolysis. In sunlit natural waters, 2,4,6-trinitrotoluene photolysis proceeds at rates 10-100 times 

more rapid than those found in distilled water, with half-lives in some natural waters of less than 

0.5 hour. Phototransformation in natural surface waters may be accelerated because of the 

complexation of 2,4,6-trinitrotoluene and natural organics, or by an indirect mechanism by which light 

absorbed by natural organic constituents is transferred to 2,4,6-trinitrotoluene, or by the chemical 

trapping by humic acids of the reactive intermediate phototransformation products (Mabey et al. 1983; 

Spanggord et al. 1985; Zepp et al. 1984). In laboratory studies using distilled water, the rate of 

transformation increases over time, since photolysis is also promoted by the presence of 

photodecomposition products in the medium. The pH of the surface water has been found to exhibit a 

small influence on the rate of transformation only in surface waters that contain few natural organic 

constituents. 2,4,6-Trinitrotoluene may be more persistent in deep quiescent water bodies or other 

water systems where sunlight is attenuated. A number of 2,4,6-trinitrotoluene photodecomposition 

products have been identified, including dinitroanthrils, trinitrobenzaldehyde, trinitrobenzyl alcohol, 

trinitrobenzene, nitroanilines, condensed azo and azoxy derivatives, and 1,3,5-trinitrobenzene 

(Burlinson 1980; Mabey et al. 1983). Recently a deep red-brown 2,4,6-trinitrotoluene degradation 

product of Mycobacterium grown in aerobic conditions has been identified (Vorbeck et al. 1994). This 
2,4,6-TRINITROTOLUENE 102 

5. POTENTIAL FOR HUMAN EXPOSURE 

type of compound (a hydride-Meisenheimer complex) may be the type of chemical causing “pink 

water.” 

2,4,6-Trinitrotoluene is also transformed in surface waters by microbial metabolism, although this 

process occurs more slowly than photolysis. For example, the estimated biodegradation half-life of 

2,4,6-trinitrotoluene in surface water, under both aerobic and anaerobic conditions, is l-6 months. 

This estimate is based on aerobic river die-away test data with unacclimated microorganisms (Howard 

et al. 1991). The relative slowness of microbial degradation may be due in part to the enhanced 

toxicity of 2,4,6-trinitrotoluene to aquatic organisms in the presence of the near-ultraviolet component 

of sunlight (Johnson et al. 1994a). Examples of biotransformation of the compound in aqueous 

systems include the white rot fungus Phanerochaete chrysosporium, which was found to degrade 

ringlabeled 14C-2,4,6-trinitrotoluene. Within 12 days, 35% of the labeled 2,4,6-trinitrotoluene added to the 

solution was recovered as 14CO2 (Fernando et al. 1990). 

Pseudomonad bacteria (Pseudomonas sp.) have been found to reduce 2,4,6-trinitrotoluene under 

aerobic conditions in laboratory studies to monoaminodinitrotoluenes and a diaminomononitrotoluene 

(Schackmann and Muller 1991). Pseudomonads isolated from mud and water samples collected at the 

U.S. Naval Ammunition Depot at McAlester, Oklahoma, have also been found to be capable of 

biotransforming 2,4,6-trinitrotoluene in laboratory studies. 2,4,6-Trinitrotoluene degraded most rapidly 

in cultures supplemented with yeast extract. In the most active isolate, complete dissimilation was 

found within 24 hours. Degradation products identified include 2,2′6,6′-tetranitro-4,4′-azoxytoluene; 

9,4′,6,6′-tetranitro-2,2′-azoxytoluene; 2-amino-4,6-dinitrotoluene; 4-hydroxylamino-2,6-dinitrotoluene; 

and nitrodiaminotoluene (Won et al. 1974). Pseudomonads isolated from Narragansett Bay, sediments, 

raw sewage, and boiler plant effluents were able to utilize ring labeled 14C-2,4,6-trinitrotoluene as a 

sole carbon source in laboratory degradation studies. The amount of 2,4,6-trinitrotoluene 

transformation varied with the concentration of the test compound in the medium. 2,2′6,6′-Tetranitro4,4′-azoxytoluene was the only transformation product identified. Nitrite was found in the test 

medium, which suggests that the transformation proceeded via removal of the nitro groups from the 

aromatic ring. The recovery of 0.8-1.2% of the label in the form of 14CO2 suggests a mechanism that 

includes cleavage of the aromatic ring (Traxler et al. 1974). 
2,4,6-TRINITROTOLUENE 103 

5. POTENTIAL FOR HUMAN EXPOSURE 

Microbial inocula isolated from sewage treatment plant effluents, waste water from a 

2,4,6-trinitrotoluene ordnance loading facility, soil suspension, pond water, and aquarium water were 

found to be capable of degrading 2,4,6-trinitrotoluene in the presence of yeast extract in shake flask 

cultures at 38°C over 6 days. 2,4,6-Trinitrotoluene concentrations were reduced from the initial 

loading of 100 mg/L to 0-6 mg/L over the 6-day incubation period. Transformation did not occur in 

cultures containing only 2,4,6-trinitrotoluene and mineral salts. Microbial inocula isolated from raw 

sewage were not effective in transforming 2,4,6-trinitrotoluene; however, inocula isolated from sewage 

sludge digester liquor (supematant) reduced 2,4,6-trinitrotoluene concentrations by 64% over the test 

period. 2,4,6-Trinitrotoluene was also degraded in tests with a pure culture of Pseudomonas 

aeruginosa when glucose and supplemental nitrogen in the form of mineral salts were added to the 

culture medium (Osmon and Klausmeier 1973). 

Sediments from Army ammunition plants containing mixtures of explosives, including 

2,4,6-trinitrotoluene, have been composted in field trials to reduce their explosives content. For 

example, sediment from a Louisiana Army Ammunition Plant containing mixed explosives, including 

56,800 mg/kg 2,4,6-trinitrotoluene, was added to a compost mix containing straw/horse manure, 

alfalfa, and horse feed. The temperature inside the pile reached 55°C. After 22 weeks, the total 

explosives content of the compost was reduced by 99% (Williams et al. 1989). 

2,4,6-Trinitrotoluene has been reported to persist in groundwater for long periods of time by 

Rosenblatt (1980). However, other estimates of the half-life of the compound in groundwater range 

from 1 to 12 months, based on estimated unacclimated aqueous anaerobic and aerobic biodegradation 

(Howard et al. 1991). 

5.3.2.3 Soil 

Solid chunks of 2,4,6-trinitrotoluene buried in soil or exposed on the soil surface can persist for many 

years (Rosenblatt 1980). In smaller amounts, 2,4,6-trinitrotoluene may undergo photolysis in surface 

soils to trinitrobenzene and trinitrobenzaldehyde (Ryon et al. 1984). 
2,4,6-TRINITROTOLUENE 104 

5. POTENTIAL FOR HUMAN EXPOSURE 

The transformation of 2,4,6-trinitrotoluene in soils has been found to be influenced by a number of 

environmental factors. In a study using ring-labeled 14C-2,4,6-trinitrotoluene, the effects of soil 

organic matter content, 2,4,6-trinitrotoluene concentration, oxygen concentration, moisture content, 

temperature, incubation period, and microbial activity on 2,4,6-trinitrotoluene transformation in soil 

were examined. The soil pH was maintained at 6.5 throughout the test. In samples collected for 

analysis after 6 months and 11 months incubation, biological transformation was highest in soils 

containing the lowest concentration of 2,4,6-trinitrotoluene (0.1%) and lowest in soils containing the 

highest starting concentration of 2,4,6-trinitrotoluene (10%). The highest concentrations of degradation 

products were recovered from the soils receiving the lowest 2,4,6-trinitrotoluene loadings. Degradation 

products identified included 2-amino-4,6-dinitrotoluene, 4-amino-2,6-dinitrotoluene, and diamines. As 

biotransformation increased, the amount of unextractable radioactive residue increased, suggesting that 

the metabolites of 2,4,6-trinitrotoluene exhibited stronger sorption to soils than the parent compound. 

Degradation decreased in sterilized soils. Of the environmental parameters evaluated in this study, the 

initial 2,4,6-trinitrotoluene concentration and the soil moisture level had the most influence on the rate 

of 2,4,6-trinitrotoluene transformation. The presence or absence of microbial activity and incubation 

temperature had less effect, and the remaining variables had no effect on 2,4,6trinitrotoluene 

transformation (Army 1985a). 

The white rot fungus Phanerochaete chrysosporium was found to degrade ring labeled 14C-2,4,6­

trinitrotoluene sorbed to soils. After 30 days incubation, 6.3% of the sorbed 2,4,6-trinitrotoluene was 

recovered as 14CO2. An additional 63.6% of the radioactivity was recovered in acetonitrile extracts, 

and 25.2% was unextractable. In the acetonitrile extract, only 2.2% of the radiolabel was in the form 

of undegraded 2,4,6-trinitrotoluene (Fernando et al. 1990). 

In the same study, soil cultures containing 10,000-mg/kg loadings of ring-labeled 14C-2,4,6­

trinitrotoluene were extracted after 30-, 60-, and 90-day incubation periods and mass balances were 

calculated. The 90-day mass balance indicated that 18.4% of the radioactivity was recovered as 14CO2, 

62.6% in the form of metabolites present in the acetonitrile extract fraction, and 11.5% was bound to 

the soil/fungal matrix. The concentration of residual undegraded 2,4,6-trinitrotoluene in the 90-day 

acetonitrile extract was 14.9%, versus the >99% activity in the control samples (Fernando et al. 1990). 
2,4,6-TRINITROTOLUENE 105 

5. POTENTIAL FOR HUMAN EXPOSURE 

In screening studies of 190 species of fungi from 98 genera, 183 species were found to be able to 

transform 2,4,6trinitrotoluene in 5-day shake culture tests. Transformation products included 4-amino2,6-dinitrotoluene, 4-hydroxylamino-2,6-dinitrotoluene, and 4,4′-azoxy-2,2′,6,6′-tetranitrotoluene. None 

of the test organisms exhibited an ability to cleave the aromatic ring of 2,4,6-trinitrotoluene (Parrish 

1977). A sulfate-reducing bacterium, Desulfovibrio, has been isolated that degrades 2,4,6­

trinitrotoluene. However, this isolate also does not degrade 2,4,6-trinitrotoluene all the way to carbon 

dioxide (Boopathy and Kulpa 1992). 

Composting of 2,4,6-trinitrotoluene in soils has been examined in laboratory scale and large-scale tests. 

In laboratory tests with ring labeled 14C-2,4,6-trinitrotoluene, rapid biotransformation was found, with 

initial average activity levels of 93.5% reduced to 46.6% and 16.6% after 3 weeks and 6 weeks, 

respectively. No degradation products were detected in samples collected after 3 weeks. Minor 

amounts (i.e., less than 2%) were detected in samples collected at 6 weeks. The degradation products 

included 2-amino-4,6-dinitrotoluene, 4-amino-2,6-dinitrotoluene, 2,6-diamino-4-nitrotoluene, and 

2,2′6,6′-tetranitro-4,4′-azoxytoluene. The decrease in 14C-2,4,6-trinitrotoluene concentration was found 

to be correlated with a reduction in the solvent extractable activity and a significant increase in the 

compost-bound radioactivity. This finding suggests that 2,4,6-trinitrotoluene was transformed into 

more polar metabolites. Similar results were found in the large scale greenhouse trials, where 

2,4,6-trinitrotoluene concentrations decreased from 19,041 μg/g to less than 17 μg/g after 3 weeks. 

2,4,6-Trinitrotoluene was not detected in leachate samples from fresh compost piles. After 3 weeks, 

the leachate was found to contain 6% of the radiolabel. The mechanism for the rapid transformation 

of 2,4,6-trinitrotoluene in these systems is unclear; however, there is no evidence to suggest that 

transformation proceeds via cleavage of the benzene ring (Isbister et al. 1984). In field studies of 

aerated static piles, the effects of temperature on cornposting were examined. Under thermophilic 

conditions, extractable 2,4,6-trinitrotoluene was reduced from 11,840 μg/g to 3 μg/g, while under 

mesophilic conditions, 2,4,6-trinitrotoluene was reduced from 11,190 μg/g to 50 μg/g (Williams et al. 

1992). 

Mixed microbial cultures isolated from two soils, one from a wooded area near a 2,4,6-trinitrotoluene 

loading facility and one from a greenhouse located 30 miles away, were tested for their ability to 
2,4,6-TRINITROTOLUENE 106 

5. POTENTIAL FOR HUMAN EXPOSURE 

degrade 2,4,6-trinitrotoluene. Both soils contained microbes capable of transforming 

2,4,6-trinitrotoluene, added at a concentration of 100 mg/L, in the presence of yeast extract and 

glucose. Over the test period, 2,4,6-trinitrotoluene degradation was greater in the inoculum isolated 

from the soil near the 2,4,6-trinitrotoluene loading facility (36%) than for the remote soil (14%). Most 

of the microorganisms exhibiting 2,4,6-trinitrotoluene activity appeared to be pseudomonads (Osmon 

and Klausmeier 1973). 

The estimated half-life of 2,4,6-trinitrotoluene in soils ranges from 1 to 6 months. This estimate was 

made on the basis of the estimated unacclimated aqueous aerobic biodegradation half-life (Howard et 

al. 1991). In laboratory tests with sandy loam and sandy silt loam soils, the aerobic degradation halflife 

of the compound was determined to be 5.7-7.7 days (EPA 1989c). 

5.4 LEVELS MONITORED OR ESTIMATED IN THE ENVIRONMENT 

5.4.1 Air 

Nitroaromatics associated with the manufacture and processing of military munitions have generally 

not been detected in atmospheric monitoring studies (EPA 1976a). 

5.4.2 Water 

2,4,6-Trinitrotoluene has been detected in surface water and groundwater samples collected only in the 

vicinity of munitions facilities. For example, the compound has been found in pink water effluents at 

concentrations of 774-998 ppb in lagoon water (Triegel et al. 1983) and 1-178 mg/L from LAP plants 

(Patterson et al. 1977). 

2,4,6-Trinitrotoluene has been detected in groundwater samples collected in several monitoring studies 

conducted in the vicinity of munitions facilities. For example, using on-site high-performance liquid 

chromatography analysis, 2,4,6-trinitrotoluene was detected at concentrations of 320 μg/L at 200 feet 

downgradient and at 1 μg/L at 1,070 feet downgradient in groundwater samples collected at a 

demilitarization facility near Hawthorne, Nevada (Goerlitz and Franks 1989). As a result of leachates 
2,4,6-TRINITROTOLUENE 107 

5. POTENTIAL FOR HUMAN EXPOSURE 

from disposal of solid wastes in cesspools, burning areas, and on-site leaching pits, 

2,4,6-trinitrotoluene was detected in groundwater samples collected at the Cornhusker Army 

Ammunition Plant near Grand Island, Nebraska (Spalding and Fulton 1988). 

5.4.3 Soil 

2,4,6-Trinitrotoluene has been detected in surface soil samples at an average concentration of 13,000 

mg/kg at the U.S. Department of Energy’s Weldon Spring site in St. Charles County, Missouri. The 

chemical plant at the site was used by the U.S. Army to produce 2,4,6-trinitrotoluene explosives in the 

1940s (Haroun et al. 1990). At the West Virginia Ordnance Works located in Mason County, West 

Virginia, 2,4,6-trinitrotoluene and other nitroaromatics have been detected in surface soils at burning 

sites in concentrations of up to 4% (40,000 mg/kg). Nitroaromatics, principally 2,4,6-trinitrotoluene, 

were detected at up to 20,000 mg/kg within 5-10 meters of the foundations of processing and refining 

facilities (Kraus et al. 1985). 

At the Lone Star Army Ammunition Plant located in Texarkana, Texas, 2,4,6-trinitrotoluene has been 

detected at a concentration of about 15% in samples of sludge taken from ponds used as solids settling 

areas for pink water effluent. 2,4,6-Trinitrotoluene concentrations were highest in surface soil samples 

(e.g., 18.8 mg/kg at 0.2-0.6 meter depth), with decreasing concentration with increased depth (e.g., 

<3 mg/kg below 4.5 meters) (Phung and Bulot 1981). Triegel et al. (1983) found 2,4,6-trinitrotoluene 

at concentrations of 200-56,700 ppm in sludge samples from pink water lagoons, and at 18.9-158 ppm 

in surface soil samples collected from directly beneath the lagoon. 

5.4.4 Other Environmental Media 

No information was found on the concentrations of 2,4,6-trinitrotoluene in other media. 

5.5 GENERAL POPULATION AND OCCUPATIONAL EXPOSURE 

According to the National Occupational Exposure Survey, a total of 31 workers were estimated to 

have been exposed to 2,4,6-trinitrotoluene in domestic workplaces in 1980 (NIOSH 1990). 
2,4,6-TRINITROTOLUENE 108 

5. POTENTIAL FOR HUMAN EXPOSURE 

Workers involved in the production of munitions can be exposed to 2,4,6-trinitrotoluene during the 

manufacture of the compound and during its use to fill artillery shells, mines, and other explosive 

armaments. Historically, more workers have been involved in shell loading than in the manufacture of 

2,4,6-trinitrotoluene. Workers are potentially exposed via inhalation of dust and vapors, and through 

dermal absorption of dust. Exposure to 2,4,6-trinitrotoluene vapors is possible when the compound is 

melted and poured into shells. Dust exposure is possible in tilling operations using 

2,4,6-trinitrotoluene powder, loading of melt kettles, drilling for fuse placement, removal of excess 

solidified 2,4,6-trinitrotoluene from shells, and recycling excess 2,4,6-trinitrotoluene. Protection only 

against inhalation of dust or vapors may still result in potentially significant systemic exposure to 

2,4,6-trinitrotoluene if skin exposure occurs, since dermal absorption is rapid and accounts for a 

significant portion of total exposure (Hathaway 1985). 

A study by the U.S. Army Environmental Hygiene Agency examined 533 workers exposed to 

2,4,6-trinitrotoluene in manufacturing and munitions processing operations. The 8-hour timeweightedaverage concentration of 2,4,6-trinitrotoluene ranged from less than 0.01 mg/m3

 to 1.84 mg/m3; 

concentrations of greater than 0.5 mg/m3 were experienced by only 12.2% of the workers (Buck and 

Wilson 1975). 

Diazo-positive metabolites and mutagenic activity of metabolites in the urine of workers have been 

used as indicators of exposure to nitro-aromatic and nitro-amino aromatic compounds, including 

2,4,6-trinitrotoluene. In two studies conducted at a 2,4,6-trinitrotoluene manufacturing plant, urine 

samples were collected from groups of 32 and 50 individuals with variable exposure to 

2,4,6-trinitrotoluene. Samples were collected at the end of a workshift and after a holiday or weekend. 

The workers were divided into three exposure categories: (1) no or low 2,4,6-trinitrotoluene exposure 

(e.g., laboratories, controlling departments, individuals with no 2,4,6-trinitrotoluene contact during the 

work shift preceding sampling); (2) medium 2,4,6-trinitrotoluene exposure (e.g., assembling grenades, 

octal-hexotol foundry, test foundry); and (3) high 2,4,6-trinitrotoluene exposure (e.g., trotyl foundry, 

sieve house). 2,4,6-Trinitrotoluene concentrations (vapor and dust) in breathing zone samples collected 

at workstations for each category were: (1) no detectable concentrations; (2) less than 0.3 mg/m3

; and 

(3) 0.3-0.5 or 0.6 mg/m3. The concentration of diazo-positive metabolites and mutagenic metabolites 

in the urine samples was significantly higher in samples collected at the end of the work shift than in 
2,4,6-TRINITROTOLUENE 109 

5. POTENTIAL FOR HUMAN EXPOSURE 

samples collected after a holiday or a weekend for all three exposure categories, with the largest mean 

differences found in the highest exposure groups (Ahlborg et al. 1988a, 1988b). 

Given the restricted production and use of 2,4,6-trinitrotoluene, exposure of members of the general 

population to the compound would probably be limited to populations living in the vicinity of 

hazardous waste sites or military munitions facilities. These individuals may be exposed to 

2,4,6-trinitrotoluene through contact with contaminated environmental media, particularly groundwater. 

For example, using the multimedia screening model GEOTOX coupled with an exposure pathway 

model, McKone and Layton (1986b) identified consumption of contaminated water and ingestion of 

contaminated fruits and vegetables as the potentially most important exposure pathways for 

populations living near sites where 2,4,6-trinitrotoluene was released to surface soils. The 

investigation examined the relative importance of the following seven routes of exposure: 

(1) inhalation; (2) water consumption; (3) fruit and vegetable ingestion; (4) meat and dairy ingestion; 

(5) fish ingestion; (6) soil ingestion; and (7) dermal absorption. The least important of these 

pathways, according to the modeling exercise, were inhalation, soil ingestion, and dermal absorption. 

As part of the baseline risk evaluation prepared for the remedial investigation of the U.S. Department 

of Energy’s Weldon Spring Site located in Charles County, Missouri, dermal contact with and 

ingestion of contaminated surface soils, and inhalation of fugitive dust particulates were identified as 

the most important potential routes of exposure to 2,4,6-trinitrotoluene for workers involved in 

remedial actions at the site and for the general public. 2,4,6-Trinitrotoluene was detected in surface 

soils at the site in concentrations of up to 13,000 mg/kg. Modeling estimates of 2,4,6-trinitrotoluene 

concentrations in ambient air, resulting from the generation of fugitive dust, were 5x10-4 mg/m3

 and 

1x10-4 mg/m3 for total particulates and respirable particulates, respectively (Haroun et al. 1990). 

Water quality criteria for the protection of human health from exposure to 2,4,6-trinitrotoluene of 

44.25 μg/L (Dacre 1980) and 134.96 μg/L (Army 1987d) have been recommended; the latter value is 

based on a calculated acceptable daily intake of 0.28 mg/day. 
 

2,4,6-TRINITROTOLUENE 110 

5. POTENTIAL FOR HUMAN EXPOSURE 

5.6 POPULATIONS WITH POTENTIALLY HIGH EXPOSURES 

Workers involved in the manufacture of 2,4,6-trinitrotoluene and the processing of munitions 

containing the compound may be exposed to high concentrations of 2,4,6-trinitrotoluene in the 

workplace. Populations living near military munitions facilities or hazardous waste sites may also be 

exposed to high concentrations of 2,4,6-trinitrotoluene through contact with contaminated media. 

5.7 ADEQUACY OF THE DATABASE 

Section 104(i)(5) of CERCLA, as amended, directs the Administrator of ATSDR (in consultation with 

the Administrator of EPA and agencies and programs of the Public Health Service) to assess whether 

adequate information on the health effects of 2,4,6-trinitrotoluene is available. Where adequate 

information is not available, ATSDR, in conjunction with NTP, is required to assure the initiation of a 

program of research designed to determine the health effects (and techniques for developing methods 

to determine such health effects) of 2,4,6-trinitrotoluene. 

The following categories of possible data needs have been identified by a joint team of scientists from 

ATSDR, NTP, and EPA. They are defined as substance-specific informational needs that, if met, 

would reduce or eliminate the uncertainties of human health assessment. This definition should not be 

interpreted to mean that all data needs discussed in this section must be filled. In the future, the 

identified data needs will be evaluated and prioritized, and a substance-specific research agenda may 

be proposed. 

5.7.1 Identification of Data Needs 

Physical and Chemical Properties. The physical and chemical properties of 2,4,6-trinitrotoluene 

are sufficiently well defined to permit an assessment of the environmental fate of the compound to be 

made. 
2,4,6-TRINITROTOLUENE 111 

5. POTENTIAL FOR HUMAN EXPOSURE 

Production, Import/Export, Use, and Release and Disposal. On the basis of the limited 

production and specialized use of 2,4,6-trinitrotoluene, the compound is expected to have a fairly low 

human exposure potential. 2,4,6-Trinitrotoluene is not produced commercially in the United States; 

production of the compound is limited to military arsenals (HSDB 1990). Data on production volumes 

are not available because production is limited to military arsenals. In addition, import/export data are 

not available. The compound is a high explosive used by the military in the production of bombs and 

grenades. 2,4,6-Trinitrotoluene is released to the environment in liquid and solid wastes generated in 

the manufacture of the compound and the processing of munitions containing the compound. Media 

most likely to be contaminated include soils, surface water, and groundwater (Army 1986e). Wastes 

generated in the manufacture of 2,4,6-trinitrotoluene are characterized as hazardous wastes by EPA. 

Therefore, EPA regulations for their disposal must be followed. Additional studies of composting 

techniques in the treatment of 2,4,6-trinitrotoluene wastes would provide useful information in 

determining the effectiveness of these techniques in waste disposal. 

According to the Emergency Planning and Community Right-to-Know Act of 1986, 42 U.S.C. Section 

11023, industries are required to submit chemical release and off-site transfer information to the EPA. 

The Toxics Release Inventory (TRI), which contains this information for 1988, became available in 

May of 1990. This database will be updated yearly and should provide a list of industrial production 

facilities and emissions. 

2,4,6-Trinitrotoluene is not subject to TRI reporting requirements. Therefore, release data for the 

compound are not available in TRI. 

Environmental Fate. Upon release to the environment, 2,4,6-trinitrotoluene partitions to and is 

transported in surface water or groundwater. The compound is not expected to partition significantly 

to the atmosphere or to soils or sediment (HSDB 1990; Spanggord et al. 1985). 2,4,6-Trinitrotoluene 

undergoes rapid photolytic breakdown in surface waters to a number of degradation products. The 

compound also undergoes biotransformation in soils and surface water (Army 1985a; Fernando et al. 

1990). Additional information on the persistence of 2,4,6-trinitrotoluene in surface water and 

groundwater, on the kinetics and characterization of the biodegradation products in soils and surface 
2,4,6-TRINITROTOLUENE 112 

5. POTENTIAL FOR HUMAN EXPOSURE 

waters, and on the identification of 2,4,6-trinitrotoluene complexes with humic materials would aid in 

determining the importance of these media with respect to potential human exposure. Since 

2,4,6-trinitrotoluene has been found to persist in the soil following disposal, effort should be made to 

develop remediation technologies to minimize human exposure. 

Bioavailability from Environmental Media. Available data from tests with laboratory animals 

and humans indicates that 2,4,6-trinitrotoluene is absorbed following dermal contact, ingestion, and 

inhalation (Army 1978a, 1981d; Hassman and Hassmanova 1976; Woollen et al. 1986). Although 

occupational exposure data indicate that the compound is absorbed via inhalation and dermal contact, 

little information is available regarding the absorption of 2,4,6-trinitrotoluene from contaminated 

environmental media. Additional information about uptake of the compound from contaminated 

environmental media, particularly following dermal contact with and ingestion of soils, would be 

helpful in identifying the most important routes of human exposure to 2,4,6-trinitrotoluene. 

Food Chain Bioaccumulation. 2,4,6-Trinitrotoluene undergoes limited bioconcentration by plants 

and aquatic organisms (Liu et al. 1983b; Palazzo and Leggett 1986). As a result of its limited 

persistence in surface soils and surface waters and metabolism by terrestrial and aquatic organisms, the 

compound is not expected to biomagnify in terrestrial or aquatic food chains. Additional information 

on food chain bioaccumulation to confirm this predicted biomagnification behavior, particularly with 

respect to identification of 2,4,6-trinitrotoluene complexes with plant tissues, would be helpful in 

determining the relative importance of this route of exposure to humans. 

Exposure Levels in Environmental Media. 2,4,6-Trinitrotoluene has been detected in soil, 

surface water, and groundwater samples taken at Army ammunition plants and at other military 

installations where the compound or munitions have been used or processed (Haroun et al. 1990; 

Kraus et al. 1985; Patterson et al. 1977; Spalding and Fulton 1988; Triegel et al. 1983). 

2,4,6-Trinitrotoluene has not been detected in ambient air samples, in foods, or in ambient surface 

water or groundwater samples taken outside of military arsenals. The acceptable daily intake of the 

compound in drinking water has been estimated by the Army to be 0.28 mg/day. Additional 

information on the concentrations of 2,4,6-trinitrotoluene in environmental media at hazardous waste 
2,4,6-TRINITROTOLUENE 113 

5. POTENTIAL FOR HUMAN EXPOSURE 

sites and military arsenals, particularly in groundwater, would be helpful in estimating the doses that 

exposed populations may be receiving as a result of contact with these media. 

Exposure Levels in Humans. Diazo-positive and mutagenically active metabolites of 

2,4,6-trinitrotoluene have been detected in workers exposed to the compound at military facilities 

(Ahlborg et al. 1988a, 1988b). Additional information from biological monitoring of populations 

living in the vicinity of hazardous waste sites or military arsenals would aid in assessing the utility of 

biomarkers as indicators of human exposure. 

Exposure Registries. No exposure registries for 2,4,6-trinitrotoluene were located. This substance 

is not currently one of the compounds for which a subregistry has been established in the National 

Exposure Registry. The substance will be considered in the future when chemical selection is made 

for subregistries to be established. The information that is amassed in the National Exposure Registry 

facilitates the epidemiological research needed to assess adverse health outcomes that may be related 

to the exposure to this substance. 

5.7.2 On-going Studies 

A study is being conducted at the University of Illinois to examine the effect of the addition of 

organic amendments to soils contaminated with 2,4,6-trinitrotoluene. The study, which is sponsored 

by the U.S. Department of Agriculture, is evaluating the use of organic amendments to stabilize and 

bioremediate soils containing residual explosives. 

At the Los Alamos National Laboratory, a study is being conducted on the uptake and 

biotransformation of explosives, including 2,4,6-trinitrotoluene, by plants. 

Remedial investigations and feasibility studies at hazardous waste sites and military arsenals known to 

be contaminated with 2,4,6-trinitrotoluene should add to the available data base for environmental 

levels, environmental fate, and human exposure. 

2,4,6-TRINITROTOLUENE 115 

6. ANALYTICAL METHODS
 

The purpose of this chapter is to describe the analytical methods that are available for detecting and/or 

measuring and monitoring 2,4,6-trinitrotoluene in environmental media and in biological samples. The 

intent is not to provide an exhaustive list of analytical methods that could be used to detect and 

quantify 2,4,6-trinitrotoluene. Rather, the intention is to identify well-established methods that are 

used as the standard methods of analysis. Many of the analytical methods used to detect 

2,4,6-trinitrotoluene in environmental samples are the methods approved by federal organizations such 

as EPA and the National Institute for Occupational Safety and Health (NIOSH). Other methods 

presented in this chapter are those that are approved by groups such as the Association of Official 

Analytical Chemists (AOAC) and the American Public Health Association (APHA). Additionally, 

analytical methods are included that refine previously used methods to obtain lower detection limits, 

and/or to improve accuracy and precision. 

6.1 BIOLOGICAL MATERIALS 

Only limited data were located regarding methods of analysis for 2,4,6-trinitrotoluene and metabolites 

in biological samples. Methods have been developed to quantify these substances in blood, urine, 

tissues, and handswab samples. Details for selected methods are shown in Table 6-l. 

The primary method that has been used to analyze for 2,4,6-trinitrotoluene and/or its metabolites in 

blood and urine is high-performance liquid chromatography (HPLC)/mass spectrometry (MS) (Yinon 

and Hwang 1985b, 1986b, 1986c, 1987). Blood samples are prepared for analysis by centrifuging to 

obtain the serum. The serum is extracted with methylene chloride and the solvent is exchanged to 

acetonitrile (Yinon and Hwang 1986b, 1987). A second method, in which plasma is extracted with 

toluene followed by solvent exchange to acetonitrile and HPLC/ultraviolet (UV) detection, had a 

detection limit in the ppb range, with good precision (10% relative standard deviation [RSD]) and 

accuracy (Army 1981b). Since no information on sensitivity or reliability was provided for the MSbased 

method, and no other methods for blood were located, the adequacy of the available HPLC 



2,4,6-TRINITROTOLUENE 119 

6. ANALYTICAL METHODS 

methods for determining 2,4,6-trinitrotoluene and/or its metabolites in blood could not be completely 

evaluated. However, HPLC/MS is known to be a highly selective and sensitive method and results 

with urine samples indicate that it should also be a good method for determining 2,4,6-trinitrotoluene 

in blood. Hydrolyzed urine samples are extracted with toluene and the solvent is exchanged to 

acetone prior to separation by HPLC (Yinon and Hwang 1985b, 1986c, 1987). The limited data on 

this method of analyzing urine show a high recovery for 2,4,6-trinitrotoluene but much lower recovery 

for its metabolites. The high sensitivity (the limit of detection is in the sub-ppb range) and selectivity 

of the MS detector compensate for the low recovery of the metabolites. Gas chromatography 

(GC)/electron capture detection (ECD) and thin-layer chromatography (TLC)/densitometry have also 

been used to detect 2,4,6-trinitrotoluene and/or its metabolites in urine. GC/ECD accurately 

determined the 2,4,6-trinitrotoluene metabolite, 4-ADNT, in a toluene extract of hydrolyzed human 

urine (Almog et al. 1983). The limit of detection for this method was in the low-ppb range with high 

recovery of the analyte. A modification of TLC that employed a computer-linked densitometer for 

detection and quantitation reliably measured 2,4,6-trinitrotoluene and its metabolites in hydrolyzed 

human urine (Liu et al. 1991). Advantages of this method were its rapidity and low cost, However, it 

is about 3-4 orders of magnitude less sensitive than HPLC/MS and requires substantially more sample. 

An HPLC/UV method has been developed for determining 2,4,6-trinitrotoluene in animal kidney, 

muscle/fat, and liver (Army 1981b). Detection limits for these matrices were in the low-to-mid ppb, 

and the analyses were reproducible with RSDs of 15% or better. There were some problems with 

recovery of the analytes, especially in liver samples. No other methods were available for comparison. 

High-resolution gas chromatography (HRGC) with ECD or thermal energy analysis (TEA) and HPLC 

with electrochemical detection (EC) using a pendant mercury drop electrode (PMDE) or TEA have 

been proposed for the detection of 2,4,6-trinitrotoluene in handswabs (Douse 1985, 1987; Douse and 

Smith 1986; Fine et al. 1984; Lloyd 1983a, 1991). Limited data available indicate that both HPLC 

and HRGC are good separation methods for this analysis. Sensitivities for all three detectors are in 

the pg-to-low-ng range. TEA is slightly more selective for nitroaromatics, but the PDME has the 

advantage of being easily renewable which reduces contamination problems. An additional method 

based on monoclonal antibody technology was also located (Fetterolf et al. 1991). The enzyme-linked 

immunosorbent assay (ELISA) had a detection limit of about 15 ng/swab and showed no 
2,4,6-TRINITROTOLUENE 120 

6. ANALYTICAL METHODS 

cross-reactivity with other explosives or common contaminants. Electron spin resonance spectrometry 

has also been tested for handswab analysis and was found to be selective and specific (Bums et al. 

1987). Sensitivity was comparable to other methods and precision was high (1.8% RSD). 

6.2 ENVIRONMENTAL SAMPLES 

Methods have been developed to detect 2,4,6-trinitrotoluene and some of its breakdown products in 

air, water, soil, plant tissue, explosives, explosives residues, and postblast debris. Methods include 

semiquantitative screening methods that can be used in the field and quantitative laboratory-based 

methods. Selected methods for analysis of environmental samples are presented in Table 6-2. 

The primary method of analyzing for 2,4,6-trinitrotoluene in air is by GC, usually with ECD 

(Andersson et al. 1983; Bishop et al. 1981, 1988; Pella 1976, 1977; Van Slyke et al. 1985). Methods 

based on MS, including ion dilution MS (IDMS) (St. John et al. 1975) and glow discharge MS 

(GDMS) (McLuckey et al. 1988), have also been used successfully to measure 2,4,6-trinitrotoluene 

vapor in air. For most methods, the sample is collected in a tube containing a solid sorbent and 

desorbed with an organic solvent. A few methods have been developed that permit direct entry of the 

sample into the detecting instrument. These include GDMS (McLuckey et al. 1988) and ion mobility 

spectrometry (IMS) (Karasek and Denney 1974; Spangler et al. 1983). The latter can be adapted to a 

portable instrument for field use. A field method based on TLC has also been used (Chrostowski et 

al. 1976), but is more time consuming and much less sensitive than IMS. The limited data on 

sensitivity, accuracy, and precision make it difficult to compare these parameters for the different 

methods. However, most of the methods will detect 2,4,6-trinitrotoluene in air at the ppb level or less. 

While GC/ECD is the most commonly used method, several of the other methods have distinct 

advantages, such as increased sensitivity (GDMS and IMS), simplicity of sample collection/preparation 

(GDMS and IMS), or portability (IMS). 

Methods have been developed to measure 2,4,6-trinitrotoluene and/or it breakdown products in 

drinking water, surface water, groundwater, waste water effluents, and sea water. The two methods 

most frequently used to analyze water for the presence of 2,4,6-trinitrotoluene and other 

polynitroaromatic hydrocarbons are HPLC/UV and HRGC/ECD. In addition, methods based on 







2,4,6-TRINITROTOLUENE 128 

6. ANALYTICAL METHODS 

colorimetry and spectrophotometry have been used to screen field samples for 2,4,6-trinitrotoluene and 

other polyaromatic hydrocarbons. A method involving direct injection of water samples into a mass 

spectrometer proved to be fast and simple, but the high detection limit makes it useful only for 

screening (Yinon and Laschever 1982). In addition, MS is expensive and requires more technical 

training than some of the other methods used for analysis of 2,4,6-trinitrotoluene in water. 

With the HPLC- and GC-based methods, sample preparation usually involves direct solvent extraction 

of the sample (Army 1985b; Bauer et al. 1986; Belkin et al. 1985; Hable et al. 1991; Hoffsommer and 

Rosen 1972; Jenkins et al. 1986; Leggett et al. 1990; Maskarinec et al. 1984; Powell et al. 1983) or 

concentration on a solid sorbent (Army 1981a, 1983b; Feltes et al. 1989, 1990; Maskarinec et al. 1984; 

Richard and Junk 1986). 

HPLC/UV is the method usually employed by the Army to measure 2,4,6-trinitrotoluene in waste 

water effluents from munitions plants (Army 1981a, 1983b, 1985b; Bauer et al. 1986; Jenkins et al. 

1986; Leggett et al. 1990). HPLC methods are relatively simple and fast, accurate, and selective. In 

explosives analysis, where many of the analytes are thermally-labile, they also have the advantage of 

not requiring heat. Sensitivity is generally in the low-to-mid ppb range. Substitution of a photodiode 

array detector (PAD) for the usual ultraviolet detector allowed detection of ppt in water (Feltes and 

Levsen 1989). HPLC with EC at a gold-mercury electrode increased sensitivity relative to UV and 

also improved selectivity (Maskarinec et al. 1984). 

HRGC/ECD is also a sensitive and selective method for determination of 2,4,6-trinitrotoluene in water. 

Detection limits in the sub-ppb range are obtainable and recoveries are high (Belkin et al. 1985; Feltes 

et al. 1990; Hable et al. 1991; Hoffsommer and Rosen 1972; Richard and Junk 1986). In addition, 

precision is excellent with the RSD usually less than 10%. Detection by TEA or MS has also been 

used with GC with good results (Feltes et al. 1990). A comparison of these detection methods with 

ECD showed that while TEA was more selective than ECD for nitro compounds and had a larger 

linear concentration range, ECD was more sensitive than TEA by about three orders of magnitude 

(Feltes et al. 1990). MS was the most selective of the three detection methods, and was determined to 

be useful for confirmatory analysis. One disadvantage of GC methods in explosives analysis is that 

thermally-labile analytes may be destroyed during analysis. 
2,4,6-TRINITROTOLUENE 129 

6. ANALYTICAL METHODS 

The available optical methods rely on the conversion of 2,4,6-trinitrotoluene to a fluorescent or colored 

complex (Army 1990b; Heller et al. 1977, 1982; Jian and Seitz 1990; Zhang et al. 1989). In general, 

these methods are not as sensitive or selective as the more commonly used HPLC and GC methods 

and they are primarily useful for simple and rapid screening of samples at field sites to determine 

which samples should be subjected to more intensive quantitative analysis. A recently proposed 

spectrophotometric method reacts a polynitroaromatic hydrocarbon-contaminated water sample with a 

membrane containing polyoxyethylamine. The reaction produces a colored product that can be 

analyzed with a spectrophotometer (Zhang et al. 1989). Since different polynitroaromatic 

hydrocarbons produce different absorption spectra, the method is selective as well as relatively 

sensitive (detection of low ppb). The method is used to screen samples in the field and, by employing 

fiber optics, may be useful for remote monitoring (Zhang and Seitz 1989). 

An HPLC/UV method developed by the Army is the method most commonly used to analyze soils 

and sediments for 2,4,6-trinitrotoluene and its breakdown products (Army 1985c, 1987c; Bauer et al. 

1990; Bongiovanni et al. 1984; Jenkins and Grant 1987; Jenkins et al. 1989). Sample extraction 

consists of homogenizing the soil or sediment, extraction with an organic solvent, and separation on a 

reverse-phase HPLC column. The method is sensitive and reliable and has been used to determine 

2,4,6-trinitrotoluene and some of its metabolites at levels in the low ppb range. GC/ECD has also 

been used to analyze soil samples for 2,4,6-trinitrotoluene (Army 1985c). Sample preparation is 

similar to that used for HPLC. Results from GC analysis were mixed, with some samples producing 

results comparable to HPLC, but others (those samples high in organic matter) subject to substantial 

interference. More recent efforts by the Army have focused on the development of simple, rapid 

methods that can be used to screen samples in the field. Two semiquantitative methods have been 

tested, one based on an indicator tube originally designed for testing water samples (Army 1990b; 

Heller 1982) and the other based on spectrophotometry (Army 1990a). Both methods could detect 

2,4,6-trinitrotoluene in the sub- to low-ppm range but were not specific for 2,4,6-trinitrotoluene. The 

indicator tube was inexpensive, simple, rapid, and easy to use. However, it was found to have poor 

accuracy and precision. The spectrophotometric method had better accuracy and precision and 

estimated concentrations correlated well with laboratory analyses of the same samples. It is not as 

convenient as the indicator tube, however, because a battery-operated spectrophotometer must also be 

carried into the field. 
2,4,6-TRINITROTOLUENE 130 

6. ANALYTICAL METHODS 

A method for determining 2,4,6-trinitrotoluene in plant stems using HPLC/UV was located (Army 

1981b). The limit of detection for the method was in the ppb, but both recovery (52%) and precision 

(33% RDS) were poor. No other methods in similar matrices were available for comparison, 

6.3 ADEQUACY OF THE DATABASE 

Section 104(i)(5) of CERCLA, as amended, directs the Administrator of ATSDR (in consultation with 

the Administrator of EPA and agencies and programs of the Public Health Service) to assess whether 

adequate information on the health effects of 2,4,6-trinitrotoluene is available. Where adequate 

information is not available, ATSDR, in conjunction with NTP, is required to assure the initiation of a 

program of research designed to determine the health effects (and techniques for developing methods 

to determine such health effects) of 2,4,6-trinitrotoluene. 

The following categories of possible data needs have been identified by a joint team of scientists from 

ATSDR, NTP, and EPA. They are defined as substance-specific informational needs that, if met, 

would reduce or eliminate the uncertainties of human health assessment. This definition should not be 

interpreted to mean that all data needs discussed in this section must be filled. In the future, the 

identified data needs will be evaluated and prioritized, and a substance-specific research agenda may 

be proposed. 

6.3.1 Identification of Data Needs 

Methods for Determining Biomarkers of Exposure and Effect. Only a few methods for 

monitoring exposure to 2,4,6-trinitrotoluene were located. These included HPLC/MS, GC/ECD, and 

TLC/densitometry for determining 2,4,6-trinitrotoluene or its metabolites in blood and/or urine (Almog 

et al. 1983; Liu et al. 1991; Yinon and Hwang 1985b, 1986c) and HPLC/UV for determining 

2,4,6-trinitrotoluene in tissues (Army 1981). In addition, there are methods for analyzing for the 

chemical and its metabolites in handswab samples (Douse 1987; Fetterolf et al. 1991; Fine et al. 1984; 

Lloyd 1991). While these methods appear to be useful and reliable for measuring 2,4,6-trinitrotoluene 

in biological samples, the limited information on sensitivity, selectivity, accuracy, and precision make 
2,4,6-TRINITROTOLUENE 131 

6. ANALYTICAL METHODS 

it difficult to compare and fully evaluate the reliability of the methods. More information is needed on 

these parameters for the different methods in order to assess their usefulness for monitoring exposure 

to 2,4,6-trinitrotoluene. 

Possible biomarkers of effect for 2,4,6-trinitrotoluene exposure include changes in hematological and 

blood chemistry parameters, such as decreased hemoglobin and hematocrit levels, increased 

mononuclear leukocyte and lymphocyte counts, and changes in levels of SGOT and LDH (Army 1976, 

1978a; Morton et al. 1976). Reliable standard clinical laboratory methods exist to measure these 

parameters; however, they are not specific to 2,4,6-trinitrotoluene exposure and have only limited use 

as biomarkers of effect for this chemical. Urine discoloration and cataracts are also observed in 

workers exposed to 2,4,6-trinitrotoluene, but no methods are available to quantitate these nonspecific 

biomarkers. 

Methods for Determining Parent Compounds and Degradation Products in 

Environmental Media. Methods exist to detect and quantify 2,4,6-trinitrotoluene in air, fresh water, 

sea water, waste-water effluents, soil, and plant material (Army 1981, 1985b; 1986c, 1988, 1990a, 

1990b; Bauer et al. 1990; Feltes and Levsen 1989; Feltes et al. 1990; Hable et al. 1991; Hoffsommer 

and Rosen 1972; Jenkins et al. 1989; McLuckey et al. 1988; Spangler et al. 1983; Van Slyke et al. 

1985; Zhang et al. 1989). The HPLC- and GC-based methods are generally considered to be sensitive 

and reliable, but in some cases (e.g., air samples) better characterization is needed. Some of the newer 

methods (e.g., IMS, GDMS) and those proposed for field use (e.g., IMS, membrane-based 

spectrophotometry) need continued research and characterization in order to be useful quantitative 

methods for analysis of environmental samples (Army 1990b; McLuckey et al. 1988; Spangler et al. 

1983; Zhang et al. 1989). 

6.3.2 On-going Studies 

No on-going analytical methods studies were located. However, it is likely that research is continuing 

on some of the more recently introduced methods for analyzing biological and environmental samples, 
2,4,6-TRINITROTOLUEN 132 

6. ANALYTICAL METHODS 

such as the use of ELISA (Fetterolf et al. 1991). GDMS (McLuckey et al. 1988), IMS (Spangler et al. 

1983), and spectrophotometric field methods (Army 1990b; Zhang et al. 1989). 
2,4,6-TRINITROTOLUENE 133 

7. REGULATIONS AND ADVISORIES
 

The international, national, and state regulations and guidelines regarding 2,4,6-trinitrotoluene in air, 

water, and other media are summarized in Table 7- 1. 

ATSDR has derived an MRL of 0.0005 mg/kg/day for intermediate oral exposure to 

2,4,6-trinitrotoluene (see Section 2.4). EPA (IRIS 1994) assigned 2,4,6-trinitrotoluene a reference dose 

(RfD) of 5.00x10-4 mg/kg/day with an uncertainty factor of 1,000 based on liver effects observed in 

dogs in a 26-week feeding study (Army 1983a). 

EPA has assigned 2,4,6-trinitrotoluene a weight-of-evidence carcinogenic classification of C, which 

indicates that 2,4,6-trinitrotoluene is a possible human carcinogen (IRIS 1994). 

The Drinking Water Equivalent Level (DWEL), a lifetime exposure at which adverse health effects 

would not be expected to occur, is 20 μg/L for 2,4,6-trinitrotoluene (EPA 1989b, 1994). Because of 

the lack of appropriate data for determination of the One-day Health Advisory and the Ten-day Health 

Advisory, it is suggested that the DWEL be used as a conservative estimate. The Longer-term Health 

Advisory for both children and adults is 20 μg/L, which is equivalent to the DWEL. The Lifetime 

Health Advisory is 2 μg/L. 

Based on EPA Guidelines, an acceptable daily intake of 44.25 μg/L was calculated (Army 1987d). 

The available data for calculating water quality criteria for 2,4,6-trinitrotoluene were insufficient to 

meet all of the EPA guidelines requirements. However, enough information was available to calculate 

a reasonable estimate of the criterion maximum concentration, 557 μg/L, to protect aquatic life. The 

other component of the criteria, the criterion continuous concentration, needs further research. The 

criterion to protect human health has been estimated to be 135 μg/L, but further research is needed to 

confirm this value. 





____________________ 

2,4,6-TRINITROTOLUENE 139 

8. REFERENCES
 

*ACGIH. 1993. Threshold limit values and biological exposure indices for 1993-1994. American 

Conference of Governmental Industrial Hygienists. Cincinnati, OH. 

Agarwal DP, Goedde HW. 1986. Pharmacogenetics and ecogenetics. Experientia (Basel) 

42(10):1148-1154. 

*Ahlborg G Jr, Bergstroem B, Hogstedt C, et al. 1985. Urinary screening for potentially genotoxic 

exposures in a chemical industry. Br J Ind Med 42:691-699. 

*Ahlborg G Jr, Einisto P, Sorsa M. 1988a. Mutagenic activity and metabolites in the urine of workers 

exposed to trinitrotoluene (TNT). Br J Ind Med 45(5):353-358. 

*Ahlborg G Jr, Ulander A, Bergstrom B, et al. 1988b. Diazo-positive metabolites in urine from 

workers exposed to aromatic nitro-amino compounds. International Archives of Occupational and 

Environmental Health (Int Arch Occup Environ Health) 60(1):51-54. 

Albanbauer J, Kraatz A, Megges G. 1983. [Forensic chemistry studies following detonation of 

explosives.] Arch Kriminol 171(3-4):89-96. (German) 

*Almog J, Kraus S, Basch A. 1983. Determination of TNT metabolites in urine. Arch Toxicol [Suppl] 

6:351-353. 

Alvarez M, Hanners JL, Botsford J, et al. 1991. Enzyme catalyzed transformation of 2,4,6-trinitrotoluene. 

In: 91st General Meeting of the American Society for Microbiology, Dallas, Texas, May 5-9, 

1991. Abstr Gen Meet Am Soc Microbial 91:217. 

Amas SA, Yallop HJ. 1966. The identification of industrial blasting explosives of the gelignite type. J 

Forensic Sci Soc 6(4):185-l 88. 

Amerkhanova NN, Naumova RP. 1978. 2,4,6-Trinitrotoluene as a source of nutrition for bacteria. 

Mikrobiologiya 47(3):393-395. 

Amr M, Allam M, Osmaan AL, et al. 1993. Neurobehavioral changes among workers in some 

chemical industries in Egypt. Environmental Research 63:295-300. 

Anastos GJ, Noland JW, Johnson NP, et al. 1988. Innovative technologies for hazardous waste 

treatment. Nucl Chem Waste Manage 8(4):269-282. 

*Cited in text 
2,4,6-TRINITROTOLUENE 140 

8. REFERENCES 

*Andersson K, Levin JO, Nilsson CA. 1983. Evaluation of solid sorbents for sampling aliphatic and 

aromatic nitrocompounds in work-room air. Chemosphere 12(3):377-384. 

Andren RK, McDonnell R, Stevens B, et al. 1977a. Explosives from wastewater. Ind Wastes 

23(2):28-31, 49. 

*Andren RK, Nystron JM, McDonnell RP, et al. 1977b. Explosives removal from munitions 

wastewater. Proc Ind Waste Conf 30:816-825. 

Anonymous. 1988. 2,4,6-Trinitrotoluene (wet). Dangerous Prop Ind Mater Rep 8(4):75-80. 

Ape1 EC, Nogar NS. 1986. Multiphoton photoionization mass spectra of nitrobenzene and 

2,4,6-trinitrotoluene. International J Mass Spectrometry Ionic Processes 70(2):243-246. 

Army. 1972. Reactions of aromatic nitrocompounds: I. Photochemistry. Dover, NJ: U.S. Army, 

Picatinny Arsenal. Document no. AD 753 923. 

Army. 1973. Mammalian toxicology and toxicity to aquatic organisms of TNT, DNT, and other 

munitions manufacturing waste constituents of pink water - a literature evaluation. Contract no. DADA 

17-73-C-3150. Washington, DC: U.S. Army Medical Research and Development Command. Document 

no. AD-777903/6GA. 

*Army. 1974. Biodegradation of alpha TNT and its product isomers. Contract no. DAAG17-73-C0276. Natick, MA: U.S. Army Natick Development Center. Document no. AD-A016128. 

*Army. 1976. Adverse health effects of selected explosives (TNT, RDX). Report no. USAEHH-32­

049-75/76. Aberdeen Proving Ground: MD: U.S. Army Environmental Hygiene Agency. Document 

no. AD-B010943. 

Army. 1977. Mutagenicity of some munition waste water chemicals and chlorine test kit reagents. 

Final report. U.S. Army Medical Research and Development Command. Contract no. DAMD 17-76-C6013. Frederick, MD: U.S. Army Medical Research and Development Command. Document no. 

AD-A057680. 

*Army. 1978a. A literature review - problem definition studies on selected toxic chemicals. Volume 

3: Occupational health and safety aspects of 2,4,6-trinitrotoluene (TNT). Contract no. DAMD 17-77-C7020. Frederick, MD: U.S. Army Medical Research and Development Command, Fort Detrick. 

Document no. AD A055683. 

*Army. 1978b. Mammalian toxicity of munitions compounds: Phase I. Acute oral toxicity, primary 

skin and eye irritation, dermal sensitization, disposition and metabolism, and Ames tests of additional 

compounds. Contract no. DAMD-17-74-C-4073. Frederick, MD: U.S. Army Medical Research and 

Development Command, Fort Detrick. Document no. AD-A069 333. 

*Army. 1978c. Mammalian toxicological evaluation of TNT wastewaters. Volume II: Acute and 

subacute mammalian toxicity of TNT and the LAP mixture. Contract no. 17-76-C-6050. Frederick, 
2,4,6-TRINITROTOLUENE 141 

8. REFERENCES 

MD: U.S. Army Medical Research and Development Command, Fort Detrick. Document no. AD-A080 

957. 

Army. 1978d. Specific air pollutants from munitions processing and their atmospheric behavior. 

Volume 2: RDX/HMX production. Contract no. DAMD17-76-C-6067. Frederick, MD: U.S. Army 

Medical Research and Development Command, Fort Detrick. Document no. AD-A060122. 

Army. 1978e. The biodegradation of TNT in enhanced soil and compost systems. Report no. ARLCDTR77032, AD-E400073. Dover, NJ: U.S. Army Armament, Research and Development Command. 

Document no. AD-A054375. 

*Army. 1979. Mammalian toxicological evaluations of TNT wastewaters. Volume III: Acute and 

subacute mammalian toxicity of condensate water. Contract no. DAMD17-76C6050. Frederick, MD: 

US Army Medical Research and Development Command, Fort Detrick. Document no. AD-A081590. 

Army. 1980a. Analytical chemistry of 2,4,6-trinitrotoluene. Report no. ARLCD-SP-8007, ADE400487. 

Dover, NJ: U.S. Army Armament Research and Development Command. Document no. ADA092348. 

*Army. 1980b. Environmental fate of RDX and TNT. Final Report, Contract no. DAMD-17-77-C7026. Frederick, MD: U.S. Army Medical Research and Development Command, Fort Detrick. 

Army. 1980c. Environmental fate studies on certain munitions wastewater constituents. Final report: 

Phase II lab studies. Contract no. DAMD 17-78-C-8081. Frederick, MD: U.S. Army Medical Research 

and Development Command, Fort Detrick. Document no. AD-A099256. 

*Army. 1980d. Mammalian toxicity of munitions compounds: Summary of toxicity of nitrotoluenes. 

Contract no. DAMD17-74-C-4073. Frederick, MD: U.S. Army Medical Research and Development 

Command, Fort Detrick. Document no. AD-A080 146/4. 

*Army. 1981a. Analytical method for concentration of trace organics from water. Aberdeen, MD: 

U.S. Army Toxic and Hazardous Materials Agency. Document no. AD-Al01 639. 

*Army. 1981b. Identification or development of chemical analysis methods for plants and animal 

tissues. Contract no. DAAKll-79-C-0110. Aberdeen Proving Ground, MD: U.S. Army Toxic and 

Hazardous Materials Agency. Document no. AD-A1073469. 

Army. 1981c. Rotating biological contactors for munitions wastewater treatment. Report no. 2319. 

Aberdeen Proving Ground, MD: Chemical Systems Laboratory. Document no. AD-A100437. 

*Army. 1981d. Species differences in the disposition and metabolism of 2,4,6-trinitrotoluene as a 

function of route of administration. Final report. Contract no. DAMD-17-76-C-6066. Frederick, MD: 

U.S. Army Medical Research and Development Command, Fort Detrick. Document no. AD-Al 14025. 
2,4,6-TRINITROTOLUENE 142 

8. REFERENCES 

Army. 1981e. Thirteen week oral (diet) toxicity study of trinitrotoluene (TNT), hexahydro-1,3,5­

trinitro-1,3,5-triazine (RDX) and TNT/RDX mixtures in the Fischer 344 rat. Final report. Contract no. 

DAMD- 17-79-C-91 61. Frederick, MD: U.S. Army Medical Research and Development Command, 

Fort Detrick. Document no. AD-A108 447. 

Army. 1982. 2,4,6-Trinitrotoluene - surfactant complexes, biodegradability, mutagenicity and soil 

leaching studies. Report no. NATICK/TR-82/006. Aberdeen Proving Ground, MD: U.S. Army Toxic 

and Hazardous Material Agency. Document no. AD-Al 13727. 

Army. 1983a. Determination of the chronic mammalian toxicological effects of TNT (twenty-six week 

chronic toxicity/carcinogenicity study of trinitrotoluene (TNT) in the beagle dog). Final report: Phase II. 

Contract no. DAMD17-79-C-9120. Frederick, MD: U.S. Army Medical Research and Development 

Command, Fort Detrick. Document no. AD-Al57 082. 

*Army. 1983b. HPLC analysis of HMX, TAX, RDX, and TNT in wastewater. Frederick, MD: U.S. 

Medical Bioengineering Research and Development Laboratory, Fort Detrick. Document no. 

ADA127348. 

Army. 1984a. Determination of the chronic mammalian toxicological effects of TNT (twenty-four 

month chronic toxicity/carcinogenicity study of trinitrotoluene (TNT) in the Fischer 344 rat). Final 

report: Phase III. Contract no. DAMD17-79-C-9120. Frederick, MD: U.S. Army Medical Research 

and Development Command, Fort Detrick. Document no. AD-Al68 637. 

Army. 1984b. Determination of the chronic mammalian toxicological effects of TNT (twenty-four 

month chronic toxicity/carcinogenicity study of trinitrotoluene (TNT) in the B6C3Fl hybrid mouse). 

Final report: Phase IV. Contract no. DAMD17-79-C-9120. Frederick, MD: U.S. Army Medical 

Research and Development Command, Fort Detrick. Document no. AD-Al68 754. 

*Army. 1985a. Effects of environmental factors on the transformation of 2,4,6-trinitrotoluene in soils. 

Report no. NATICK/TR-85/052. Aberdeen Proving Ground, MD: U.S. Army Toxic and Hazardous 

Materials Agency. Document no. AD-A157812. 

*Army. 1985b. Reverse phase HPLC method for analysis of TNT, RDX, HMX, and 2,4-DNT in 

munitions wastewater. Report no. CRREL84-29. Aberdeen Proving Ground, MD: U.S. Army Toxic and 

Hazardous Materials Agency, Technology Division. 

*Army. 1985c. TNT, RDX and HMX explosives in soils and sediments: Analysis techniques and 

drying losses. Aberdeen, MD: U.S. Army Toxic and Hazardous Materials Agency. Document no. 

AD-Al63 278. 

*Army. 1986a. Cornposting explosives/organics contaminated soils. Contract no. DAAKl l-84-C0057. Aberdeen, MD: U.S. Army Toxic and Hazardous Materials Agency. Document no. AD-Al69 

994. 
2,4,6-TRINITROTOLUENE 143 

8. REFERENCES 

Army. 1986b. Database assessment of pollution control in the military explosives and propellants 

production industry. Contract no. PO-83PP3802. Frederick, MD: U.S. Army Medical Research and 

Development Command, Fort Detrick. Document no. 29. 

*Army. 1986c. Data summary for trinitrotoluene. Frederick, MD: U.S. Army Medical Research and 

Development Command, Fort Detrick. Document no. AD-A199 118. 

Army. 1986d. Demilitarization of conventional ordnance: Priorities for data-base assessments of 

environmental contaminants. Frederick, MD: U.S. Army Medical Research and Development 

Command, Fort Detrick. Document no. AD-A182 922. 

Army. 1986e. Demilitarization of conventional ordnance: Priorities for data base assessments of 

environmental contaminants. Frederick, MD: U.S. Army Medical Research and Development 

Command, Fort Detrick. Document no. AD UCRL-15902. 

*Army. 1987a. Adsorption and desorption of 2,4,6-trinitrotoluene by soils. Technical report EL-87-17. 

Washington, DC: Department of the Army. 

Army. 1987b. Conventional weapon demilitarization: A health and environmental effects data base 

assessment: Explosives and their co-contaminants. Final report: Phase 2. Frederick, MD: U.S. Army 

Medical Research and Development Command, Fort Detrick. Document no. AD-A220588. 

*Army. 1987c. Development of an analytical method for explosive residues in soil. Report 87-7. 

Report no. AMXTH-TE-FR-86102. Aberdeen Proving Ground, MD: Army Toxic and Hazardous 

Materials Agency, Technology Division. 

*Army. 1987d. Water quality criteria for 2,4,6-trinitrotoluene (TNT). Final report. Report no. ORNL6304. Frederick, MD: US Army Medical Research and Development Command, Fort Detrick. 

Document no. AD-Al 8895 1. 

Army. 1988a. Conventional weapons demilitarization: A health and environmental effects data base 

assessment: Methods for estimating multi-pathway exposures to environmental contaminants. Final 

report: Phase 2. Frederick, MD: U.S. Army Medical Research and Development Command, Fort 

Detrick. Document no. AD-A211656. 

*Army. 1988b. Soil sorption and plant uptake of 2,4,6-trinitrotoluene. Report no. TR/EL-88-12. 

Project no. 4A161101A91D. Washington, DC: Department of the Army, Assistant Secretary of the 

Army, U.S. Army Biomedical Research and Development. 

*Army. 1989a. An evaluation of the environmental fate and behavior of munitions material (TNT, 

RDX) in soil and plant systems: Environmental fate and behavior of TNT. Project no. 88PP8853. 

Frederick, MD: U.S. Army Medical Research and Development Command, Fort Detrick. Document no. 

AD-A223 546/3. 

*Army. 1989b. Validation of a sorbent tube/high performance liquid chromatographic procedure for 

the determination of eight explosives in water. Aberdeen Proving Ground, MD: U.S. Army 
2,4,6-TRINITROTOLUENE 144 

8. REFERENCES 

Environmental Hygiene Agency, U.S. Army Toxic and Hazardous Material Agency. Document no. 

ADA210777. 

*Army. 1990a. Development of a simplified field method for the determination of TNT in soil, 

Special report 90-38. Report no. CETHA-TS-CR-90125. Aberdeen Proving Ground, MD: U.S. Army 

Toxic and Hazardous Materials Agency. 

*Army. 1990b. Evaluation of a field kit for detection of TNT in water and soils. Special report 90-20. 

Report no. CETHA-TE-CR-90056. Aberdeen Proving Ground, MD: U.S. Army Toxic and Hazardous 

Materials Agency. 

Army. 1990c. TNT metabolites in animal tissues. Quarterly technical progress report no. 6, January 

l-March 31, 1990. Report no. ORNL-M-1142. Contract no. 88PP8866. Frederick, MD: US. Army 

Biomedical Research and Development Laboratories, Fort Detrick. Document no. DE90-011273. 

*Ashby J, Burlinson B, Levre PA, et al. 1985. Non-genotoxicity of 2,4,6-trinitrotoluene (TNT) to the 

mouse bone marrow and the rat liver: Implications for its carcinogenicity. Arch Toxicol 58:14-19. 

Asplund J. 1986. Differential pulse polarographic analysis of powders and explosives. Propellants 

Explosives and Pyrotechnology 11(3):69-80. 

Assa S, Weisselberg S, Steir M. 1987. Elevated serum enzyme levels in exposure to trinitrotoluene. 

Harefuah, Journal of the Israel Med Assoc 113(1-2):Summaries. 

Atkinson R, Tuazon EC, Wallington TJ, et al. 1987. Atmospheric chemistry of aniline, n,n,­

dimethylaniline, pyridine, 1,3,5-triazine, and nitrobenzene. Environ Sci Technol 21:64-72. 

Aust SD. 1990. Degradation of environmental pollutants by phanerochaete chrysosporium. Microbial 

Ecology 20(2):197-210. 

Bailey HC. 1982. Development and testing of a laboratory model ecosystem for use in evaluating 

biological effects and chemical fate of pollutants. In: Pearson JG, Foster RB, Bishop WE, eds. Aquatic 

toxicology and hazard assessment, Fifth Symposium, ASTM STP802. Philadelphia, PA: American 

Society for Testing and Materials, 221-233. 

Bailey HC, Spanggord RJ. 1983. The relationship between the toxicity and structure of nitroaromatic 

chemicals. In: Bishop WE, Cardwell RD, Heidoph BB, eds. Aquatic toxicology and hazard assessment, 

Sixth Symposium, ASTM STP802. Philadelphia, PA: American Society for Testing and Materials, 

98-107. 

Bajpayee TS, Mainiero RJ. 1988. Methods of evaluating explosive reactivity of explosive-contaminated 

solid waste substances. Bur Mines Rep Invest RI9217:9. 

*Barnes DG, Dourson M. 1988. Reference dose (RfD): Description and use in health risk 

assessments. Regul Toxicol Pharmacol 8:471-486. 
2,4,6-TRINITROTOLUENE 145 

8. REFERENCES 

Basch A, Kraus S. 1979. Analysis and characterization of military-grade trinitrotoluene by gas 

chromatography. J Forensic Sci 24(4):870-874. 

*Bauer CF, Grant CL, Jenkins TF. 1986. Interlaboratory evaluation of high-performance liquid 

chromatographic determination of nitroorganics in munition plant wastewater. Anal Chem 

58(1):176-182. 

*Bauer CF, Koza SM, Jenkins TF. 1990. Liquid chromatographic method for determination of 

explosives residues in soil: Collaborative study. J Assoc Off Anal Chem 73(4):541-552. 

Bearman JC, Castling RL, Skelton RL. 1983. The fluid bed incineration of the waste red liquor from 

the ROF Bridgwater TNT plant. Inst Chem Eng Symp Ser 69:273-283. 

*Belkin F, Bishop RW, Sheely MV. 1985. Analysis of explosives in water by capillary gas 

chromatography. J Chromatogr Sci 23(12):532-534. 

Bell BA, Burrows WD. 1989. Removal and degradation of TNT in a semicontinuous activated sludge 

system. Hazardous Industrial Waste 21:344-356. 

Berberich DW, Yost RA, Fetterolf DD. 1988. Analysis of explosives by liquid chromatography/ 

thermospray/mass spectrometry. J Forensic Sci 33(4):946-959. 

Bhattacharyya D, Garrison KA, Grieves RB. 1977a. Membrane ultrafiltration for treatment and water 

reuse of TNT-manufacturing wastes. J Water Pollut Control Fed 49(5):800-808. 

Bhattacharyya D, Garrison KA, Grieves RB. 1977b. Membrane ultrafiltration of nitrotoluenes from 

industrial wastes. Proc Ind Waste Conf 31:139-149. 

*Bishop RW, Rinehart DS, Ayers TA. 1981. The use of a solid sorbent as a collection medium for 

TNT and RDX vapors. Am Ind Hyg Assoc J 42(8):586-589. 

*Bishop RW, Kennedy JL, Podolak GE, et al. 1988. A field evaluation of air sampling methods for 

TNT and RDX. Am Ind Hyg Assoc J 49(12):635-638. 

Bogatyrev O. 1973. Influence of aromatic nitrated hydrocarbons on the activated sludge process. Acta 

Hydrochim Hydrobiol 1(5):455-460. 

Boileau J, Fauquignon C, Napoly C. 1987. Explosives. In: Ullmann’s encyclopedia of industrial 

chemistry. 5th ed., A10, 143-172. 

*Bongiovanni R, Podolak GE, Clark LD, et al. 1984. Analysis of trace amounts of 6 selected 

poly-nitro compounds in soils. Am Ind Hyg Assoc J 45(4):222-226. 
2,4,6-TRINITROTOLUENE 146 

8. REFERENCES 

*Boopathy R, Kulpa CF. 1992. Trinitrotoluene (TNT) as a sole nitrogen source for a sulfate-reducing 

bacterium Desulfovibrio sp. (B Strain) isolated from an anaerobic digester. Current Microbiology 

25:235-241. 

Boublik T, Fried V, Hala E, eds. 1984. The vapor pressures of pure substances: Selected values of the 

temperature dependence of the vapour pressures of some pure substances in the normal and low pressure 

region. Amsterdam, The Netherlands: Elsevier, Vol. 17. 

Bowermaster J, McNair HM. 1983. Detection of explosive residues by microbore HPLC. In: 

Proceedings of the International Symposium for the Analytical Detection of Explosives, FBI Academy, 

March 29-31, 1983. Quantico, VA: Federal Bureau of Investigation, 321-327. 

Bratin K, Kissinger PT, Briner RC, et al. 1981. Determination of nitro aromatic, nitramine, and nitrate 

ester explosive compounds in explosive mixtures and gunshot residue by liquid chromatography and 

reductive electrochemical detection. Anal Chim Acta 130(2):295-311. 

Bringmann G, Keuhn R. 197 1. Biological decomposition of nitrotoluenes and nitrobenzenes by 

azotobacter agilis. Gesundh Ing 92:273-276. 

*Bronstein AC, Currance PL. 1988. Emergency care for hazardous materials exposure. St. Louis, MO: 

The C.V. Mosby Company, 85-86. 

*Budavari S, O’Neil MJ, Smith A, et al. 1989. The Merck index: An encyclopedia of chemicals, 

drugs, and biologicals. Eleventh edition. Rahway, NJ: Merck and Co., Inc., 1530-1531. 

Bulich AA, Isenberg DL. 1980. Use of the luminescent bacterial system for the rapid assessment of 

aquatic toxicity. Advanced Instrumentation 35:35-40. 

Bulich AA, Isenberg DL. 1981. Use of the luminescent bacterial system for the rapid assessment of 

aquatic toxicity. ISA Trans 20(1):29-33. 

*Burlinson NE. 1980. Fate of TNT in an aquatic environment: photodecomposition vs. 

biotransformation. Naval Surface Weapons Center, NSWC TR 79-445. Document no. AD B045846. 

*Burns DT, Eltayeb MA-Z, Flockhart BD. 1987. Identification and determination of aromatic nitro 

compounds by electron spin resonance spectrometty. Analytica Chimica Acta 200(1):481-490. 

Burrows WD, Chyrek RH, Noss CI, et al. 1984. Treatment for removal of munition chemicals from 

Army industrial wastewaters. Toxic Hazard Wastes Proc Mid-At1 Ind Waste Conf 16:331-342. 

Carotti A, Thomas JC. 1976. How the Army does a bang-up job of treating effluents. Environ Sci 

Technol 10(8):751-756. 

Carpenter DF, McCormick NG, Cornell JH, et al. 1978. Microbial transformation of 14C-labeled 

2,4,6-trinitrotoluene in an activated-sludge system. Appl Environ Microbial 35(5):949-954. 
2,4,6-TRINITROTOLUENE 147 

8. REFERENCES 

Carper WR, Dorey RC, Tomer KB, et al. 1984. Mass spectral fragmentation pathways in 

2,4,6-trinitrotoluene derived from a MS/MS unimolecular and collisionally activated dissociation study. 

Organic Mass Spectrometry 19(12):623-626. 

Carrazza J, Pregun E, Chandler C, et al. 1985. Treatment of wastewater (red water) resulting from 

TNT (trinitrotoluene) purification. In: Proceedings of the Environmental Systems Syposium (13th) 

Held at Bethesa, Maryland on 20-22 March 1984, 179-197. 

Carroll JW, Guinivan TL, Tuggle RM, et al. 1979. Assessment of hazardous air pollutants from 

disposal of munitions in a prototype fluidized bed incinerator. Am Ind Hyg Assoc J 40(2):147-158. 

Carver FWS, Wyndham DP, Sinclair TJ. 1985. Spectroscopic studies of explosives: II. Detection of 

nitro-compounds on silica gel and glass with a Raman micro-probe. J Raman Spectrosc 16(5):332-336. 

Cattran DE, Stanford TB, Graffeo AP. 1963. Quantification of the munitions HMX, RDX, and TNT in 

waste water by liquid chromatography. U.S. Patent no. 4252537 02/24/81. Washington, D.C.: Secretary 

of the Army. 

CELDS. 1991. Computer-Environmental Legislative Data Systems. University of Illinois, Urbana, IL. 

June 20, 1991. 

Chambers CW, Tabak HH, Kabler PW. 1963. Degradation of aromatic compounds by phenol-adapted 

bacteria. J Water Pollut Contr Fed 35(12):1517-1528. 

*Channon HJ, Mills GT, Williams RT. 1944. The metabolism of 2,4,6-trinitrotoluene (alpha-TNT). 

Biochem J 38:70-85. 

Chen TH, Campbell C, Fisco W. 1980. Characterization of pollutants at Army ammunition plants. 

Internationale Jahrestagung-Fraunhofer-Institut fhur Treib-Explosivstoffe (Mess-Pruefmethoden 

Treib-Sprengst):613-635. 

*Chrostowski JE, Holmes RN, Rehn BW. 1976. The collection and determination of ethylene glycol 

dinitrate, nitroglycerine, and trinitrotoluene explosive vapors. J Forensic Sci 21(3):611-615. 

Copisarow M. 1915. Trinitrotoluene. Chem News 112(2921):247-248. 

Crosby WH. 1981. Reticulocyte counts. Arch Intern Med 141:1747-1748. 

Cumming AS, Park KP. 1983. The analysis of trace levels of explosive by gas chromatography/mass 

spectrometry. In: Proceedings of the International Symposium for the Analytical Detection of 

Explosives, FBI Academy, March 29-31, 1983. Quantico, VA: Federal Bureau of Investigation, 

259-265. 

Cumming AS, Park KP, Clench MR. 1983. The analysis of post-detonation carbon residues by mass 

spectrometry. In: Proceedings of the International Symposium for the Analytical Detection of 
2,4,6-TRINITROTOLUENE 148 

8. REFERENCES 

Explosives, FBI Academy, March 29-31, 1983. Quantico, VA: Federal Bureau of Investigation, 

235-239. 

Davenport R, Johnson LR, Schaeffer DJ, et al. 1994. Phototoxicology: 1. Light-enhanced toxicity of 

TNT and some related compounds to Daphnia magna and Lytechinus variagatus embryos. 

Ecotoxicology and Environmental Safety 27: 14-22. 

Dilley JV, Tyson CA, Spanggord RJ, et al. 1982a. Short-term oral toxicity of 2,4,6-trinitrotoluene and 

hexahydro-1,3,5-trinitro- 1,3,5triazine mixture in mice, rats, and dogs. J Toxicol Environ Health 

9(4):587-610. 

*Dilley JV, Tyson CA, Spanggord RJ, et al. 1982b. Short-term oral toxicity of 2,4,6-trinitrotoluene in 

mice, rats, and dogs. J Toxicol Environ Health 9(4):565-585. 

Dionne BC, Rounbehler DP, Achter EK, et al. 1986. Vapor pressure of explosives. J Energetic 

Materials 4( l-4):447-472. 

*Djerassi LS, Vitany L. 1975. A report on 3 cases of acute hemolytic disease in glucose-6-phosphate 

dehydrogenase deficient workers exposed to trinitrotoluene: Onset of the disease was within 2 or 4 days 

after start of exposure. Br J Ind Med 32(1):54-58. 

Donnelly KC, Brown KW, Giam CS, et al. 1993. Acute and genetic toxicity of extracts of munitions 

wastewater contaminated soils. Chemosphere 27(8):1439-1450. 

*DOT. 1989a. Hazardous materials table and hazardous materials communications regulations. U.S. 

Department of Transportation. Code of Federal Regulations. 49 CFR 172.101. 

*DOT. 1989b. Hazardous materials table. U.S. Department of Transportation. Federal Regulations 54 

(185):39501-39505. 

Douse JMF. 1981. Trace analysis of explosives at the low picogram level by silica capillary column 

gas-liquid chromatography with electron-capture detection. J Chromatogr 208( 1):83-88. 

Douse JMF. 1982. Trace analysis of explosives in handswab extracts using amberlite XAD-7 porous 

polymer beads, silica capillary column gas chromatography with electron-capture detection and thinlayer 

chromatography. J Chromatogr 234(2):415-425. 

*Douse JMF. 1985. Trace analysis of explosives at the low nanogram level in handswab extracts using 

columns of Amberlite XAD-7 porous polymer beads and silica capillary column gas chromatography 

with thermal energy analysis and electron-capture detection. J Chromatogr 328:155-165. 

*Douse JMF. 1987. Improved method for the trace analysis of explosives by silica capillary column 

gas chromatography with thermal energy analysis detection. J Chromatogr 410(1):181-189. 
2,4,6-TRINITROTOLUENE 149 

8. REFERENCES 

Douse JMF, Smith RN. 1986. Trace analysis of explosives and firearm discharge residues in the 

metropolitan police forensic science laboratory. J Energetic Materials 4( l-4): 169- 186. 

Doyle RC, Isbister JD, Forgacs TW, et al. 1985. Composting explosives contaminated sediments. 

Proceedings of the American Defense Preparedness Association, 14th Environmental Systems 

Symposium, Oct. 23-25, 1985. Baltimore, MD: American Defense Preparedness Association, 40-44. 

Dura G, Krasovski GN, Zholdakova ZI, et al. 1985. Prediction of toxicity using quantitative 

structure-activity relationships. Arch Toxicol Suppl 8:481-487. 

Einisto P. 1991. Role of bacterial nitroreductase and o-acetyltransferase in urine mutagenicity assay of 

rats exposed to 2,4,6-trinitrotoluene (TNT). Mutat Res 262(3): 167-169. 

*Einisto P, Watanabe M, Ishidate Jr. M, et al. 1991. Mutagenicity of 30 chemicals in Salmonella 

tphimurium strains possessing different nitroreductase of O-acetyltransferase activities. Mutation 

Research 259:95-102. 

Eisenreich SJ, Looney BB, Thornton DJ. 1981. Airborne organic contaminants in the great lakes 

ecosystem. Environ Sci Technol 15:30-38. 

*Ellenhorn NJ, Barceloux DG. 1988. Medical toxicology diagnosis and treatment of human poisoning. 

New York, NY: Elsevier Science Publishing Company, Inc., 35,845,1006. 

*EPA. 1976a. Investigation of selected potential environmental contaminants: Nitroaromatics. Contract 

no. EPA 68-01-2999, EPA-560/2-76-010. Washington, D.C.: U.S. Environmental Protection Agency, 

Office of Toxic Substances. Document no. PB-2750278. 

EPA. 1976b. State-of-the-art: Military explosives and propellants production industry. Volume III: 

Wastewater treatment. Report no. EPA-600/2-76-213c. Cincinnati, OH: US. Environmental Protection 

Agency, Office of Research Development, Industrial Environmental Research Laboratory. Document 

no. PB-265042. 

*EPA. 1979a. Evaluation of the ultraviolet-ozone and ultraviolet-oxidant treatment of pink water. 

Contract no. IAG-D6-0059. Cincinnati, OH: U.S. Environmental Protection Agency, Industrial 

Environmental Research Lab. Document no. PB-300 763/0. 

EPA. 1979b. Water-related fate: 129 Priority Pollutant. Vol. II: halogenated aliphatic hydrocarbons, 

halogenated ethers, monocyclic aromatics, phthalate esters, polycyclic aromatic hydrocarbons, 

nitrosamines and miscellaneous compounds. Contract no. 68-01-3852, 68-01-3867. Washington, D.C.: 

U.S. Environmental Protection Agency, Monitoring and Data Support Division. Document no. PB80­

204381. 

*EPA. 1982. Management of hazardous waste leachate. Contract no. 68-03-2766. Cincinnati, OH: 

U.S. Environmental Protection Agency, Office of Research and Development. 
2,4,6-TRINITROTOLUENE 150 

8. REFERENCES 

EPA. 1987. Superfund record of decision: West Virginia ordnance works, Mason County, West 

Virginia. First remedial action. Washington, DC: U.S. Environmental Protection Agency. Document 

no. PB88-106455, Issue 02. 

EPA. 1988. Super-fund record of decision (EPA region 3): West Virginia ordinance works, Mason 

County, West Virginia, (second remedial action), September 1988. Report ISS EPA/ROD/R03-88/053. 

Washington, DC: U.S. Environmental Protection Agency. Document no. PB89-189468. 

EPA. 1989a. Drinking water health advisory for 2,4,6-trinitrotoluene. Washington, DC: Office of 

Drinking Water. 

*EPA. 1989b. Health advisory on 2,4,6-trinitrotoluene. Washington, DC: U.S. Environmental 

Protection Agency, Office of Drinking Water. ISS order no. PB90-273566. 

*EPA. 1989c. Treatability potential for EPA listed hazardous wastes in soil. Report no. EPA/600/S2­

89/011. Ada, OK: U.S. Environmental Protection Agency, Robert S. Kerr Environmental Research 

Laboratory. Document no. PB89-166581. 

EPA. 1989d. Use of innovative freezing technique for in-situ treatment of contaminated soils. 

Cincinnati, OH: U.S. Environmental Protection Agency, Risk Reduction Engineering Laboratory. 

Document no. ISS EPA/600/9-89/072. 

*EPA. 1990a. Interim methods for development of inhalation reference doses. U.S. Environmental 

Protection Agency. EPA/600/8-90/066A. 

*EPA. 199Ob. Lists of hazardous wastes. U.S. Environmental Protection Agency. Code of Federal 

Regulations. 40 CFR 261.32, Subpart D. 

EPA. 1991. Land disposal restrictions for third schedule wastes. U.S. Environmental Protection 

Agency. Federal Register 55(21):3864-3928. 

EPA. 1994. Drinking Water Regulations and Health Advisories. Washington, D.C., Office of Water. 

Erickson ED, Johnson JH, Smith SR, et al. 1989. Study of the organic contaminants released to the 

environment during the disposal of rocket motors by burning. J Hazardous Materials 21(2): 161-176. 

*Eveleth WT, Kollonitsch V, eds. 1990. Kline guide to the U.S. chemical industry. Fairfield, NJ: 

Kline and Company, Inc., 106-109. 

Faust SD. 1975. Nonbiological degradation and transformations of organic pesticides in aqueous 

systems. American Chemical Society Symposium Series 18:572-595. 

*FEDRIP. 1989-1992. Reaction of organic compounds with soils. Washington, D.C.: U.S. Department 

of Agriculture/Cooperative State Research Service Federal Research In Progress Database, National 

Technical Information Service (NTIS). 
2,4,6-TRINITROTOLUENE 151 

8. REFERENCES 

Feeney EC. 1979. Removal of organic materials from wastewaters with polymeric adsorbents. In: 

Prober R, Calmon C, Gold H, eds. Ion exchange for pollution control. Volume 2. Boca Raton, FL: 

CRC Press, Inc, 29-37. 

Fellows RJ, Harvey SD, Cataldo DA, et al. 1990. Environmental fate and behavior of TNT and RDX 

in a soil/plant system. SETAC ‘90-Global Environmental Issues: Challenge for the ‘90s, Arlington, VA, 

November 11-15, 1990. Washington, D.C.: Society for Environmental Toxicology and Chemistry, 

P195. 

*Feltes J, Levsen K. 1989. Reversed phase high performance liquid chromatographic determination 

with photodiode-array detection of nitroaromatics from former ammunition plants in surface waters. J 

High Resolution Chromatography 12(9):613-619. 

*Feltes J, Levsen K, Volmer D, et al. 1990. Gas chromatographic and mass spectrometric 

determination of nitroaromatics in water. J Chromatogr 518( 1):21-40. 

Fernando T, Aust SD. 1991. Biodegradation of munition waste, TNT (2,4,6-trinitrotoluene), and RDX 

(hexahydro-1,3,5-trinitro-1,3,5-triazine) by Phanerochaete chrysosporium. American Chemical Society 

Symposium Series #468(Emerging Technologies in Hazardous Waste Management - 2):214-232. 

*Fernando T, Bumpus JA, Aust SD. 1990. Biodegradation of TNT (2,4,6-trinitrotoluene) by 

Phanerochaete chrysosporium. Appl Environ Microbial 56(6): 1666- 1671. 

*Fetterolf DD, Mudd JL, Teten K. 1991. An enzyme-linked immunosorbent assay (ELISA) for 

trinitrotoluene (TNT) residue on hands. J Forensic Sci 36(2):343-349. 

Fine DA, Miles MH. 1983. The reduction of propylene glycol dinitrate, nitroglycerin, dinitrotoluene 

and trinitrotoluene on silver electrodes. Anal Chim Acta 153:141-147. 

Fine DH, Yu WC, Goff EU. 1983. Applications of the nitro/nitroso specific detector to explosive 

residue analysis. In: Proceedings of the International Symposium for the Analytical Detection of 

Explosives, FBI Academy, March 29-31, 1983. Quantico, VA: Federal Bureau of Investigation, 

169-179. 

*Fine DH, Yu WC, Goff EU, et al. 1984. Picogram analyses of explosive residues using the thermal 

energy analyzer (TEA). J Forensic Sci 29(3):732-746. 

Fisco WA. 1975. A portable explosives identification kit for field use. J Forensic Sci 20(1):141-148. 

*Fisher RH, Taylor JM. 1983. Munitions and explosive wastes. In: Parr JF, Marsh PB, Kla JM, eds. 

Land treatment of hazardous wastes. Park Ridge, NJ: Noyes Data Corporation, 297-303. 

Flora SD. 1981. Study of 106 organic and inorganic compounds in the Salmonella/microsome test. 

Carcinogenesis 2(4):283-293. 
2,4,6-TRINITROTOLUENE 152 

8. REFERENCES 

Forsten I. 1980. Disposal of hazardous toxic munition waste. National Conference of Environmental 

Engineers, Proceedings of the ASCE Environmental Engineers Division Special Conference, 440-452. 

Foussereau J, Benezra C, Maibach HI, et al. 1982. Army arsenals: Occupational contact dermatitis, 

clinical and chemical aspects. Philadelphia, PA: W. B. Saunders Company, 171-176. 

*Freeman DJ. 1985. Continuous fixation and removal of explosive wastes from pink water using 

surfactant technology. Proc Ind Waste Conf 40:659-676. 

*Freeman DJ, Colitti OA. 1982. Removal of explosives from load-assemble-pack wastewater (pink 

water) using surfactant technology. Proc Ind Waste Conf 36:383-394. 

Funk SB, Roberts DJ, Crawford DL, 1993. Initial-phase optimization for bioremediation of munition 

compound-contaminated soils. Applied and Environmental Microbiology, July 1993, 2171-2177. 

*Garfinkel D, Sidi Y, Steier M, et al. 1988. Liver cirrhosis and hepatocellular carcinoma after 

prolonged exposure to TNT: Causal relationship or mere coincidence? Med Intern 26(4):287-290. 

Germanov AI, Zakharova AI. 1974. [Metabolism of vitamin b12 in patients with chronic 

trinitrotoluene poisoning.] Gig Tr Prof Zabol 18( 1):42-44. (Russian) 

Geshev G. 1967. Changes in the menstrual cycle of females working with trinitrotoluene 

(TNT)[abstract]. Parva Nacionalna Koferencia Na Aspirantite. April 1967, 159-262. 

Geshev G, Kincheva V. 1974. Chromosomal changes in rats after trinitrotoluene treatment. Probl 

Akush Ginekol 2:111-114. 

*Gibbs TR, Popolato A, eds. 1980. LASL explosive property data. Berkeley, CA: University of 

California Press, 163- 171. 

Gibson DG, Doran JH, Traill TA, et al. 1978. Regional abnormalities of left ventricular wall 

movement during isovolumic relaxation in patients with ischemic heart disease. Eur J Cardiol 

7(Suppl):251-264. 

Glaser JA. 1990. Hazardous waste degradation by wood degrading fungi. In: Kamely D, Chakrabarty 

A, Omenn GS, eds. Advances in applied biotechnology series. Vol. 4: Biotechnology and 

biodegradation, International Workshop, Lisbon, Portugal, June 1989. 

Glaser JA, Sferra PR. 1987. White rot fungus detoxification research: Status and direction. Second 

International Conference On New Frontiers for Hazardous Waste Management, September 27-30, 1987. 

Pittsburg, PA: Hazardous Waste Engineering Research Laboratory, 277-284. 

*Goerlitz DF, Franks BJ. 1989. Use of on-site high performance liquid chromatography to evaluate the 

magnitude and extent of organic contaminants in aquifers. Ground Water Monit Rev 9(2):122-129. 
2,4,6-TRINITROTOLUENE 153 

8. REFERENCES 

Goh CL. 1984. Allergic contact dermatitis from tetryl and trinitrotoluene. Contact Dermatitis 

10(2):108. 

*Gob CL. 1988. Erythema multiforme-like eruption from trinitrotoluene allergy. Int J Dermatol 

27(9):650-651. 

*Goh CL, Rajan VS. 1983. Contact sensitivity to trinitrotoluene. Contact Dermatitis 9(5):433-434. 

*Goodwin JW. 1972. Twenty years handling TNT in a shell loading plant. Am Ind Hyg Assoc J 

33(1):41-44. 

*Gosselin RE, Hodge HC, Smith RP. 1984. Clinical toxicology of commercial products. Fifth edition, 

Baltimore, MD: Williams and Wilkins, II-215, III-34. 

Gribova IA, Gabulgalimova RA, Dymova EG. 1983. [Changes in blood parameters after exposure to 

low concentrations of trinitrotoluene: A clinical and experimental study.] Gig Tr Prof Zabol (9):24-28. 

(Russian) 

Griest WH, Guzman C, Dekker M. 1989. Packed-column supercritical fluid chromatographic 

separation of highly explosive compounds. Journal of Chromatography 467(2):423-429. 

Gring DM. 1971. Biological effects of trinitrotoluene (TNT). Diss Abstr Int B 32(8): 113. 

Haas R, Stork G. 1989. [Conception for the investigation of contaminated munition plants: I. 

Investigation of former TNT plants and filling-stations.] Fresenius Z Anal Chem 335(7):839-846. 

(German) 

*Hable M, Stem C, Asowata C, et al. 1991. The determination of nitroaromatics and nitramines in 

ground and drinking water by wide-bore capillary gas chromatography. J Chromatogr Sci 

29(4):131-135. 

*Haddad LM, Winchester JF, eds. 1990. Clinical management of poisoning and drug overdose second 

edition. Philadelphia, PA: W.B. Saunders Company, 85,285,300. 

Hall LH, Kier LB. 1986. Structure-activity relationship studies on the toxicities of benzene derivatives: 

II. An analysis of benzene substituent effects on toxicity. Environ Toxicol Chem 5(4):333-337. 

Hall LH, Kier LB, Phipps G. 1984. Structure-activity relationship studies on the toxicities of benzene 

derivatives: I. An additivity model. Environ Toxicol Chem 3(3):355-365. 

Hall LH, Maynard EL, Kier LB. 1989a. QSAR investigation of benzene toxicity to fathead minnow 

using molecular connectivity. Environ Toxicol Chem 8(9):783-788. 

Hall LH, Maynard EL, Kier LB. 1989b. Structure-activity relationship studies on the toxicity of 

benzene derivatives: III. Predictions and extension to new substituents. Environ Toxicol Chem 

8(5):431-436. 
2,4,6-TRINITROTOLUENE 154 

8. REFERENCES 

*Hamilton A, Hardy HL. 1974. Industrial toxicology. Third edition. Acton, MA: Publishing Sciences 

Group, Inc., 308, 319. 

Hankenson K, Schaeffer DJ. 1991. Microtox assay of trinitrotoluene, diaminonitrotoluene, and 

dinitromethylaniline mixtures. Bull Environ Contam Toxicol 46(4):550-553. 

Hao OJ, Phull KK, Chen JN. 1994. Wet oxidation of TNT red water and bacterial toxicity of treated 

waste. Water Resource. 28(2):283-290. 

*Harkonen H, Karki M, Lahti A, et al. 1983. Early equatorial cataracts in workers exposed to 

trinitrotoluene. Am J Ophthalmol 95(6):807-810. 

*Haroun LA, MacDonell MM, Peterson JM, et al. 1990. Multimedia assessment of health risks for the 

Weldon Spring site remedial action project. Proc A&WMA Annu Meet 83(4):19. 

Hart ER. 1974. Subacute toxicity of RDX and TNT in dogs. Final report. Contract no. N00014-73-C0162. Kensington, MD: Litton Bionetics, Inc. 

Harvey SD, Fellows RJ, Cataldo DA, et al. 1990. Analysis of 2,4,6-trinitrotoluene and its 

transformation products in soils and plant tissues by high-performance liquid chromatography. J 

Chromatogr 518(2):361-374. 

Hassman P. 1971. Correlation between Webster’s reaction and values of 2,6-dinitro-4-aminotoluene in 

urine of workers with trinitrotoluene. Prac Lek 23(9):312-314. 

*Hassman P, Hassmanova V. 1976. Exposure tests in trinitrotoluene workers. Sb Ved Pr Lek Fak 

Univ Karlovy 19(1):51-60. 

Hassman P, Hassamanova V, Borovska D, et al. 1978a. [Neurological and psychiatric health status of 

workers processing trinitrotoluene for long periods of time.] Cesk Neurol Neurochir 41(6):372-379. 

(Czechoslovakian) 

Hassman P, Hassamanova V, Borovsk D, et al. 1978b. [State of health in workers processing TNT for 

prolonged periods of time seen in terms of neurology and psychiatry.] Cesk Nuerol Neurochir 41:372­

379. (Czechloslovakian) 

*Hathaway JA. 1977. Trinitrotoluene: A review of reported dose-related effects providing 

documentation for a workplace standard. J Occup Med 19(5):341-345. 

*Hathaway JA. 1985. Subclinical effects of trinitrotoluene: A review of epidemiology studies. In: 

Rickett DE, ed. Toxicity of nitroaromatic compounds. New York, NY: Hemisphere Publishing 

Corporation, 255-274. 

*HAZDAT. 1991. Agency for Toxic Substances and Disease Registry (ATSDR), Atlanta, GA. 
2,4,6-TRINITROTOLUENE 155 

8. REFERENCES 

Heidelberger W. 1974. Incineration systems for the disposal of explosive and propellant waste 

materials. Eng Bull Purdue Univ Eng Ext Ser 145(Pt. 2):662-668. 

*Heller CA, Greni SR, Erickson ED. 1982. Field detection of 2,4,6-trinitrotoluene in water by 

ion-exchange resins. Anal Chem 54(2):286-289. 

*Heller CA, McBride RR, Ronning MA. 1977. Detection of trinitrotoluene in water by fluorescent 

ion-exchange resins. Anal Chem 49(14):2251-2253. 

*Hoffsommer JC, Rosen JM. 1972. Analysis of explosives in sea water. Bull Env Cont Tox 

7:177-181. 

*Hoffsommer JC, Rosen JM. 1973. Hydrolysis of explosives in sea water. Bull Environ Contam 

Toxicol 10(2):78-79. 

Hogue C Jr, Brewster MA. 1991. The potential of exposure biomarkers in epidemiologic studies of 

reproductive health. Environ Health Perspect 90:261-270. 

Howard PH, Santodonato J, Durkin PR. 1982. Syracuse Research Corporation’s approach to chemical 

hazard assessment. In: Conway RA, ed. Environmental risk analysis for chemicals. New York, NY: 

Van Nostrand Reinhold, 379-398. 

*Howard PH, Boethling RS, Jarvis WF, et al. 1991. Handbook of environmental degradation rates. 

Chelsea, MI: Lewis Publishers, 454-455. 

*HSDB. 1994. TNT. Hazardous Substances Data Bank. National Library of Medicine, National 

Toxicology Information Program, Bethesda, MD. May 1994. 

*IRIS. 1994. TNT. Integrated Risk Information Systems. Cincinnati, OH: U.S. Environmental 

Protection Agency, Office of Health and Environmental Assessment, Environmental Criteria and 

Assessment Office. 

*Isbister JD, Anspach GL, Kitchens JF, et al. 1984. Composting for decontamination of soils 

containing explosives. Microbiologica 7:47-73. 

Jain KK, Bryce AJ. 1978. Feasibility of munitions wastewater treatment by adsorption-oxidation. In: 

Cheremisinoff PN, Ellerbusch F, eds. Carbon adsorption handbook. Ann Arbor, MI: Ann Arbor 

Science Publishers, 661-686. 

Jenkins A. 1975. Method for the qualitative and quantitative detection of vapours from low volatility 

compounds. U.S. patent no. 38837390, 5/13/75. 

*Jenkins TF, Grant CL. 1987. Comparison of extraction techniques for munitions residues in soil. 

Anal Chem 59(9):1326-1331. 
2,4,6-TRINITROTOLUENE 156 

8. REFERENCES 

*Jenkins TP, Leggett DC, Grant CL, et al. 1986. Reversed-phase high-performance liquid 

chromatographic determination of nitroorganics in munitions wastewater. Anal Chem 58(1):170-175. 

*Jenkins TP, Walsh ME, Schumacher PW, et al. 1989. Liquid chromatographic method for 

determination of extractable nitroaromatic and nitramine residues in soil. J Assoc Off Anal Chem 

72(6):890-899. 

Jerger DE, Chynoweth DP. 1976. The microbiological degradation m Toxicol 10(2):78-79. 

Jerger DE, Chynoweth DP. 1976. The microbiological degradation of 2,4,6-trinitrotoluene under 

anaerobic conditions. In: 82nd Annual Meeting of the American Society for Microbial, Atlanta, GA, 

USA, March 7-12, 1982. Abstr Annu Meet Am Sot Microbial 76:201,Q63. 

*Jian C, Seitz WR. 1990. Membrane for in situ optical detection of organic nitro compounds based on 

fluorescence quenching. Anal Chim Acta 237(2):265-271. 

*Jiang QG, Sun JG, Qin XF. 1991. The effects of trinitrotoluene toxicity on zinc and copper 

metabolism. Toxicol Lett 55(3):343-349. 

Johnson JG, Erickson ED, Ruven Smith S, et al. 1988a. Products from the detonation of trinitrotoluene 

and some other navy explosive in air and nitrogen: I. Low molecular weight gases. J Hazardous 

Materials 18(2):145-160. 

Johnson JH, Erickson ED, Ruven Smith S, et al. 1988b. Products from the detonation of trinitrotoluene 

and some other navy explosive in air and nitrogen: II. Polycyclic aromatic hydrocarbons. J Hazardous 

Materials 18(2):161-170. 

*Johnson LR, Davenport R, Balbach H, et al. 1994a. Phototoxicology: 2. Near-ultraviolet light 

enhancement of microtox assays of trinitrotoluene and aminodinitrotoluenes. Ecotoxicology and 

Environmental Safety 27:23-33. 

Johnson LR, Davenport R, Balbach H, et al. 1994b. Phototoxicology: 3. Comparative toxicity of 

trinitrotoluene and aminodinitrotoluenes to Daphnia magna, Dugesia dorotocephalu and sheep 

erythrocytes. Ecotoxicology and Environmental Safety 27:34-49. 

Joyce TW, Chang HM, Caifant Y. 1989. Ligninases from white rot fungi can degrade hazardous 

chemicals. 197th American Chemical Society National Meeting, Dallas, Texas, USA, April 9-14, 1989. 

Abstract Paper of the American Chemical Society 197(0):Mbtd 17. 

Joyce TW, Chang HM, Vasudevan B, et al. 1987. Degradation of hazardous organics by the white rot 

fungus Phanerochaete-chrysoporium. 184th American Chemical Society National Meeting, New 

Orleans, Louisiana, USA. August 30-September 4, 1987. Abstract Paper of the American Chemical 

Society 194(0):Envr 217. 
2,4,6-TRINITROTOLUENE 157 

8. REFERENCES 

Jurinski NG, Podolak GE, Hess TL. 1975. Comparison of analytical methods for trace quantities of 

2,4,6-trinitrotoluene. Am Ind Hyg Assoc J 36(7):497-502. 

Kanekar P, Godbole SH. 1981. Thin layer chromatographic (TLC) method for quantitative estimation 

of a-trinitrotoluene (a-TNT). Biovigyanam 7(2):115-119. 

Kanekar P, Godbole SH. 1984. Microbial degradation of trinitrotoluene (TNT). Indian J Environ 

Health 26(2):89-101. 

Kaplan DL. 1990. Biotransformation pathways of hazardous energetic organo-nitro compounds. In: 

Kamely D, Chakrabarty A, Omenn GS, eds. Advances in applied biotechnology series. Vol. 4: 

Biotechnology and biodegradation, International Workshop, Lisbon, Portugal, June 1989. Houston, TX: 

Gulf Publishing Co., 155-182. 

Kaplan DL, Kaplan AM. 1982a. Cornposting industrial wastes biochemical consideration. Biocycle 

23(3):42-44. 

Kaplan DL, Kaplan AM. 1982b. Cornposting of 2,4,6-trinitrotoluene. In: 82nd Annual Meeting of the 

American Society for Microbiology, Atlanta, GA, March 7-12, 1982. Abstr Annu Meet Am Sot 

Microbial 82: 193, N90. 

*Kaplan DL, Kaplan AM. 1982c. Mutagenicity of 2,4,6-trinitrotoluene-surfactant complexes. Bull 

Environ Contam Toxicol 28(1):33-38. 

Kaplan DL, Kaplan AM. 1982d. Separation of mixtures of 2,4,6-trinitrotoluene reduction products with 

liquid chromatography. Anal Chim Acta 136:425-428. 

Kaplan DL, Kaplan AM. 1982e. Thermophilic biotransformations of 2,4,6-trinitrotoluene under 

simulated cornposting conditions. Appl Environ Microbial 44(3):757-760. 

Kaplan DL, Kaplan AM. 1982f. 2,4,6-Trinitrotoluene-surfactant complexes: Decomposition, 

mutagenicity, and soil leaching studies. Environ Sci Technol 16(9):566-57 1. 

*Karasek PW, Denney DW. 1974. Detection of 2,4,6-trinitrotoluene vapours in air by plasma 

chromatography. J Chromatogr 93(1):141-147. 

Karelin YA, Evseeva LA. 1974. Deep purification of waste waters by the adsorbtion method. 

Vodosnabzh Sanit Tekh Iss 12:12-14. 

*Kayser EG, Burlinson NE. 1988. Migration of explosives in soil: Analysis of RDX, TNT, and tetryl 

from carbon-14 lysimeter study. J Energetic Materials 6(1-2): 45-71. 

Keamey PC, Zeng Q, Ruth J. 1983. Oxidative pretreatment accelerates TNT metabolism in soil. 

Chemosphere 12(11/12):1583-1597. 
2,4,6-TRINITROTOLUENE 158 

8. REFERENCES 

Klausmeier RE, Osmon JL, Walls DR. 1984. The effect of trinitrotoluene on microorganisms. Dev 

Ind Microbial 15:309-317. 

Klausmeier RE, Appelton JA, Dupre ES, et al. 1976. The enzymology of trinitrotoluene reduction. In: 

Sharpleys, goals, challenges, Gaithersburg, MD, Sept 28-Oct 1, 1987. J Res Nat1 Bur Stand 93(3):428­

431. 

*Kolb G, Becker N, Scheller S, et al. 1993. Increased risk of acute myelogenous leukemia (AML) and 

chronic myelogenous leukemia (CML) in a county of Hesse, Germany. Soz. Praventivmed 38:190-195. 

*Kong L, Jiang Q, Qu Q. 1989. Formation of superoxide by trinitrotoluene in rat liver, brain, kidney, 

and testicle in vitro and monkey liver in vivo. Biomedical and Environmental Sciences 2:72-77. 

*Kraus DL, Henchy CD, Keirn MA, et al. 1985. US Department of Defense Superfund implementation 

at a former TNT manufacturing facility. 6th National Conference on Management of Uncontrolled 

Hazardous Waste Sites, Nov. 4-6. Washington DC, Silver Spring, MD: Hazardous Materials Control 

Research Institute. 

Lee YJ, Caspary WJ. 1983. Mathematical model of L5178Y mouse lymphoma forward mutation assay. 

Mutat Res 113:417-430. 

Leggett DC. 1977. Determination of 2,4,6-trinitrotoluene in water by conversion to nitrate: Letter. 

Anal Chem 49(6):880. 

*Leggett DC, Jenkins TF, Miyares PH. 1990. Salting-out solvent extraction for preconcentration of 

neutral polar organic solutes from water. Anal Chem 62(13): 1355-1356. 

Lemasters GK, Selevan SG. 1993. Toxic exposures and reproduction: A view of epidemiology and 

surveillance. In: Reproductive toxicology and infertility, 307-321. 

*Lemberg R, Callaghan JP. 1945. Metabolism of aromatic nitro compounds: 3. Isolation of reduction 

products of 2,4,6-trinitrololuene from urine of rats and from human urine. Aust J Exp Biol Med Sci 

23:13-20. 

Leventhal BG, Khan AB. 1985. Hematopoietic system. In: Karle Mottet N, ed. Environmental 

pathology. New York, NY: Oxford University Press, 344-355. 

*Levine BS, Furedi EM, Gordon DE, et al. 1984. Subchronic toxicity of trinitrotoluene in Fischer 344 

rats. Toxicology 32(3):253-265. 

*Levine BS, Furedi EM, Gordon DE, et al. 1990a. Toxic interactions of the munitions compounds 

TNT and RDX in F344 rats. Fundam Appl Toxicol 15(2):373-380. 

*Levine BS, Rust JH, Barkley JJ, et al. 1990b. Six month oral toxicity study of trinitrotoluene in 

beagle dogs. Toxicology 63(2):233-244. 
2,4,6-TRINITROTOLUENE 159 

8. REFERENCES 

*Li GY, Wang T, Huggins Jr. EM, et al. 1992. Cholyglycine measured in serum by RIA and 

interleukin- 1 p determined by ELISA in differentiating viral hepatitis from chemical liver injury. JOM 

34(9):930-933. 

*Li J, Jiang QG, Zhong WD. 1991. Persistent ethanol drinking increases liver injury induced by 

trinitrotoluene exposure: An in-plant case-control study. Human and Experimental Toxicology 10:405­

409. 

Li W, Yang YX, Yang HF. 1989. TNT-degrading enzyme of Citrobacter freundii and its regulation by 

carbon and nitrogen source. Wei Sheng Wu Hsueh Pao 29(2):117-123. 

*Li Y, Jiang Q, Yao S, et al. 1993. Effects of exposure to trinitrotoluene on male reproduction. 

Biomedical and Environmental Sciences 6: 154-l 60. 

Linch AL. 1983. Nitro-compounds, aromatic. Encyclopedia of Occupational Health and Safety 

2:1451-1454. 

Liu DHW, Bailey HC, Pearson JG. 1983a. Toxicity of a complex munitions wastewater to aquatic 

organisms. In: Bishop WE, Cardwell RD, Heidolph BB, eds. Aquatic toxicology and hazard 

assessment, Sixth Symposium, ASTM STP 802. Philadelphia, PA: American Society for Testing and 

Materials, 135- 150. 

*Liu DHW, Spanggord RJ, Bailey HC, et al. 1983b. Toxicity of TNT wastewaters to aquatic 

organisms. Volume I: Acute toxicity of LAP wastewaters to 2,4,6-trinitrotoluene. Final report. 

Contract no. DAMD17-75-C-5056. Menlo Park, CA: Stanford Research Institute. Document no. 

ADA142-144. 

*Liu Y, Wei W, Wang M, et al. 1991. Simultaneous determination of the residues of TNT and its 

metabolites in human urine by thin-layer chromatography. J Planar Chromatogr 4:146-149. 

*Liu YY, Lu AYH, Steams RA, et al. 1992. In vivo covalent binding of [14C] trinitrotoluene to proteins 

in the rat. Chemical Biological Interactions 82: 1-19. 

*Lloyd JBF. 1983a. Clean-up procedures for the examination of swabs for explosive traces by 

highperformance liquid chromatography with electrochemical detection at a pendent mercury drop 

electrode. J Chromatogr 261(3):391-406. 

Lloyd JBF. 1983b. High-performance liquid chromatography of organic explosives components with 

electrochemical detection at a pendant mercury drop electrode. J Chromatogr 257(2):227-236. 

Lloyd JBF. 1985a. Adsorption characteristics of organic explosives compounds on adsorbents typically 

used in cleanup and related trace analysis techniques. J of Chromatography 328: 145-154. 

Lloyd JBF. 1985b. Microcolumn clean-up and recovery techniques for organic ,explosives compounds 

and for propellants traces in firearms discharge residues. J Chromatogr 330(1):121-129. 
2,4,6-TRINITROTOLUENE 160 

8. REFERENCES 

*Lloyd JBF. 1991. Forensic explosive and firearms traces: Trapping of HPLC peaks for gas 

chromatography. J Energetic Materials 9(1-2): 1 - 17. 

Lyman WJ, Reehl WF, Rosenblatt DH, et al. 1982. Handbook of chemical property estimation
 

methods: Environmental behavior of organic compounds. New York, NY: McGraw-Hill Book Company,
 

5-10, 7-4, 15-15 - 15-29.
 

Lyter AH II. 1983. A high-performance liquid chromatographic (HPLC) study of seven common 

explosive materials. J Forensic Sci 28(2):446-450. 

*Mabey WR, Tse D, Baraze A, et al. 1983. Photolysis of nitroaromatics in aquatic systems: 1. 

2,4,6-Trinitrotoluene. Chemosphere 12(1):3-16. 

Margalit Y, Abramovich-Bar S, Bamberger Y, et al. 1986. Analysis of explosives by nuclear magnetic 

resonance spectrometry. J Energ Mater 4(1-4):363-376. 

Margolin BH, Kaplan N, Zeiger E. 1981. Statistical analysis of the Ames Salmonella/microsome test. 

Proc Nat1 Acad Sci USA 78(6):3779-3783. 

Margolin BH, Kim BS, Risko KJ. 1989. The Ames Salmonella/microsome mutagenicity assay: Issues 

of inference and validation. J Am Stat Assoc 84(407):651-661. 

*Mark HF, Othmer DF, Overberger CF, et al. 1980. Encyclopedia of chemical technology. 3rd 

edition, volume 9. New York, NY: John Wiley and Sons, 587-598. 

*Martin DP, Hart ER. 1974. Subacute toxicity of RDX and TNT in monkeys. Contract no. N00014­

73-C-0172, NR 108-985. Kensington, MD: Litton Bionetics. 

*Maskarinec MP, Manning DL, Harvey RW, et al. 1984. Determination of munitions components in 

water by resin adsorption and high-performance liquid chromatography-electrochemical detection. J 

Chromatogr 302:51-63. 

*McConnell WJ, Flinn RH. 1946. Summary of twenty-two trinitrotoluene fatalities in World War II. J 

Ind Hyg Tox 28:76-86. 

McConnell EE, Solleveld HA, Swenberg JA, et al. 1986. Guidelines for combining neoplasms for 

evaluation of rodent carcinogenesis studies. J Nat1 Cancer Inst 76(2):283-289. 

McCormick NG, Feeherry FE, Levinson HS. 1976. Microbial transformation of 2,4,6-trinitrotoluene 

and other nitroaromatic compounds. Appl Environ Microbial 31(6):949-958. 

McKone TE, Daniels JI. 1991. Estimating human exposure through multiple pathways from air, water, 

and soil. Regul Toxicol Pharmacol 13(1):36-61. 
2,4,6-TRINITROTOLUENE 161 

8. REFERENCES 

McKone TE, Layton DW. 1986a. Exposure and risk assessment of toxic waste in a multimedia context. 

In: Proceedings of the APCA Annual Meeting 79(Vol. l), Minneapolis, MN, June 22-27, 1986. 

Pittsburgh, PA: Air Pollution Control Association, 1-15. 

*McKone TE, Layton DW. 1986b. Screening the potential risks of toxic substances using a multimedia 

compartment model: Estimation of human exposure. Regul Toxicol Pharmacol 6(4):359-380. 

McLuckey SA, Glish GL, Carter JA. 1985. The analysis of explosives by tandem mass spectrometry. 

J Forensic Sci 30(3):773-788. 

*McLuckey SA, Glish GL, Grant BC. 1988. Atmospheric sampling glow discharge ionization source 

for the determination of trace organic compounds in ambient air. Analytical Chemistry 

60(20):2220-2227. 

Meyer KA Jr. 1989. Designing chemical soil characterization programs for mixed waste sites. In: Proc 

Symp Waste Manage. 2(Waste Manage, 1989):531-533. 

Mierzwinski A, Witkiewcz Z. 1989. The application of piezoelectric detectors for investigations of 

environmental pollution. Environmental Pollution 57: 18 1- 198. 

Miller CR, Mayer AS. 1989. Fate and effects of pollutants: Groundwater. J Water Pollut Control Fed 

61(6):954-984. 

*Morton AR, Ranadive MV, Hathaway JA. 1976. Biological effects of trinitrotoluene from exposure 

below the threshold limit value. Am Ind Hyg Assoc J 37(1):56-60. 

Mul’menko AM, Martsinkevich GA. 1973. Metabolism of vitamins niacin and b6 in experimental 

trinitrotoluene poisoning. Gig Tr Prof Zabol 17( 12):36-39. 

Murphy LJ, Siggia S, Uden PC. 1986. High-performance liquid chromatography of nitroaromatic 

compounds on an n-propylaniline-bonded stationary phase. J Chromatogr 366: 161- 170. 

*NAS/NRC. 1989. Biologic markers in reproductive toxicology. National Academy of 

Sciences/National Research Council. Washington, DC: National Academy Press, 15-35. 

NATICH. 1992. National Air Toxics Information Clearinghouse. Data base report on state, local, and 

EPA air toxics activities. Washington, D.C.: U.S. Environmental Protection Agency, Office of Air 

Quality Planning and Standards. August 13, 1991. 

Naumova RP, Amerkhanova NN, Belousova TO. 1982a. Reductive transformation of aromatic nitro 

compounds by bacteria. Mikrobiologiia 51(5):735-739. 

Naumova RP, Amerkhanova NN, Zolotukhina LM. 1983. Characteristics of nitroreduction as the key 

stage in the microbial destruction of aromatic nitro compounds. Prikl Biokhim Mikrobiol 

19(4):507-512. 
2,4,6-TRINITROTOLUENE 162 

8. REFERENCES 

Naumova RP, Belousova TO, Gilyazova RM. 1982b. Microbial transformation of 2,4,6-trinitrotoluene. 

Appl Biochem Microbial 18( 1):85-90. 

Naumova RP, Belousova TO, Giliazova RM. 1982c. Transformation of 2,4,6-trinitrotoluene by 

microorganisms. Prikl Biokhim Mikrobiol 18( 1):85-90. 

Naumova RP, Ofitserov EN, Belousova TO, et al. 1986. Pathways of 2,4,6-trinitrotoluene 

biotransformation. Izv Akad Nauk SSSR, Ser Biol (3):448-455. 

Naumova RP, Selivanovskaia SI, Cherepneva IE. 1988a. Transformation of 2,4,6-trinitrotoluene during 

oxygen and nitrate respiration in pseudomonas fluorescens. Prikl Biokhim Mikrobiol 24(4):493-498. 

Naumova RP, Selivanovskaia SI, Mingatina FA. 1988b. Possibilities for the deep bacterial destruction 

of 2,4,6-trinitrotoluene. Mikrobiologiia 57(2):218-222. 

Navy. 1974a. Subacute toxicity of RDX and TNT in dogs. Contract no. N00014-73-C-0162. 

Arlington, VA: Office of Naval Research. Document no. AD-A035 717. 

Navy. 1974b. Subacute toxicity of RDX and TNT in monkeys. Final report. Contract no. N00014-73­

C-0162, NR 108-985. Arlington, VA: Office of Naval Research. Document no. AD-A044 650. 

Navy. 1978. Biodegradability of TNT: A three-year pilot plant study. Report no. 

NSWC/WOL-TR-77-136. Silver Spring, MD: White Oak Lab, Naval Surface Weapons Center. 

Document no. AD-A06 1144. 

*Nay MW Jr, Randall CW, King PH. 1972a. Factors affecting color development during the treatment 

of TNT waste. Eng Bull Purdue Univ, Eng Ext Ser 141(Pt. 2):983-993. 

Nay MW Jr., Randall CW, King PH. 1972b. Factors affecting color development during treatment of 

TNT wastes. Industrial Wastes 18:20-29. 

Nay MW Jr, Randall CW, King PH. 1974. Biological treatability of trinitrotoluene manufacturing 

wastewater. J Water Pollut Control Fed 46(3):485-497. 

*NIOSH. 1973. The industrial environment its evaluation and control. National Institute for 

Occupational Safety and Health. Washington, DC. 

*NIOSH. 1990. NIOSH pocket guide to chemicals hazards. Washington, DC: U.S. Department of 

Health and Human Service, Center for Disease Control, National Institute for Occupational Safety and 

Health, Division of Standard Development and Technology Transfer. NIOSH publication no. 90-117. 

Nissenbaum A. 1975. The distribution of natural stable isotopes of carbon as a possible tool for the 

differentiation of samples of TNT. J Forensic Sci 20(3):455-459. 

*NOES. 1992. National Occupational Exposure Survey: TNT. Cincinnati, OH: U.S. Department of 

Health and Human Services, National Institute for Occupational Safety and Health. 
2,4,6-TRINITROTOLUENE 163 

8. REFERENCES 

Northrop DM, Martire DE, MacCrehan WA. 1991. Separation and identification of organic gunshot 

and explosive constituents by micellar electrokinetic capillary electrophoresis. Anal Chem 

63(10):1038-1042. 

*OHM/TADS. 1985. TNT. Oil and Hazardous Material/Technical Assistance Data System. Chemical 

Information Systems, Inc., Baltimore, MD. December, 1985. 

Okamoto Y, Chou EJ, Croce M, et al. 1982. Removal of 2,4,6-trinitrotoluene (TNT) and 

1,3,5-trinitro-1,3,5-triazacyclohexane (RDX) from aqueous solutions with surfactants. Propellants 

Explosives and Pyrotechnology 7(1): 18-21. 

Okamoto Y, Chou EJ, Wang J et al. 1977. The removal of 2,4,6-trinitrotoluene (TNT) from aqueous 

solution with surfactants. In: Proceedings of the 1977 National Conference Treat Disposal Industrial 

Wastewaters Residues, Houston, Texas, April 26-28, 1977. Rockville, MD: Information Transfer, Inc., 

249-253. 

Okamoto Y, Wang JY, Chou EJ. 1978. Removal of trinitrotoluene from aqueous media. U.S. patent 

no. 4073726 2/14/78. Brooklyn, NY: Polytechnic Institute of New York. 

OSHA. 1987. Access to employee exposure and medical records. U.S. Department of Labor, 

Occupational Safety and Health Administration. Code of Federal Regulations. 29 CFR 1910.20. 

OSHA. 1988. Access to employee exposure and medical records. U.S. Department of Labor, 

Occupational Safety and Health Administration. Federal Register 53:30163-30164. 

OSHA. 1989a. Toxic and hazardous substances. U.S. Department of Labor, Occupational Safety and 

Health Administration. Code of Federal Regulations. 29 CFR 1910.1000. 

OSHA. 1989b. Toxic and hazardous substances. U.S. Department of Labor, Occupational Safety and 

Health Administration. Federal Register 54:2920-2960. 

*Osmon JL, Klausmeier RE. 1973. The microbial degradation of explosives. Dev Ind Microbial 

14:247-252. 

Painter HA. 1986. Review of microbial transformation. Comm Eur Communities (Eur 10388, Org 

Micro Pollut Aquat Environ):292-304. 

*Palazzo AJ, Leggett DC. 1986. Effect and disposition of TNT in a terrestrial plant. J Environ Qua1 

15( 1):49-52. 

Parker LV, Jenkins TF. 1986. Suitability of polyvinyl chloride well casings for monitoring munitions 

in ground water. Ground Water Monit Rev 6(3):92-98. 

Parker RG, McOwen JM, Cherolis JA. 1975. Analysis of explosives and explosive residues. Part 2: 

Thin-layer chromatography. J Forensic Sci 20(2):254-260. 
2,4,6-TRINITROTOLUENE 164 

8. REFERENCES 

Parmelee RW, Wenstel RS, Phillips CT, et al. 1993. Soil microcosm for testing the effects of chemical 

pollutants on soil fauna communities and trophic structure. Environmental Toxicology and Chemistry 

12:1477-1486. 

*Parrish FW. 1977. Fungal transformation of 2,4-dinitrotoluene and 2,4,6-trinitrotoluene. Appl 

Environ Microbial 34(2):232-233. 

Paterson JD. 1983. Trinitrotoluene. Encyclopaedia of Occupational Health and Safety 2:2218-2219. 

Patterson JW. 1985. Industrial wastewater treatment technology. 2nd Edition. Stoneham, MO: 

Butterworth Publishers, 303-357. 

*Patterson JW, Shapira NI, Brown J. 1977. Pollution abatement in the military explosives industry. 

Proc Ind Waste Conf 31:385-394. 

*Pearson JG, Glennon JP, Barkley JJ, et al. 1979. An approach to the toxicological evaluation of a 

complex industrial wastewater. ASTM Spec Tech Pub1 Iss STP 667, Aquat Toxicol 284-301. 

*Pella PA. 1976. Generator for producing trace vapor concentrations of 2,4,6-trinitrotoluene, 

2,4-dinitrotoluene, and ethylene glycol dinitrate for calibrating explosives vapor detectors. Anal Chem 

48(11):1632-1637. 

*Pella PA. 1977. Measurement of the vapor pressures of TNT, 2,4-DNT, and EGDN. J Chemical 

Thermodynamics 9:301-305. 

*Pennington JC, Patrick WH Jr. 1990. Adsorption and desorption of 2,4,6-trinitrotoluene by soils. J 

Environ Qua1 19(3):559-567. 

Pereira WE, Short DL, Manigold DB. 1979. Isolation and characterization of TNT and its metabolites 

in groundwater by gas chromatograph-mass spectrometer-computer techniques. Bull Environ Contam 

Toxicol 21(4-5):554-562. 

*Phung HT, Bulot MW. 1981. Subsurface investigation of metal sludge and explosive disposal pond 

areas. In: Conway RA, Malloy DC, eds. Hazardous solid waste testing, First Conference, ASTM STP 

760. Philadelphia, PA: American Sot for Test and Mat, 305-320. 

*Powell DH, Shroads AL, Mousa JJ, et al. 1983. Use of detector ratios for contaminant screening by 

high-pressure liquid chromatography. In: National Conference Manage Uncontrolled Hazard Waste 

Sites, Washington, D.C., October 31-November, 1983. Silver Spring, MD: Hazardous Materials Control 

Research Institute. 

Preslan JE, Hatrel BB, Emerson M, et al. 1993. An improved HPLC method for analysis of TNT and 

metabolites from compost and contaminated soils. Journal of Hazardous Materials 33(3)329-337. 

*Richard JJ, Junk GA. 1986. Determination of munitions in water using macroreticular resins. Anal 

Chem 58(4):723-725. 
2,4,6-TRINITROTOLUENE 165 

8. REFERENCES 

Rickert DE. 1987. Metabolism of nitroaromatic compounds. Drug Metab Rev 18(1):23-53. 

Riddell RH, Mills TI. 1983. Analysis of explosives by HPLC-FTIR. In: Proceedings of the 

International Symposium on Analytical Detection of Explosives, FBI Academy, March 29-31, 1983. 

Quantico, VA: Federal Bureau of Investigation, 289-307. 

Roberts DJ, Crawford DL. Anaerobic degradation of TNT. In: 91st General Meeting of the American 

Society for Microbiology, Dallas, Texas, May 5-9, 1991. Abstracts of the General Meeting of the 

American Society for Microbiology 91:303. 

*Rosenblatt DH. 1980. Toxicology of explosives and propellants. In: Kaye SM, ed. Encyclopedia of 

explosives and related items. Vol. 9. Dover, NJ: U.S. Army Armament Research and Development 

Command, 332-345. 

*Rosenblatt DH, Small MJ, Barkley JJ. 1973. Munitions production products of potential concern as 

waterborne pollutants - phase I. Report no. 73-07. Edgewood Arsenal, MD: U.S. Army Medical 

Environmental Engineering Research Unit. 

Rosenkrantz HS, Mermelstein R. Mutagenicity and genotoxicity of nitroarenes all nitro-containing 

chemicals were not created equal. Mutation Research 114:217-267. 

Ross RH, Hartley WR. 1990. Comparison of water quality criteria and health advisories for 

2,4,6-trinitrotoluene. Regul Toxicol Pharmacol 11(2):114-l 17. 

Ryon MG, Ross RH. 1990. Water quality criteria for 2,4,6-trinitrotoluene. Regul Toxicol Pharmacol 

11(2):104-l 13. 

*Ryan MG, et al. 1984. Database assessment of the health and environmental effects of munition 

production waste products. Final report. Report no. ORNL-6018. Document no. DE84-016512. 

Sampaolo A, Binetti R. 1989. Improvement of a practical method for priority selection and risk 

assessment among existing chemicals. Regul Toxicol Pharmacol 10(2): 183- 195. 

Sanotskii IV, Timofievskaya LA. 1980. [Need for an international list of standards for toxic substances 

in the air of work areas.] Gig Tr Prof Zabol 0 (6):47-50. (Russian) 

*Savolainen H, Tenhunen R, Harkonen H. 1985. Reticulocyte haem synthesis in occupational exposure 

to trinitrotoluene. Br J Ind Med 42(5):354-355. 

Sawsan SS, El-Ghazali MM, El-Batanouni MM, et al. 1987. Chromosomal aberrations among workers 

engaged in the explosives industry. In: Foa V, Emmett EA, Maroni M, et al, eds. Occupational and 

environmental chemical hazards: Cellular and biochemical indices for monitoring toxicity. New York, 

NY: Halsted Press, 466-472. 

*Sax NI, Lewis RJ SR. 1987. Hawley’s condensed chemical dictionary. 11th Edition. New York, 

NY: Van Nostrand Reinhold Co., 1191. 
2,4,6-TRINITROTOLUENE 166 

8. REFERENCES

 *Schackmann A, Muller R. 1991. Reduction of nitroaromatic compounds by different (pseudomonas) 

species under aerobic conditions. Applied Microbiology and Biotechnology 34:809-813. 

Schulte GR, Hoehn RC, Randall CW. 1973. The treatability of a munitions-manufacturing waste with 

activated carbon. Engineering Bulletin of Purdue University, Engineering Extended Series 142(Pt. 

1):150-162. 

Selavka CM, Krull IS. 1986. Liquid chromatography with photolysis - electrochemical detection for 

nitro-based high explosives and water gel formulation sensitizers. J Energ Mater 4(1-4):273-303. 

Selavka CM, Tontarski RE Jr, Strobe1 RA. 1987. Improved determination of nitrotoluenes using liquid 

chromatography with photolytically assisted thermal energy analysis (LC-PAT). J Forensic Sci 

32(4):941-952. 

Selizanovskaia SI, Akhmetova DZ, Naumova RP. 1986. Final stages of the preliminary metabolism of 

2,4,6-trinitrotoluene in pseudomonas fluorescens. Mikrobiologiia 55(6):1040-1041. 

Semmens MJ, Barnes D, O’Hara M. 1985. Treatment of an RDX-TNT waste from a munitions 

factory. Proc Ind Waste Conf 39:837-842. 

Sharma J. 1983. X-ray photoelectron spectroscopic (XPS) detection and identification of explosives 

residues. In: Proceedings of the International Symposium of Analytical Detection of Explosives, FBI 

Academy, March 29-31, 1983. Quantico, VA: Federal Bureau of Investigation, 181-185. 

*Short RD, Lee CC. 1980. Effect of some nitrotoluenes on the biotransformation of xenobiotics in 

rats. Experientia 36(1):100-101. 

Shou J, Wu C, Zhuang Z. 1986. Effects of trinitrotoluene on hepatic mixed-function oxidase. In: 

Fourth International Congress of Toxicology, Tokyo, Japan, July 21-25, 1986. Toxicol Lett (AMST) 

31(Suppl):177. 

Sierka RA. 1985. The high temperature treatment of trinitrotoluene (TNT) and 

cyclotrimethylenetrinitramine (RDX) with ozone and ultrasound. Ozone: Sci and Eng 6(4):275-290. 

*Small MJ, Rosenblatt DH. 1974. Munitions production products of potential concern as waterborne 

pollutants - phase II. Aberdeeen Proving Ground, MD: Army Medical Bioengineering Research and 

Development Laboratory. 

Smith LL, Carrazza J, Wong K. 1982. Biological treatment for waste streams from propellants and 

explosives manufacturing. J Hazardous Materials 5(4):277-296. 

Smock LA, Stoneburner DL, Clark JR. 1976. The toxic effects of trinitrotoluene (TNT) and its 

primary degradation products on two species of algae and the fathead minnow. Water Res 

10(6):537-543. 
2,4,6-TRINITROTOLUENE 167 

8. REFERENCES 

*Spalding RF, Fulton JW. 1988. Groundwater munition residues and nitrate near Grand Island, 

Nebraska. J Contamination Hydrology 2: 139-153. 

*Spanggord RJ, Suta BE. 1982. Effluent analysis of wastewater generated in the manufacture of 

2,4,6-trinitrotoluene: 2. Determination of a representative discharge of ether-extractable components. 

Environ Sci Technol 16(4):233-236. 

*Spanggord RJ, Gibson BW, Keck RG, et al. 1982a. Effluent analysis of wastewater generated in the 

manufacture of 2,4,6-trinitrotoluene: 1. Characterization study. Environ Sci Technol 16(4):229-232. 

*Spanggord RJ, Mabey WR, Chou TW, et al. 1985. Environmental fate of selected nitroaromatic 

compounds in the aquatic environment. In: Rickert DE, ed. Chemical industry institute of toxicology 

series: Toxicity of nitroaromatic compounds. Washington, DC: Hemisphere publishing corporation, 15­

34. 

*Spanggord RJ, Mortelmans KE, Griffin AF, et al. 1982b. Mutagenicity in Salmonella typhimurium 

and structure-activity relationships of wastewater components emanating from the manufacture of 

trinitrotoluene. Environ Mutagen 4(2):163-179. 

Spangler GE, Carrico JP, Campbell DN. 1985. Recent advances in ion mobility spectrometry for 

explosives vapor detection. J Test Evaluation 13(3):234-240. 

*Spangler GE, Carrico JP, Kim SH. 1983. Analysis of explosives and explosive residues with ion 

mobility spectrometry (IMS). In: Proceedings of the International Symposium on Analytical Detection 

of Explosives, FBI Academy, March 29-31, 1983. Quantico, VA: Federal Bureau of Investigation, 

267-282. 

Spiker JK, Crawford’DL, Crawford RL. 1992. Influence of 2,4,6-trinitrotoluene (TNT) concentration 

on the degradation of TNT in explosive-contaminated soils by the white rot fungus Phanerochaete 

chrysosporium. Applied and Environmental Microbiology, Sept. 1992, 3199-3202. 

*St. John GA, McReynolds JH, Blucher WG, et al. 1975. Determination of the concentration of 

explosives in air by isotope dilution analysis. Forensic Sci 6(1-2):53-66. 

Stevanovic S, Mitrovic M. 1990. Calorimetric method for semiquantitative determination of 

nitroorganics in water. Int J Environ Anal Chem 40(1-4):69-76. 

*Stutz DR, Ulin MD. 1992. Hazardous materials injuries a handbook for pre-hospital care. Third 

edition, 328-329. 

*Styles JA, Cross MF. 1983. Activity of 2,4,6-trinitrotoluene in an in vitro mammalian gene mutation 

assay. Cancer Lett 20(1):103-108. 
2,4,6-TRINITROTOLUENE 168 

8. REFERENCES 

Sullivan Jr. JB. 1992. Cryogenics, oxidizers, reducing agents, and explosives. In: Sullivan Jr. JB, 

Krieger GR, eds. Hazardous materials toxicology clinical principles of environmental health. Baltimore, 

MD: Williams and Wilkins, 1192-1201. 

Swann RL, Laskowski DA, McCall PJ, et al. 1983. A rapid method for the estimation of the 

environmental parameters 0ctanoVwater partition coefficient, soil sorption constant, water to air ratio, 

and water solubility. In: Residue reviews. Volume 85. New York, NY: Springer-Verlag, 16-28. 

Tabak HH, Chambers CW, Kabler PW. 1964. Microbial metabolism of aromatic compounds: I. 

Decomposition of phenolic compounds and aromatic hydrocarbons by phenol-adapted bacterial. J 

Bacterial 87:910-919. 

Tamiri T, Zitrin S. 1986. Capillary column gas chromatography/mass spectrometry of explosives. J 

Energetic Material 4(1-4):215-237. 

Tamura RN, Garriott ML, Parton JW. 1990. Pooled inference across sexes for the in vivo 

micronucleus assay. Mutat Res 240:127-133. 

*Tan EL, Ho CH, Griest WH, et al. 1992. Mutagenicity of trinitrotouluene and its metabolites formed 

during cornposting. Journal of Toxicology and Environmental Health 36:163-175. 

Teir H, Grenquist-Norden B. 1990. Peripheral cataracts and trinitrotoluene exposure - follow-up-study. 

Grankulla, Finland: Institute for Occupational Health, Acta Ophthalmologica 68(S 195):49-5 1. 

Tenhunen R, Zitting A, Nickels J, et al. 1984. Trinitrotoluene-induced effects on rat heme metabolism. 

Exp Mol Pathol 40(3):362-6. 

Tian LX, Fu RN. 1986. Analysis of TNT, RDX and DNN in wastewater by using capillary column gas 

chromatography. Int Jahrestag Fraunhofer Inst Treib Explosivst 17(Anal Propellants Explos: Chem 

Phys Methods):63/1-63/9. 

*Traxler RW, Wood E, Delaney JM. 1974. Bacterial degradation of alpha-TNT. Developmental 

Industrial Microbiology 16:71. 

*TRI88. 1990. Toxic Chemical Release Inventory. National Library of Medicine, National Toxicology 

Information Program, Bethesda, MD. 

*Triegel EK, Kolmer JR, Ounanian DW. 1983. Solidification and thermal degradation of TNT waste 

sludges using asphalt encapsulation. In: National Conference on Management of Uncontrolled Hazard 

Waste Sites, Washington, D.C., October 31-November 2, 1983. Silver Spring, MD: Hazardous 

Materials Controls Research Institute, 270-274. 

Tsai TS. 1991. Biotreatment of red water - a hazardous-waste stream from explosive manufacture ­

with fungal systems. Hazardous Waste and Hazardous Material 8(3):231-244. 
2,4,6-TRINITROTOLUENE 169 

8. REFERENCES 

Twibell JD, Turner SL, Smalldon KW, et al. 1984a. The persistence of military explosives on hands. 

J Forensic Sci 29( 1):284-290. 

Twibell JD, Wright T, Sanger DG, et al. 1984b. The efficient extraction of some common organic 

explosives from hand swabs for analysis by gas liquid and thin-layer chromatography. J Forensic Sci 

29(1):277-283. 

*USDOC. 1986. U.S. imports for consumption and general imports. Report no. FT246/annual 1985. 

Washington, DC: U.S. Bureau of the Census, U.S. Department of Commerce. 

*Van Slyke SM, Scheibler ST, Williams KE, et al. 1985. Sampling and analytical techniques for air 

pollution source tests of incinerators of explosive materials. In: Proceedings of the APCA 78th Annual 

Meeting (Vol. 6), Detroit, MI, June 16-21, 1985. Pittsburgh, PA: Air Pollution Control Association, 85 

83.3. 

Vigliani EC. 1968. Permissible levels of occupational exposure to airborne toxic substances: Sixth 

report of the joint ILO/WHO committee on occupational health. World Health Organization Technical 

Report Series 415:5-16. 

*Vorbeck C, Lenke H, Fischer P, et al. 1994. Identification of a hydride-Meisenheimer complex as a 

metabolite of 2,4,6-trinitrotoluene by a Mycobacterium strain. Journal of Bacteriology, February 1994, 

932-934. 

Vouros P, Petersen BA, Colwell L, et al. 1977. Analysis of explosives by high performance liquid 

chromatography and chemical ionization mass spectrometry. Anal Chem 49(7):1039-1044. 

Vysochin VI. 1987. Temporary disability in workers exposed to trinitrotoluene-containing explosives 

in open cuts of ore mining and beneficiation plants. Gig Tr Prof Zabol (12):40-44. 

Waldron HA. 1979. Target organs: The blood. J Soc Occup Med 29(2):65-71. 

Walsh ME, Jenkins TF. 1990. Liquid chromatographic separation of 2,4,6-trinitrotoluene and its 

principal reduction products. Analytica Chimica Acta 23 1(2):3 13-3 15. 

Walsh JT, Chalk RC, Merritt C Jr. 1973. Application of liquid chromatography to pollution abatement 

studies of munition wastes. Anal Chem 45(7):1215-1220. 

Wannlund J, DeLuca M. 1982. A sensitive bioluminescent immunoassay for dinitrophenol and 

trinitrotoluene. Anal Biochem 122(2):385-393. 

Wannlund J, DeLuca M. 1983. Bioluminescent immunoassays. Methods Enzymol 92:426-432. 

Wellington DR, Mitchell WR. 1991. In Vitro cytotoxicity of certain munition nitroaromatic 

compounds. Chemosphere 23(3):363-373. 
2,4,6-TRINITROTOLUENE 170 

8. REFERENCES 

*Whong WZ, Edwards GS. 1984. Genotoxic activity of nitroaromatic explosives and related 

compounds in Salmonella typhimurium. Mutat Res 136(3):209-215. 

Whong WZ, Speciner ND, Edwards GS, et al. 1980. Mutagenicity of polynitroaromatic explosives in 

microbial test systems. In: Proceedings of the American Association for Cancer. Proc Amer Assoc 

Cancer Res Annu Meet 21:195. 

Williams RT, Myler CA. 1991. Composting of explosives contaminated sediments. In: 9lst General 

meeting of the American Society for Microbiology, Dallas, Texas, May 5-9, 1991. Abstract of the 

General Meeting of the American Society for Microbiology 91:302. 

*Williams RT, Ziegenfuss PS, Mohrman GB, et al. 1989. Composting of explosives and propellant 

contaminated sediments. In: Cole C, Long D, eds. Proceedings of the 21st Mid-Atlantic Industrial 

Waste Conference, Hazardous Industrial Wastes. Lancaster, PA: Technomic Publishers, 599-611. 

*Williams RT, Zeigenfuss PS, Sisk WE. 1992. Composting of explosives and propellant contaminated 

soils under termophilic and mesophilic conditions. Journal of Industrial Microbiology 9: 137-144. 

*Won WD, DiSalvo LH, Ng J. 1976. Toxicity and mutagenicity of 2,4,6-trinitrotoluene and its 

microbial metabolites. Appl Environ Microbial 31(4):576-580. 

Won WD, Heckly RJ, Glover DJ, et al. 1974. Metabolic disposition of 2,4,6-trinitrotoluene. Appl 

Microbial 27(3):513-516. 

*Woollen BH, Hall MG, Craig R, et al. 1986. Trinitrotoluene: Assessment of occupational absorption 

during manufacture of explosives. Br J Ind Med 43(7):465-473. 

Yang Y, Yin P, Li W, et al. 1979. Bacteria transforming 2,4,6-trinitrotoluene (alpha-TNT) and their 

application. Wei Sheng Wu Hsueh Pao 19(4):408-415. 

Yang YX, Li WZ, Yin P, et al. 1986. Biological treatment for mixed TNT-RDX wastewater by 

screened bacteria strains. Wei Sheng Wu Hsueh Pao 26(1):53-59. 

Yinon J. 1983. Forensic applications of LC/MS. J Mass Spectrometry and Ion Physics 48:253-256. 

Yinon J, Hwang DG. 1984. Metabolic studies of explosives: 1-E1 and CI mass spectrometry of 

metabolites of 2,4,6-trinitrotoluene. Biomed Mass Spectrom 11(11):594-600. 

Yinon J, Hwang DG. 1985a. Metabolic studies of explosives: II. High-performance liquid 

chromatography-mass spectrometry of metabolites of 2,4,6-trinitrotoluene. J Chromatogr 339( 1): 127-37. 

*Yinon J, Hwang DG. 1985b. Metabolic studies of explosives: Part 3. Identification of urinary 

metabolites of 2,4,6-trinitrotoluene in rats by liquid chromatography-mass spectrometry. Toxicol Lett 

26:205-209. 
2,4,6-TRINITROTOLUENE 171 

8. REFERENCES 

Yinon J, Hwang DG. 1986a. Detection of TNT and its metabolites in body fluids of laboratory animals 

and in occupationally exposed humans. J Energetic Material 4(l-4):305-3 13. 

*Yinon J, Hwang DG. 1986b. Metabolic studies of explosives: IV. Determination of 

2,4,6-trinitrotoluene and its metabolites in blood of rabbits by high-performance liquid 

chromatography-mass spectrometry. Journal of Chromatography 375(l): 154-158. 

*Yinon J, Hwang DG. 1986c. Metabolic studies of explosives: 5. Detection and analysis of 

2,4,6-trinitrotoluene and its metabolites in urine of munition workers by micro liquid 

chromatography/mass spectrometry. Biomed Chromatogr l(3): 123- 125. 

*Yinon J, Hwang DG. 1987. Applications of liquid chromatography - mass spectrometry in metabolic 

studies of explosives. J Chromatogr 394( 1):253-257. 

*Yinon J, Laschever M. 1982. Direct-injection chemical ionization mass spectrometry of explosives in 

water. Eur J Mass Spectrom Biochem Med Environ Res 2(3-4):101-104. 

Yinon J, Zitrin S. 1977. Processing and interpreting mass spectral data in forensic identification of 

drugs and explosives. J Forensic Sci 22(4):742-777. 

Yu WC, Goff EU, Fine DH. 1983. Determination of nitrate esters, nitramines, nitroaromatics, and their 

metabolites in biological fluids and wastewater by gas and liquid chromatography with a nitro/nitroso 

specific detector. In: Proceedings of the International Symposium on Analytical Detection of 

Explosives, FBI Academy, March 29-31, 1983. Quantico, VA: Federal Bureau of Investigation, 

329-340. 

Zeiger E. 1987. Carcinogenicity of mutagens: Predictive capability of the Salmonella mutagenesis 

assay for rodent carcinogenicity. Cancer Res 47:1287-1296. 

*Zepp RG, Schlotzhquer PF, Simmons MS, et al. 1984. Dynamics of pollutant photoreactions in the 

hydrosphere. Fresebuye Z Anal Chem 319: 119-125. 

*Zhang Y, Seitz WR. 1989. Single fibre absorption measurements for remote detection of 

2,4,6-trinitrotoluene. Anal Chim Acta 221(1):1-9. 

*Zhang Y, Seitz WR, Grant CL, et al. 1989. A clear, amine-containing poly(viny1 chloride) membrane 

for in situ optical detection of 2,4,6-trinitrotoluene (TNT). Anal Chim Acta 217(2):217-227. 

Zitrin S, Yinon J. 1976. Chemical ionization mass spectrometry of explosives. Advances in Mass 

Spectrometry Biochemical Medicine 1:369-381. 

Zitting A, Szumanska G, Nichols J, et al. 1982. Acute toxic effects of trinitrotoluene on rat brain, liver 

and kidney: Role of radical production. Arch Toxicol 51:53-64. 

2,4,6-TRINITROTOLUENE 173 

9. GLOSSARY
 

Acute Exposure -- Exposure to a chemical for a duration of 14 days or less, as specified in the 

Toxicological Profiles. 

Adsorption Coefficient (Koc) -- The ratio of the amount of a chemical adsorbed per unit weight of 

organic carbon in the soil or sediment to the concentration of the chemical in solution at equilibrium. 

Adsorption Ratio (Kd) -- The amount of a chemical adsorbed by a sediment or soil (i.e., the solid 

phase) divided by the amount of chemical in the solution phase, which is in equilibrium with the solid 

phase, at a fixed solid/solution ratio. It is generally expressed in micrograms of chemical sorbed per 

gram of soil or sediment. 

Bioconcentration Factor (BCF) -- The quotient of the concentration of a chemical in aquatic 

organisms at a specific time or during a discrete time period of exposure divided by the concentration 

in the surrounding water at the same time or during the same period. 

Cancer Effect Level (CEL) -- The lowest dose of chemical in a study, or group of studies, that 

produces significant increases in the incidence of cancer (or tumors) between the exposed population 

and its appropriate control. 

Carcinogen -- A chemical capable of inducing cancer. 

Ceiling Value -- A concentration of a substance that should not be exceeded, even instantaneously. 

Chronic Exposure -- Exposure to a chemical for 365 days or more, as specified in the Toxicological 

Profiles. 

Developmental Toxicity -- The occurrence of adverse effects on the developing organism that may 

result from exposure to a chemical prior to conception (either parent), during prenatal development, or 

postnatally to the time of sexual maturation. Adverse developmental effects may be detected at any 

point in the life span of the organism. 

Embryotoxicity and Fetotoxicity -- Any toxic effect on the conceptus as a result of prenatal exposure 

to a chemical; the distinguishing feature between the two terms is the stage of development during 

which the insult occurred. The terms, as used here, include malformations and variations, altered 

growth, and in utero death. 

EPA Health Advisory -- An estimate of acceptable drinking water levels for a chemical substance 

based on health effects information. A health advisory is not a legally enforceable federal standard, 

but serves as technical guidance to assist federal, state, and local officials. 
2,4,6-TRINITROTOLUENE 174 

9. GLOSSARY 

Immediately Dangerous to Life or Health (IDLH) -- The maximum environmental concentration of 

a contaminant from which one could escape within 30 min without any escape-impairing symptoms or 

irreversible health effects. 

Intermediate Exposure -- Exposure to a chemical for a duration of 15-364 days, as specified in the 

Toxicological Profiles. 

Immunologic Toxicity -- The occurrence of adverse effects on the immune system that may result 

from exposure to environmental agents such as chemicals. 

In Vitro -- Isolated from the living organism and artificially maintained, as in a test tube. 

In Vivo -- Occurring within the living organism. 

Lethal Concentration(LO) (LCLO) -- The lowest concentration of a chemical in air which has been 

reported to have caused death in humans or animals. 

Lethal Concentration(50) (LC50) -- A calculated concentration of a chemical in air to which exposure 

for a specific length of time is expected to cause death in 50% of a defined experimental animal 

population. 

Lethal Dose(LO) (LDLO) -- The lowest dose of a chemical introduced by a route other than inhalation 

that is expected to have caused death in humans or animals. 

Lethal Dose(50) (LD50) -- The dose of a chemical which has been calculated to cause death in 50% of a 

defined experimental animal population. 

Lethal Time(50) (LT50) -- A calculated period of time within which a specific concentration of a 

chemical is expected to cause death in 50% of a defined experimental animal population. 

Lowest-Observed-Adverse-Effect Level (LOAEL) -- The lowest dose of chemical in a study, or 

group of studies, that produces statistically or biologically significant increases in frequency or severity 

of adverse effects between the exposed population and its appropriate control. 

Malformations -- Permanent structural changes that may adversely affect survival, development, or 

function. 

Minimal Risk Level -- An estimate of daily human exposure to a dose of a chemical that is likely to 

be without an appreciable risk of adverse noncancerous effects over a specified duration of exposure. 

Mutagen -- A substance that causes mutations. A mutation is a change in the genetic material in a 

body cell. Mutations can lead to birth defects, miscarriages, or cancer. 

Neurotoxicity -- The occurrence of adverse effects on the nervous system following exposure to 

chemical. 
2,4,6-TRINITROTOLUENE 175 

9. GLOSSARY 

No-Observed-Adverse-Effect Level (NOAEL) -- The dose of chemical at which there were no 

statistically or biologically significant increases in frequency or severity of adverse effects seen 

between the exposed population and its appropriate control. Effects may be produced at this dose, but 

they are not considered to be adverse. 

Octanol-Water Partition Coefficient (Kow) -- The equilibrium ratio of the concentrations of a 

chemical in n-octanol and water, in dilute solution. 

Permissible Exposure Limit (PEL) -- An allowable exposure level in workplace air averaged over an 

8-hour shift. 

q1* -- The upper-bound estimate of the low-dose slope of the dose-response curve as determined by 

the multistage procedure. The q1* can be used to calculate an estimate of carcinogenic potency, the 

incremental excess cancer risk per unit of exposure (usually μg/L for water, mg/kg/day for food, and 

μg/m3 for air). 

Reference Dose (RfD) -- An estimate (with uncertainty spanning perhaps an order of magnitude) of 

the daily exposure of the human population to a potential hazard that is likely to be without risk of 

deleterious effects during a lifetime. The RfD is operationally derived from the NOAEL (from animal 

and human studies) by a consistent application of uncertainty factors that reflect various types of data 

used to estimate RfDs and an additional modifying factor, which is based on a professional judgment 

of the entire database on the chemical. The RfDs are not applicable to nonthreshold effects such as 

cancer. 

Reportable Quantity (RQ) -- The quantity of a hazardous substance that is considered reportable 

under CERCLA. Reportable quantities are (1) 1 pound or greater or (2) for selected substances, an 

amount established by regulation either under CERCLA or under Sect. 311 of the Clean Water Act. 

Quantities are measured over a 24-hour period. 

Reproductive Toxicity -- The occurrence of adverse effects on the reproductive system that may 

result from exposure to a chemical. The toxicity may be directed to the reproductive organs and/or the 

related endocrine system. The manifestation of such toxicity may be noted as alterations in sexual 

behavior, fertility, pregnancy outcomes, or modifications in other functions that are dependent on the 

integrity of this system. 

Short-Term Exposure Limit (STEL) -- The maximum concentration to which workers can be 

exposed for up to 15 min continually. No more than four excursions are allowed per day, and there 

must be at least 60 min between exposure periods. The daily TLV-TWA may not be exceeded. 

Target Organ Toxicity -- This term covers a broad range of adverse effects on target organs or 

physiological systems (e.g., renal, cardiovascular) extending from those arising through a single limited 

exposure to those assumed over a lifetime of exposure to a chemical. 

Teratogen -- A chemical that causes structural defects that affect the development of an organism. 
2,4,6-TRINITROTOLUENE 176 

9. GLOSSARY 

Threshold Limit Value (TLV) -- A concentration of a substance to which most workers can be 

exposed without adverse effect. The TLV may be expressed as a TWA, as a STEL, or as a CL. 

Time-Weighted Average (TWA) -- An allowable exposure concentration averaged over a normal 8­

hour workday or 40-hour workweek. 

Toxic Dose (TD50) -- A calculated dose of a chemical, introduced by a route other than inhalation, 

which is expected to cause a specific toxic effect in 50% of a defined experimental animal population. 

Uncertainty Factor (UF) -- A factor used in operationally deriving the RfD from experimental data. 

UFs are intended to account for (1) the variation in sensitivity among the members of the human 

population, (2) the uncertainty in extrapolating animal data to the case of human, (3) the uncertainty in 

extrapolating from data obtained in a study that is of less than lifetime exposure, and (4) the 

uncertainty in using LOAEL data rather than NOAEL data. Usually each of these factors is set equal 

to 10. 
2,4,6-TRINITROTOLUENE A-l 

APPENDIX A 

USER’S GUIDE 

Chapter 1 

Public Health Statement 

This chapter of the profile is a health effects summary written in non-technical language. Its intended 

audience is the general public especially people living in the vicinity of a hazardous waste site or 

chemical release. If the Public Health Statement were removed from the rest of the document, it 

would still communicate to the lay public essential information about the chemical. 

The major headings in the Public Health Statement are useful to find specific topics of concern. The 

topics are written in a question and answer format. The answer to each question includes a sentence 

that will direct the reader to chapters in the profile that will provide more information on the given 

topic. 

Chapter 2 

Tables and Figures for Levels of Significant Exposure (LSE) 

Tables (2-1, 2-2, and 2-3) and figures (2-l and 2-2) are used to summarize health effects and illustrate 

graphically levels of exposure associated with those effects. These levels cover health effects observed 

at increasing dose concentrations and durations, differences in response by species, minimal risk levels 

(MRLs) to humans for noncancer endpoints, and EPA’s estimated range associated with an 

upper-bound individual lifetime cancer risk of 1 in 10,000 to 1 in 10,000,000. Use the LSE tables and 

figures for a quick review of the health effects and to locate data for a specific exposure scenario. The 

LSE tables and figures should always be used in conjunction with the text. All entries in these tables 

and figures represent studies that provide reliable, quantitative estimates of No-Observed-AdverseEffect Levels (NOAELs), Lowest-Observed-Adverse-Effect Levels (LOAELs), or Cancer Effect Levels 

(CELs). 

The legends presented below demonstrate the application of these tables and figures. Representative 

examples of LSE Table 2-l and Figure 2-l are shown. The numbers in the left column of the legends 

correspond to the numbers in the example table and figure. 

LEGEND 

See LSE Table 2-l 

(1) Route of Exposure One of the first considerations when reviewing the toxicity of a substance 

using these tables and figures should be the relevant and appropriate route of exposure. When 

sufficient data exists, three LSE tables and two LSE figures are presented in the document. The 

three LSE tables present data on the three principal routes of exposure, i.e., inhalation, oral, and 

dermal (LSE Table 2-1, 2-2, and 2-3, respectively). LSE figures are limited to the inhalation 

(LSE Figure 2-l) and oral (LSE Figure 2-2) routes. Not all substances will have data on each 

route of exposure and will not therefore have all five of the tables and figures. 
2,4,6-TRINITROTOLUENE A-2 

APPENDIX A 

(2)	 Exposure Period Three exposure periods - acute (less than 15 days), intermediate (15-364 days), 

and chronic (365 days or more) are presented within each relevant route of exposure. In this 

example, an inhalation study of intermediate exposure duration is reported. For quick reference 

to health effects occurring from a known length of exposure, locate the applicable exposure 

period within the LSE table and figure. 

(3)	 Health Effect The major categories of health effects included in LSE tables and figures are 

death, systemic, immunological, neurological, developmental, reproductive, and cancer. 

NOAELs and LOAELs can be reported in the tables and figures for all effects but cancer. 

Systemic effects are further defined in the “System” column of the LSE table (see key number 

18). 

(4)	 Key to Figure Each key number in the LSE table links study information to one or more data 

points using the same key number in the corresponding LSE figure. In this example, the study 

represented by key number 18 has been used to derive a NOAEL and a Less Serious LOAEL 

(also see the 2 “18r” data points in Figure 2-l). 

(5)	 Species The test species, whether animal or human, are identified in this column. Section 2.4, 

“Relevance to Public Health,” covers the relevance of animal data to human toxicity and Section 

2.3, “Toxicokinetics,” contains any available information on comparative toxicokinetics. 

Although NOAELs and LOAELs are species specific, the levels are extrapolated to equivalent 

human doses to derive an MRL. 

(6)	 Exposure Frequency/Duration The duration of the study and the weekly and daily exposure 

regimen are provided in this column. This permits comparison of NOAELs and LOAELs from 

different studies. In this case (key number lS), rats were exposed to toxaphene via inhalation for 

6 hours per day, 5 days per week, for 3 weeks. For a more complete review of the dosing 

regimen refer to the appropriate sections of the text or the original reference paper, i.e., Nits&e 

et al. 1981. 

(7)	 System This column further defines the systemic effects. These systems include: respiratory, 

cardiovascular, gastrointestinal, hematological, musculoskeletal, hepatic, renal, and dermal/ocular. 

“Other” refers to any systemic effect (e.g., a decrease in body weight) not covered in these 

systems. In the example of key number 18, 1 systemic effect (respiratory) was investigated. 

(8)	 NOAEL A No-Observed-Adverse-Effect Level (NOAEL) is the highest exposure level at which 

no harmful effects were seen in the organ system studied. Key number 18 reports a NOAEL of 

3 ppm for the respiratory system which was used to derive an intermediate exposure, inhalation 

MRL of 0.005 ppm (see footnote “b”). 

(9)	 LOAEL A Lowest-Observed-Adverse-Effect Level (LOAEL) is the lowest dose used in the 

study that caused a harmful health effect. LOAELs have been classified into “Less Serious” and 

“Serious” effects. These distinctions help readers identify the levels of exposure at which 

adverse health effects first appear and the gradation of effects with increasing dose. A brief 

description of the specific endpoint used to quantify the adverse effect accompanies the LOAEL. 

The respiratory effect reported in key number 18 (hyperplasia) is a Less serious LOAEL of 10 

ppm. MRLs are not derived from Serious LOAELs. 

(10) Reference The complete reference citation is given in chapter 8 of the profile. 
A-3 

APPENDIX A 

(11) CEL A Cancer Effect Level (CEL) is the lowest exposure level associated with the onset of 

carcinogenesis in experimental or epidemiologic studies. CELs are always considered serious 

effects. The LSE tables and figures do not contain NOAELs for cancer, but the text may report 

doses not causing measurable cancer increases. 

(12) Footnotes Explanations of abbreviations or reference notes for data in the LSE tables are found 

in the footnotes. Footnote “b” indicates the NOAEL of 3 ppm in key number 18 was used to 

derive an MRL of 0.005 ppm. 

LEGEND 

See Figure 2-1 

LSE figures graphically illustrate the data presented in the corresponding LSE tables. Figures help the 

reader quickly compare health effects according to exposure concentrations for particular exposure 

periods. 

(13)	 Exposure Period The same exposure periods appear as in the LSE table. In this example, health 

effects observed within the intermediate and chronic exposure periods are illustrated. 

(14)	 Health Effect These are the categories of health effects for which reliable quantitative data 

exists. The same health effects appear in the LSE table. 

(15)	 Levels of Exposure concentrations or doses for each health effect in the LSE tables are 

graphically displayed in the LSE figures. Exposure concentration or dose is measured on the log 

scale “y” axis. Inhalation exposure is reported in mg/m3

 or ppm and oral exposure is reported in 

mg/kg/day . 

(16)	 NOAEL In this example, 18r NOAEL is the critical endpoint for which an intermediate 

inhalation exposure MRL is based. As you can see from the LSE figure key, the open-circle 

symbol indicates to a NOAEL for the test species-rat. The key number 18 corresponds to the 

entry in the LSE table. The dashed descending arrow indicates the extrapolation from the 

exposure level of 3 ppm (see entry 18 in the Table) to the MRL of 0.005 ppm (see footnote “b” 

in the LSE table). 

(17)	 CEL Key number 38r is 1 of 3 studies for which Cancer Effect Levels were derived. The 

diamond symbol refers to a Cancer Effect Level for the test species-mouse. The number 38 

corresponds to the entry in the LSE table. 

(18)	 Estimated Upper-Bound Human Cancer Risk Levels This is the range associated with the 

upper-bound for lifetime cancer risk of 1 in 10,000 to 1 in 10,000,000. These risk levels are 

derived from the EPA’s Human Health Assessment Group’s upper-bound estimates of the slope 

of the cancer dose response curve at low dose levels (q1*). 

(19)	 Key to LSE Figure The Key explains the abbreviations and symbols used in. the figure. 


A-6 

APPENDIX A 

Chapter 2 (Section 2.4) 

Relevance to Public Health 

The Relevance to Public Health section provides a health effects summary based on evaluations of 

existing toxicologic, epidemiologic, and toxicokinetic information. This summary is designed to 

present interpretive, weight-of-evidence discussions for human health endpoints by addressing the 

following questions. 

1. What effects are known to occur in humans? 

2. What effects observed in animals are likely to be of concern to humans? 

3. What exposure conditions are likely to be of concern to humans, especially around hazardous

 waste sites? 

The section covers endpoints in the same order they appear within the Discussion of Health Effects by 

Route of Exposure section, by route (inhalation, oral, dermal) and within route by effect. Human data 

are presented first, then animal data. Both are organized by duration (acute, intermediate, chronic). In 

vitro data and data from parenteral routes (intramuscular, intravenous, subcutaneous, etc.) are also 

considered in this section. If data are located in the scientific literature, a table of genotoxicity 

information is included. 

The carcinogenic potential of the profiled substance is qualitatively evaluated, when appropriate, using 

existing toxicokinetic, genotoxic, and carcinogenic data. ATSDR does not currently assess cancer 

potency or perform cancer risk assessments. Minimal risk levels (MRLs) for noncancer endpoints (if 

derived) and the endpoints from which they were derived are indicated and discussed. 

Limitations to existing scientific literature that prevent a satisfactory evaluation of the relevance to 

public health are identified in the Data Needs section. 

Interpretation of Minimal Risk Levels 

Where sufficient toxicologic information is available, we have derived minimal risk levels (MRLs) for 

inhalation and oral routes of entry at each duration of exposure (acute, intermediate, and chronic). 

These MRLs are not meant to support regulatory action; but to acquaint health professionals with 

exposure levels at which adverse health effects are not expected to occur in humans. They should 

help physicians and public health officials determine the safety of a community living near a chemical 

emission, given the concentration of a contaminant in air or the estimated daily dose in water. MRLs 

are based largely on toxicological studies in animals and on reports of human occupational exposure. 

MRL users should be familiar with the toxicologic information on which the number is based. 

Chapter 2.4, “Relevance to Public Health,” contains basic information known about the substance. 

Other sections such as 2.6, “Interactions with Other Substances,” and 2.7, “Populations that are 

Unusually Susceptible” provide important supplemental information. 

MRL users should also understand the MRL derivation methodology. MRLs are derived using a 

modified version of the risk assessment methodology the Environmental Protection Agency (EPA) 

provides (Barnes and Dourson 1988) to determine reference doses for lifetime exposure (RfDs). 
2,4,6-TRINITROTOLUENE A-7 

APPENDIX A 

To derive an MRL, ATSDR generally selects the most sensitive endpoint which, in its best judgement, 

represents the most sensitive human health effect for a given exposure route and duration. ATSDR 

cannot make this judgement or derive an MRL unless information (quantitative or qualitative) is 

available for all potential systemic, neurological, and developmental effects. If this information and 

r&at& quantitative data on the chosen endpoint are available, ATSDR derives an MRL using the 

most sensitive species (when information from multiple species is available) with the highest NOAEL 

that does not exceed any adverse effect levels. When a NOAEL is not available, a 

lowest-observed-adverse-effect level (LOAEL) can be used to derive an MRL, and an uncertainty 

factor (UF) of 10 must be employed. Additional uncertainty factors of 10 must be used both for 

human variability to protect sensitive subpopulations (people who are most susceptible to the health 

effects caused by the substance) and for interspecies variability (extrapolation from animals to 

humans). In deriving an MRL, these individual uncertainty factors are multiplied together. The 

product is then divided into the inhalation concentration or oral dosage selected from the study. 

Uncertainty factors used in developing a substance-specific MRL are provided in the footnotes of the 

LSE Tables.